BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ;  ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407-477. [PMID: 31504439 DOI: 10.1093/eurheartj/ehz425] [Cited by in Crossref: 1201] [Cited by in F6Publishing: 1760] [Article Influence: 1201.0] [Reference Citation Analysis]
Number Citing Articles
1 Yoon Y, Park G, Roh J, Her S, Lim S, Kang TS, Lee SJ, Bae J, Choi W, Yang Y, Kim J, Choi YJ, Choi SW, Lee J, Chang X. Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent. Cardiology Research and Practice 2022;2022:1-9. [DOI: 10.1155/2022/2914385] [Reference Citation Analysis]
2 Benz DC, Nagao M, Gräni C. Digital positron emission tomography - Making cardiac risk stratification fit for the future. Int J Cardiol 2022:S0167-5273(22)01407-3. [PMID: 36179906 DOI: 10.1016/j.ijcard.2022.09.057] [Reference Citation Analysis]
3 Eurlings CGMJ, Bektas S, Sanders-van Wijk S, Tsirkin A, Vasilchenko V, Meex SJR, Failer M, Oehri C, Ruff P, Zellweger MJ, Brunner-La Rocca HP. Use of artificial intelligence to assess the risk of coronary artery disease without additional (non-invasive) testing: validation in a low-risk to intermediate-risk outpatient clinic cohort. BMJ Open 2022;12:e055170. [PMID: 36167368 DOI: 10.1136/bmjopen-2021-055170] [Reference Citation Analysis]
4 Outi K, Anne O, Heikki M, Hannu V, Helvi K, Juha H. A concise and informative title: Perceived health among percutaneous coronary intervention patients over a six‐year follow‐up period. Journal of Clinical Nursing. [DOI: 10.1111/jocn.16545] [Reference Citation Analysis]
5 Gaba P, Gersh BJ, Muller J, Narula J, Stone GW. Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research. Nat Rev Cardiol 2022. [PMID: 36151312 DOI: 10.1038/s41569-022-00769-8] [Reference Citation Analysis]
6 Ten Berg J, Rocca B, Angiolillo DJ, Hayashida K. The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties. Eur Heart J 2022:ehac385. [PMID: 36130256 DOI: 10.1093/eurheartj/ehac385] [Reference Citation Analysis]
7 Herling de Oliveira LL, Correia VM, Nicz PFG, Soares PR, Scudeler TL. MINOCA: One Size Fits All? Probably Not—A Review of Etiology, Investigation, and Treatment. JCM 2022;11:5497. [DOI: 10.3390/jcm11195497] [Reference Citation Analysis]
8 Al-Abdouh A, Mhanna M, Jabri A, Abusnina W, As-Sayaideh M, Upadhrasta S, Paul TK. Meta-Analysis of Coronary Computed Tomography Versus Invasive Coronary Angiography in Stable Chest Pain. Am J Cardiol 2022:S0002-9149(22)00855-4. [PMID: 36127181 DOI: 10.1016/j.amjcard.2022.08.014] [Reference Citation Analysis]
9 Sechtem U, Seitz A, Ong P, Bekeredjian R. Management des chronischen Koronarsyndroms. Herz. [DOI: 10.1007/s00059-022-05137-3] [Reference Citation Analysis]
10 Estrada A, Sousa AS, Mesquita CT, Villacorta H. Tortuosidade das Artérias Coronárias como um Novo Fenótipo para Isquemia sem Doença Arterial Coronariana. Arquivos Brasileiros de Cardiologia 2022. [DOI: 10.36660/abc.20210787] [Reference Citation Analysis]
11 Merinopoulos I, Gunawardena T, Corballis N, Bhalraam U, Gilbert T, Maart C, Richardson P, Ryding A, Sarev T, Sawh C, Sulfi S, Wickramarachchi U, Wistow T, Mohamed MO, Mamas MA, Vassiliou VS, Eccleshall SC. Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice. Clin Res Cardiol. [DOI: 10.1007/s00392-022-02106-y] [Reference Citation Analysis]
12 Lim S, Cha J, Hong SJ, Kim JH, Joo HJ, Park JH, Yu CW, Ahn TH, Lim D. Association between High Lipid Burden of Target Lesion and Slow TIMI Flow in Coronary Interventions. JCM 2022;11:5401. [DOI: 10.3390/jcm11185401] [Reference Citation Analysis]
13 Ko C, Lin S, Huang C, Chang Y, Ko K, Cheng M, Wang S, Chen C, Wu Y. Polar map-free 3D deep learning algorithm to predict obstructive coronary artery disease with myocardial perfusion CZT-SPECT. Eur J Nucl Med Mol Imaging. [DOI: 10.1007/s00259-022-05953-z] [Reference Citation Analysis]
14 Wester M, Koll F, Luedde M, Langer C, Resch M, Luchner A, Müller K, Zeman F, Koller M, Maier LS, Sossalla S. Effects of percutaneous coronary intervention on dyspnea in stable coronary artery disease. Clin Res Cardiol 2022. [PMID: 36100700 DOI: 10.1007/s00392-022-02107-x] [Reference Citation Analysis]
15 Doenst T, Sousa-Uva M. How to deal with nonsevere stenoses in coronary artery bypass grafting - a critical perspective on competitive flow and surgical precision. Curr Opin Cardiol 2022. [PMID: 36094465 DOI: 10.1097/HCO.0000000000000993] [Reference Citation Analysis]
16 Yan W, Eikelboom R, Muller Moran HR, Arora RC. It's not all about ISCHEMIA: the case for coronary artery bypass grafting in stable coronary artery disease. Curr Opin Cardiol 2022. [PMID: 36094460 DOI: 10.1097/HCO.0000000000000994] [Reference Citation Analysis]
17 Johri AM, Singh KV, Mantella LE, Saba L, Sharma A, Laird JR, Utkarsh K, Singh IM, Gupta S, Kalra MS, Suri JS. Deep learning artificial intelligence framework for multiclass coronary artery disease prediction using combination of conventional risk factors, carotid ultrasound, and intraplaque neovascularization. Comput Biol Med 2022;150:106018. [PMID: 36174330 DOI: 10.1016/j.compbiomed.2022.106018] [Reference Citation Analysis]
18 Freene N, McManus M, Mair T, Tan R, Davey R. Association of device-measured physical activity and sedentary behaviour with cardiovascular risk factors, health-related quality-of-life and exercise capacity over 12-months in cardiac rehabilitation attendees with coronary heart disease. BMC Sports Sci Med Rehabil 2022;14:169. [PMID: 36071477 DOI: 10.1186/s13102-022-00562-7] [Reference Citation Analysis]
19 Gelbenegger G, Jilma B. Clinical pharmacology of antiplatelet drugs. Expert Rev Clin Pharmacol 2022. [PMID: 36065676 DOI: 10.1080/17512433.2022.2121702] [Reference Citation Analysis]
20 Dillinger JG, Pezel T, Fauvel C, Delmas C, Schurtz G, Trimaille A, Gerbaud E, Roule V, Dib JC, Boccara A, Millischer D, Thuaire C, Fabre J, Levasseur T, Boukertouta T, Darmon A, Azencot R, Merat B, Haugel-Moreau M, Grentzinger A, Charbonnel C, Zakine C, Bedossa M, Lattuca B, Roubille F, Aboyans V, Puymirat E, Cohen A, Vicaut E, Henry P; ADDICT-ICCU investigators. Prevalence of psychoactive drug use in patients hospitalized for acute cardiac events: Rationale and design of the ADDICT-ICCU trial, from the Emergency and Acute Cardiovascular Care Working Group and the National College of Cardiologists in Training of the French Society of Cardiology. Arch Cardiovasc Dis 2022:S1875-2136(22)00155-3. [PMID: 36154799 DOI: 10.1016/j.acvd.2022.05.012] [Reference Citation Analysis]
21 Liu SL, Feng BY, Song QR, Zhang YM, Wu SL, Cai J. Neutrophil to high-density lipoprotein cholesterol ratio predicts adverse cardiovascular outcomes in subjects with pre-diabetes: a large cohort study from China. Lipids Health Dis 2022;21:86. [PMID: 36057713 DOI: 10.1186/s12944-022-01695-x] [Reference Citation Analysis]
22 Mortensen MB, Sand NP, Busk M, Jensen JM, Grove EL, Dey D, Iraqi N, Updegrove A, Fonte T, Mathiassen ON, Hosbond S, Bøtker HE, Leipsic J, Narula J, Nørgaard BL. Influence of intensive lipid-lowering on CT derived fractional flow reserve in patients with stable chest pain: Rationale and design of the FLOWPROMOTE study. Clin Cardiol 2022. [PMID: 36056636 DOI: 10.1002/clc.23895] [Reference Citation Analysis]
23 Pinto E, Penha D, Hochhegger B, Monaghan C, Marchiori E, Taborda-barata L, Irion K. Variability of pulmonary nodule volumetry on coronary CT angiograms. Medicine 2022;101:e30332. [DOI: 10.1097/md.0000000000030332] [Reference Citation Analysis]
24 Matsumoto H, Masaki R, Higuchi S, Tanaka H, Kondo S, Tsujita H, Shinke T. Impact of overestimation of fractional flow reserve by adenosine on anatomical-functional mismatch. Sci Rep 2022;12:14962. [PMID: 36056128 DOI: 10.1038/s41598-022-19330-1] [Reference Citation Analysis]
25 Battistoni A, Volpe M. Flu Vaccination as a Key Prevention Recommendation for Patients at High Cardiovascular Risk: The Next Season's Scenario. High Blood Press Cardiovasc Prev 2022. [PMID: 36053448 DOI: 10.1007/s40292-022-00540-7] [Reference Citation Analysis]
26 Greco A, Sciahbasi A, Abizaid A, Mehran R, Rigattieri S, de la Torre Hernandez JM, Alfonso F, Cortese B. Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial. Catheter Cardiovasc Interv 2022. [PMID: 36054266 DOI: 10.1002/ccd.30358] [Reference Citation Analysis]
27 Luo J, Huang T, Xu R, Wang X, Yang Y, Li L, Zhang X, Zhang Y, Yang R, Wang J, Yang H, Ma Y, Yang B, Wang T, Jiao L. Impact of conventional lipid-lowering therapy on circulating levels of PCSK9: protocol for a systematic review and meta-analysis of randomised controlled trials. BMJ Open 2022;12:e061884. [DOI: 10.1136/bmjopen-2022-061884] [Reference Citation Analysis]
28 Mochula AV, Kopeva KV, Maltseva AN, Grakova EV, Gulya M, Smorgon AV, Gusakova A, Zavadovsky KV. The myocardial flow reserve in patients with heart failure with preserved ejection fraction. Heart Vessels 2022. [PMID: 36045268 DOI: 10.1007/s00380-022-02161-5] [Reference Citation Analysis]
29 . Tranexamic Acid in Patients Undergoing Noncardiac Surgery. N Engl J Med 2022;387:858-9. [DOI: 10.1056/nejmc2208614] [Reference Citation Analysis]
30 Yamanaka F, Shishido K, Yokota S, Moriyama N, Ochiai T, Yamada T, Hayashi T, Miyashita H, Yokoyama H, Yamanaga K, Tabata N, Yamaguchi M, Yamagishi T, Matsumoto T, Tobita K, Mizuno S, Tanaka Y, Murakami M, Takahashi S, Saito S, Tsujita K. Discordance between fractional flow reserve and instantaneous wave-free ratio in patients with severe aortic stenosis: A retrospective cohort study. Journal of Cardiology 2022. [DOI: 10.1016/j.jjcc.2022.08.005] [Reference Citation Analysis]
31 Hansen B, Holtzman JN, Juszczynski C, Khan N, Kaur G, Varma B, Gulati M. Ischemia with No Obstructive Arteries (INOCA): A review of the prevalence, diagnosis and management. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101420] [Reference Citation Analysis]
32 Shen X, Lv K, Hou B, Ao Q, Zhao J, Yang G, Cheng Q. Impact of Diabetes on the Recurrence and Prognosis of Acute Kidney Injury in Older Male Patients: A 10-Year Retrospective Cohort Study. Diabetes Ther 2022. [PMID: 36044176 DOI: 10.1007/s13300-022-01309-w] [Reference Citation Analysis]
33 Sager R, Keller LS, Stehli J, Jakob P, Michel J, Kasel M, Templin C, Stähli BE. Association of N-terminal pro-B-type natriuretic peptide with mortality in elderly (≥80 years) patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2022. [PMID: 36040724 DOI: 10.1002/ccd.30365] [Reference Citation Analysis]
34 Citro R, Bursi F, Bellino M, Picano E. The Role of Stress Echocardiography in Valvular Heart Disease. Curr Cardiol Rep 2022. [PMID: 36040552 DOI: 10.1007/s11886-022-01765-7] [Reference Citation Analysis]
35 Shiina T, Goto-Hirano K, Takura T, Daida H. Cost-effectiveness of follow-up invasive coronary angiography after percutaneous coronary stenting: a real-world observational cohort study in Japan. BMJ Open 2022;12:e061617. [PMID: 36041769 DOI: 10.1136/bmjopen-2022-061617] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Møller MB, Schuijf JD, Oyama-Manabe N, Linde JJ, Kühl JT, Lima JAC, Kofoed KF. Technical Considerations for Dynamic Myocardial Computed Tomography Perfusion as Part of a Comprehensive Evaluation of Coronary Artery Disease Using Computed Tomography. J Thorac Imaging 2022. [PMID: 36044617 DOI: 10.1097/RTI.0000000000000673] [Reference Citation Analysis]
37 Anderson HVS, Masri SC, Abdallah MS, Chang AM, Cohen MG, Elgendy IY, Gulati M, LaPoint K, Madan N, Moussa ID, Ramirez J, Simon AW, Singh V, Waldo SW, Williams MS; Writing Committee Members. 2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Data Standards. J Am Coll Cardiol 2022:S0735-1097(22)05033-1. [PMID: 36055903 DOI: 10.1016/j.jacc.2022.05.012] [Reference Citation Analysis]
38 Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, De Hert S, de Laval I, Geisler T, Hinterbuchner L, Ibanez B, Lenarczyk R, Mansmann UR, McGreavy P, Mueller C, Muneretto C, Niessner A, Potpara TS, Ristić A, Sade LE, Schirmer H, Schüpke S, Sillesen H, Skulstad H, Torracca L, Tutarel O, Van Der Meer P, Wojakowski W, Zacharowski K, Knuuti J, Kristensen SD, Aboyans V, Ahrens I, Antoniou S, Asteggiano R, Atar D, Baumbach A, Baumgartner H, Böhm M, Borger MA, Bueno H, Čelutkienė J, Chieffo A, Cikes M, Darius H, Delgado V, Devereaux PJ, Duncker D, Falk V, Fauchier L, Habib G, Hasdai D, Huber K, Iung B, Jaarsma T, Konradi A, Koskinas KC, Kotecha D, Landmesser U, Lewis BS, Linhart A, Løchen ML, Maeng M, Manzo-Silberman S, Mindham R, Neubeck L, Nielsen JC, Petersen SE, Prescott E, Rakisheva A, Saraste A, Sibbing D, Siller-Matula J, Sitges M, Stankovic I, Storey RF, Ten Berg J, Thielmann M, Touyz RM; ESC Scientific Document Group. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J 2022:ehac270. [PMID: 36017553 DOI: 10.1093/eurheartj/ehac270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH; ESC Scientific Document Group . 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 2022:ehac244. [PMID: 36017568 DOI: 10.1093/eurheartj/ehac244] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Yu H, Li L, Deng Y, Zhang G, Jiang M, Huang H, Li C, Lv Z, Zhou Y, Liu X. The relationship between the number of stenotic coronary arteries and the gut microbiome in coronary heart disease patients. Front Cell Infect Microbiol 2022;12:903828. [DOI: 10.3389/fcimb.2022.903828] [Reference Citation Analysis]
41 Wei W, Liang Y, Guo D, Xu X, Xu Q, Li S, Li Y, Liu J, Liu Y, Tu M, Chen K, Chen H, Chen S. Hyperglycemia Newly Detected by Glycated Hemoglobin Affects All-cause Mortality in Coronary Artery Disease Patients: A Retrospective Cohort Study. Diabetes Res Clin Pract 2022;:110053. [PMID: 36038089 DOI: 10.1016/j.diabres.2022.110053] [Reference Citation Analysis]
42 Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH; ESC Scientific Document Group . 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J Cardiovasc Imaging 2022:jeac106. [PMID: 36017575 DOI: 10.1093/ehjci/jeac106] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Zhao M, Liu C, Feng Y, Chen H. Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study. Front Pharmacol 2022;13:946415. [DOI: 10.3389/fphar.2022.946415] [Reference Citation Analysis]
44 John JE, Claggett B, Skali H, Solomon SD, Cunningham JW, Matsushita K, Konety SH, Kitzman DW, Mosley TH, Clark D 3rd, Chang PP, Shah AM. Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study. J Am Heart Assoc 2022;:e021660. [PMID: 36000416 DOI: 10.1161/JAHA.121.021660] [Reference Citation Analysis]
45 Vitola B, Trusinskis K, Mintale I, Kalnina M, Erglis A. Coronary Artery Disease in Women: Lessons Learned from Single-Center SPECT Registry and Future Directions for INOCA Patients. Medicina 2022;58:1139. [DOI: 10.3390/medicina58091139] [Reference Citation Analysis]
46 Andreini D, Collet C, Leipsic J, Nieman K, Bittencurt M, De Mey J, Buls N, Onuma Y, Mushtaq S, Conte E, Bartorelli AL, Stefanini G, Sonck J, Knaapen P, Ghoshhajra B, Serruys P. Pre-procedural planning of coronary revascularization by cardiac computed tomography. J Cardiovasc Comput Tomogr 2022:S1934-5925(22)00274-X. [PMID: 36008263 DOI: 10.1016/j.jcct.2022.08.003] [Reference Citation Analysis]
47 Camm AJ, Sabbour H, Schnell O, Summaria F, Verma A. Managing thrombotic risk in patients with diabetes. Cardiovasc Diabetol 2022;21:160. [PMID: 35996159 DOI: 10.1186/s12933-022-01581-x] [Reference Citation Analysis]
48 Bárdyová Z, Horváthová M, Gomola I, Neuschl V, Šimková J. PRECAUTION IN THE USE OF EFFECTIVE DOSE IN CORONARY CT ANGIOGRAPHY. Radiat Prot Dosimetry 2022;198:547-53. [PMID: 36005971 DOI: 10.1093/rpd/ncac097] [Reference Citation Analysis]
49 Seiler T, Attinger-Toller A, Cioffi GM, Madanchi M, Teufer M, Wolfrum M, Moccetti F, Toggweiler S, Kobza R, Bossard M, Cuculi F. Treatment of in-stent restenosis using a dedicated super high-pressure balloon. Cardiovasc Revasc Med 2022:S1553-8389(22)00719-9. [PMID: 36085285 DOI: 10.1016/j.carrev.2022.08.018] [Reference Citation Analysis]
50 Mikail N, Rossi A, Bengs S, Haider A, Stähli BE, Portmann A, Imperiale A, Treyer V, Meisel A, Pazhenkottil AP, Messerli M, Regitz-Zagrosek V, Kaufmann PA, Buechel RR, Gebhard C. Imaging of heart disease in women: review and case presentation. Eur J Nucl Med Mol Imaging 2022. [PMID: 35974185 DOI: 10.1007/s00259-022-05914-6] [Reference Citation Analysis]
51 Fordyce CB, Hill CL, Foldyna B, Douglas PS; PROMISE Investigators. Eligibility for Noninvasive Testing Based on the 2021 American Heart Association/American College of Cardiology Guideline for the Evaluation and Diagnosis of Stable Chest Pain: Implications From the PROMISE Trial. Circulation 2022;146:582-4. [PMID: 35969650 DOI: 10.1161/CIRCULATIONAHA.122.059024] [Reference Citation Analysis]
52 Hosseinkhani S, Emamgholipour S, Salari P, Khalagi K, Shirani S, Najjar N, Larijani B, Pasalar P, Razi F. Evaluating the association between amino acid and acylcarnitine profiles and different levels of coronary artery disease risk in postmenopausal women using targeted metabolomics technique. Menopause 2022. [PMID: 35969879 DOI: 10.1097/GME.0000000000002016] [Reference Citation Analysis]
53 Hamilton MCK, Charters PFP, Lyen S, Harries IB, Armstrong L, Richards GHC, Strange JW, Johnson T, Manghat NE. Computed tomography-derived fractional flow reserve (FFRCT) has no additional clinical impact over the anatomical Coronary Artery Disease - Reporting and Data System (CAD-RADS) in real-world elective healthcare of coronary artery disease. Clin Radiol 2022:S0009-9260(22)00330-0. [PMID: 35985847 DOI: 10.1016/j.crad.2022.05.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Wang K, Ding Y, Wang R, Yang J, Liu X, Han H, Shen H, Sun Y, Zhou Y, Ge H. Remnant Cholesterol and the Risk of Coronary Artery Disease in Patients With Type 2 Diabetes. Angiology. [DOI: 10.1177/00033197221121008] [Reference Citation Analysis]
55 Dobrolinska MM, van Praagh GD, Oostveen LJ, Poelhekken K, Greuter MJW, Fleischmann D, Willemink MJ, de Lange F, Slart RHJA, Leiner T, van der Werf NR. Systematic assessment of coronary calcium detectability and quantification on four generations of CT reconstruction techniques: a patient and phantom study. Int J Cardiovasc Imaging. [DOI: 10.1007/s10554-022-02703-y] [Reference Citation Analysis]
56 Neumann FJ. Diabetes, heart failure, and myocardial revascularization: Is there a new message from the ISCHEMIA trial? Herz 2022. [PMID: 35962199 DOI: 10.1007/s00059-022-05132-8] [Reference Citation Analysis]
57 Sabbag A, Essayagh B, Barrera JDR, Basso C, Berni A, Cosyns B, Deharo JC, Deneke T, Di Biase L, Enriquez-Sarano M, Donal E, Imai K, Lim HS, Marsan NA, Turagam MK, Peichl P, Po SS, Haugaa KH, Shah D, de Riva Silva M, Bertrand P, Saba M, Dweck M, Townsend SN, Ngarmukos T, Fenelon G, Santangeli P, Sade LE, Corrado D, Lambiase P, Sanders P, Delacrétaz E, Jahangir A, Kaufman ES, Saggu DK, Pierard L, Delgado V, Lancellotti P. EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. Europace 2022:euac125. [PMID: 35951656 DOI: 10.1093/europace/euac125] [Reference Citation Analysis]
58 Medilek K, Zaloudkova L, Borg A, Brozova L, Stasek J. Myocardial injury in stress echocardiography: Comparison of dobutamine, dipyridamole and dynamic stressors-single center study. Echocardiography 2022. [PMID: 35950564 DOI: 10.1111/echo.15411] [Reference Citation Analysis]
59 Feng C, Abdu FA, Mohammed A, Zhang W, Liu L, Yin G, Feng Y, Mohammed AA, Mareai RM, Lv X, Shi T, Xu Y, Yu X, Che W. Prognostic impact of coronary microvascular dysfunction assessed by caIMR in overweight with chronic coronary syndrome patients. Front Endocrinol 2022;13:922264. [DOI: 10.3389/fendo.2022.922264] [Reference Citation Analysis]
60 Akrivou D, Perlepe G, Kirgou P, Gourgoulianis KI, Malli F. Pathophysiological Aspects of Aging in Venous Thromboembolism: An Update. Medicina 2022;58:1078. [DOI: 10.3390/medicina58081078] [Reference Citation Analysis]
61 Fallo F, Di Dalmazi G, Beuschlein F, Biermasz NR, Castinetti F, Elenkova A, Fassnacht M, Isidori AM, Kastelan D, Korbonits M, Newell-Price J, Parati G, Petersenn S, Pivonello R, Ragnarsson O, Tabarin A, Theodoropoulou M, Tsagarakis S, Valassi E, Witek P, Reincke M. Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens 2022. [PMID: 35950979 DOI: 10.1097/HJH.0000000000003252] [Reference Citation Analysis]
62 Sucato V, Madaudo C, Galassi AR. Classification, Diagnosis, and Treatment of Coronary Microvascular Dysfunction. J Clin Med 2022;11:4610. [PMID: 35956225 DOI: 10.3390/jcm11154610] [Reference Citation Analysis]
63 Andre F, Fortner P, Emami M, Seitz S, Brado M, Gückel F, Sokiranski R, Sommer A, Frey N, Görich J, Buss SJ. Factors influencing the safety of outpatient coronary CT angiography: a clinical registry study. BMJ Open 2022;12:e058304. [PMID: 35940836 DOI: 10.1136/bmjopen-2021-058304] [Reference Citation Analysis]
64 Dourado LOC, Moreno CPD, Grobe SF, Gowdak LHW, Cesar LAM. Concomitant Use of Ranolazine and Trimetazidine in Patients with Refractory Angina: An Initial Experience. Arq Bras Cardiol 2022:S0066-782X2022005012204. [PMID: 35946755 DOI: 10.36660/abc.20210711] [Reference Citation Analysis]
65 Liu L, Dai N, Yin G, Zhang W, Mohammed AQ, Xu S, Lv X, Shi T, Feng C, Mohammed AA, Mareai RM, Xu Y, Yu X, Abdu FA, Yu F, Che W. Prognostic value of combined coronary angiography-derived IMR and myocardial perfusion imaging by CZT SPECT in INOCA. J Nucl Cardiol 2022. [PMID: 35918592 DOI: 10.1007/s12350-022-03038-w] [Reference Citation Analysis]
66 van der Sangen NM, Küçük IT, Ten Berg JM, Beijk MA, Delewi R, den Hartog AW, Appelman Y, Verouden NJ, Kikkert WJ, Henriques JP, Claessen BE. P2Y12-inhibitor monotherapy after coronary stenting: are all P2Y12-inhibitors equal? Expert Rev Cardiovasc Ther 2022;:1-9. [PMID: 35916833 DOI: 10.1080/14779072.2022.2104248] [Reference Citation Analysis]
67 Feenstra RGT, Boerhout CKM, Woudstra J, Vink CEM, Wittekoek ME, de Waard GA, Appelman Y, Eringa EC, Marques KMJ, de Winter RJ, Beijk MAM, van de Hoef TP, Piek JJ. Presence of Coronary Endothelial Dysfunction, Coronary Vasospasm, and Adenosine-Mediated Vasodilatory Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries. Circ Cardiovasc Interv 2022;15:e012017. [PMID: 35904014 DOI: 10.1161/CIRCINTERVENTIONS.122.012017] [Reference Citation Analysis]
68 Sonaglioni A, Nicolosi GL, Rigamonti E, Lombardo M. Modified Haller index is inversely correlated with true positive exercise stress echocardiographic results. J Cardiovasc Med (Hagerstown) 2022;23:524-34. [PMID: 35905007 DOI: 10.2459/JCM.0000000000001344] [Reference Citation Analysis]
69 Altersberger M, Goliasch G, Khafaga M, Schneider M, Cho Y, Winkler R, Funk GC, Binder T, Huber G, Zwick RH, Genger M. Echocardiography and Lung Ultrasound in Long COVID and Post-COVID Syndrome A Review Document of the Austrian Society of Pneumology and the Austrian Society of Ultrasound in Medicine. J Ultrasound Med 2022. [PMID: 35906952 DOI: 10.1002/jum.16068] [Reference Citation Analysis]
70 Hyafil F. Myocardial perfusion imaging with PET-CT: let's think global! Eur Heart J Cardiovasc Imaging 2022:jeac153. [PMID: 35906862 DOI: 10.1093/ehjci/jeac153] [Reference Citation Analysis]
71 Feuchtner GM, Plank F, Beyer C, Barbieri F, Widmann G, Spitaler P, Dichtl W. Cardiac Computed Tomography: State of the Art and Future Horizons. JCM 2022;11:4429. [DOI: 10.3390/jcm11154429] [Reference Citation Analysis]
72 Klidsar MH, Esfahanizadeh M, Haghverdi P, Amidi S, Kobarfard F. Synthesis, and docking studies of arylhydrazone compounds and evaluation of their platelet aggregation inhibitory effect and cytotoxicity. Med Chem Res. [DOI: 10.1007/s00044-022-02931-w] [Reference Citation Analysis]
73 Crisci G, De Luca M, D’assante R, Ranieri B, D’agostino A, Valente V, Giardino F, Capone V, Chianese S, Rega S, Cocchia R, Israr MZ, Debiek R, Heaney LM, Salzano A. Effects of Exercise on Heart Failure with Preserved Ejection Fraction: An Updated Review of Literature. JCDD 2022;9:241. [DOI: 10.3390/jcdd9080241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Ilie AC, Taranu SM, Stefaniu R, Sandu IA, Pislaru AI, Sandu CA, Turcu AM, Alexa ID. Chronic Coronary Syndrome in Frail Old Population. Life (Basel) 2022;12:1133. [PMID: 36013312 DOI: 10.3390/life12081133] [Reference Citation Analysis]
75 Greco A, Spagnolo M, Capodanno D. Antithrombotic therapy after transcatheter aortic valve implantation. Expert Rev Med Devices 2022. [PMID: 35881777 DOI: 10.1080/17434440.2022.2106853] [Reference Citation Analysis]
76 Marino M, Digiacomo S, Cacucci M, Catanoso A, Valentini P, Landolina M. Complete Percutaneous Revascularization in Patients Aged ≥85 Years With Acute Coronary Syndrome and Multivessel Coronary Artery Disease. Am J Cardiol 2022:S0002-9149(22)00700-7. [PMID: 35906125 DOI: 10.1016/j.amjcard.2022.06.030] [Reference Citation Analysis]
77 Vecsey-Nagy M, Jermendy ÁL, Kolossváry M, Vattay B, Boussoussou M, Suhai FI, Panajotu A, Csőre J, Borzsák S, Fontanini DM, Csobay-Novák C, Merkely B, Maurovich-Horvat P, Szilveszter B. Heart Rate-Dependent Degree of Motion Artifacts in Coronary CT Angiography Acquired by a Novel Purpose-Built Cardiac CT Scanner. J Clin Med 2022;11:4336. [PMID: 35893427 DOI: 10.3390/jcm11154336] [Reference Citation Analysis]
78 Maniar YM, Al-Abdouh A, Michos ED. Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis. Curr Cardiol Rep 2022. [PMID: 35876953 DOI: 10.1007/s11886-022-01748-8] [Reference Citation Analysis]
79 Morrone D, Gentile F, Aimo A, Cameli M, Barison A, Picoi ME, Guglielmo M, Villano A, DeVita A, Mandoli GE, Pastore MC, Barillà F, Mancone M, Pedrinelli R, Indolfi C, Filardi PP, Muscoli S, Tritto I, Pizzi C, Camici PG, Marzilli M, Crea F, Caterina R, Pontone G, Neglia D, Lanza G; Coronary Physiopathology and Microcirculation Working Group and Cluster Imaging of the Italian Society of Cardiology (SIC). Perspectives in noninvasive imaging for chronic coronary syndromes. Int J Cardiol 2022:S0167-5273(22)01108-1. [PMID: 35901907 DOI: 10.1016/j.ijcard.2022.07.038] [Reference Citation Analysis]
80 Alkhouli M, Lurz P, Rodés-Cabau J, Gulati R, Rihal CS, Lerman A, Latib A. Transcatheter Coronary Sinus Interventions. JACC Cardiovasc Interv 2022;15:1397-412. [PMID: 35863788 DOI: 10.1016/j.jcin.2022.05.039] [Reference Citation Analysis]
81 Pelliccia F, Gragnano F, Pasceri V, Marazzi G, Cacciotti L, Placanica A, Niccoli G, Palmerini T, Speciale G, Granatelli A, Calabrò P. Gender-related differences in changes of estimated bleeding risk in patients on dual antiplatelet therapy: the RE-SCORE multicenter prospective registry. Platelets. [DOI: 10.1080/09537104.2022.2102602] [Reference Citation Analysis]
82 Jucan AE, Gavrilescu O, Dranga M, Popa IV, Mihai BM, Prelipcean CC, Mihai C. Ischemic Heart Disease in Patients with Inflammatory Bowel Disease: Risk Factors, Mechanisms and Prevention. Life (Basel) 2022;12:1113. [PMID: 35892915 DOI: 10.3390/life12081113] [Reference Citation Analysis]
83 Yamazaki T, Saito Y, Kobayashi T, Kitahara H, Kobayashi Y. Relation of hyperemic response during fractional flow reserve measurement to coronary flow reserve. J Cardiol 2022:S0914-5087(22)00167-8. [PMID: 35882611 DOI: 10.1016/j.jjcc.2022.07.005] [Reference Citation Analysis]
84 Stocker TJ, Abdel-Wahab M, Möllmann H, Deseive S, Massberg S, Hausleiter J. Trends and predictors of radiation exposure in percutaneous coronary intervention: the PROTECTION VIII study. EuroIntervention 2022;18:e324-32. [PMID: 35076020 DOI: 10.4244/EIJ-D-21-00856] [Reference Citation Analysis]
85 Berger M, Baaten CCFMJ, Noels H, Marx N, Schütt K. [Heart and diabetes : Platelet function and antiplatelet therapy in chronic kidney disease]. Herz 2022. [PMID: 35861809 DOI: 10.1007/s00059-022-05129-3] [Reference Citation Analysis]
86 Rozanski A, Miller RJH, Gransar H, Han D, Slomka P, Dey D, Hayes SW, Friedman JD, Thomson L, Berman DS. Benefit of Early Revascularization Based on Inducible Ischemia and Left Ventricular Ejection Fraction. J Am Coll Cardiol 2022;80:202-15. [PMID: 35835493 DOI: 10.1016/j.jacc.2022.04.052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Demandt JPA, Koks A, Haest R, Heijmen E, Thijssen E, Otterspoor LC, van Veghel D, El Farissi M, Eerdekens R, Vervaat F, Pijls NHJ, Veer MVT, Tonino PAL, Dekker LRC, Vlaar PJ. Prehospital triage of patients with suspected non-ST-segment elevation acute coronary syndrome: Rationale and design of the TRIAGE-ACS study. Contemp Clin Trials 2022;119:106854. [PMID: 35863696 DOI: 10.1016/j.cct.2022.106854] [Reference Citation Analysis]
88 Nedoshivin A, Petrova PTS, Karpov Y. Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis. Adv Ther. [DOI: 10.1007/s12325-022-02222-1] [Reference Citation Analysis]
89 Martínez-Milla J, Aceña Á, Pello A, López-Castillo M, Gaebelt HP, González-Lorenzo Ó, Tarín N, Cristóbal C, Blanco-Colio LM, Martín-Ventura JL, Huelmos A, Kallmeyer A, Alonso J, Gutiérrez-Landaluce C, López Bescós L, Egido J, Mahíllo-Fernández I, Lorenzo Ó, González-Casaus ML, Tuñón J. NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease. J Clin Med 2022;11:4153. [PMID: 35887917 DOI: 10.3390/jcm11144153] [Reference Citation Analysis]
90 Tarsitano MG, Pandozzi C, Muscogiuri G, Sironi S, Pujia A, Lenzi A, Giannetta E. Epicardial Adipose Tissue: A Novel Potential Imaging Marker of Comorbidities Caused by Chronic Inflammation. Nutrients 2022;14:2926. [PMID: 35889883 DOI: 10.3390/nu14142926] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
91 Vecsey-Nagy M, Szilveszter B, Kolossváry M, Boussoussou M, Vattay B, Gonda X, Rihmer Z, Merkely B, Maurovich-Horvat P, Nemcsik J. Cyclothymic affective temperament is independently associated with left ventricular hypertrophy in chronic hypertensive patients. J Psychosom Res 2022;160:110988. [PMID: 35863114 DOI: 10.1016/j.jpsychores.2022.110988] [Reference Citation Analysis]
92 Badescu MC, Badulescu OV, Scripcariu DV, Butnariu LI, Bararu-Bojan I, Popescu D, Ciocoiu M, Gorduza EV, Costache II, Rezus E, Rezus C. Myocardial Ischemia Related to Common Cancer Therapy-Prevention Insights. Life (Basel) 2022;12:1034. [PMID: 35888122 DOI: 10.3390/life12071034] [Reference Citation Analysis]
93 Kato T, Momose M, Uemura Y, Naya M, Matsumoto N, Hida S, Yamauchi T, Nakajima T, Suzuki E, Inoko M, Tamaki N. Association of the extent of myocardial ischemia with outcomes in patients with suspected coronary artery disease in Japan. J Cardiol 2022:S0914-5087(22)00158-7. [PMID: 35835641 DOI: 10.1016/j.jjcc.2022.06.012] [Reference Citation Analysis]
94 Mavrogeni S, Pepe A, Nijveldt R, Ntusi N, Sierra-Galan LM, Bratis K, Wei J, Mukherjee M, Markousis-Mavrogenis G, Gargani L, Sade LE, Ajmone-Marsan N, Seferovic P, Donal E, Nurmohamed M, Cerinic MM, Sfikakis P, Kitas G, Schwitter J, Lima JAC, Dawson D, Dweck M, Haugaa KH, Keenan N, Moon J, Stankovic I, Donal E, Cosyns B. Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2022:jeac134. [PMID: 35808990 DOI: 10.1093/ehjci/jeac134] [Reference Citation Analysis]
95 Disabato G, Camporeale A, Lo Rito M, Tondi L, Zuniga Olaya KG, Frigiola A, Agnifili ML, Bedogni F, Lombardi M, Pica S. Myocardial infarction with non-obstructive disease and anomalous coronary origin: look for the common in the uncommon. ESC Heart Fail 2022. [PMID: 35809025 DOI: 10.1002/ehf2.14075] [Reference Citation Analysis]
96 Xu Y, Ye Z, Wang B, Tang L, Sun J, Chen X, Yang Y, Wang J. Novel Insights into the Predictors of Obstructive Sleep Apnea Syndrome in Patients with Chronic Coronary Syndrome: Development of a Predicting Model. Oxid Med Cell Longev 2022;2022:5497134. [PMID: 35795859 DOI: 10.1155/2022/5497134] [Reference Citation Analysis]
97 Na Takuathung M, Sakuludomkan W, Khatsri R, Dukaew N, Kraivisitkul N, Ahmadmusa B, Mahakkanukrauh C, Wangthaweesap K, Onin J, Srichai S, Buawangpong N, Koonrungsesomboon N. Adverse Effects of Angiotensin-Converting Enzyme Inhibitors in Humans: A Systematic Review and Meta-Analysis of 378 Randomized Controlled Trials. IJERPH 2022;19:8373. [DOI: 10.3390/ijerph19148373] [Reference Citation Analysis]
98 Cury RC, Blankstein R, Leipsic J, Abbara S, Achenbach S, Berman D, Bittencourt M, Budoff M, Chinnaiyan K, Choi AD, Ghoshhajra B, Jacobs J, Koweek L, Lesser J, Maroules C, Rubin GD, Rybicki FJ, Shaw LJ, Williams MC, Williamson E, White CS, Villines TC. CAD-RADS™ 2.0 - 2022 Coronary Artery Disease - Reporting and Data System an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR) and the North America society of cardiovascular imaging (NASCI). J Cardiovasc Comput Tomogr 2022:S1934-5925(22)00240-4. [PMID: 35864070 DOI: 10.1016/j.jcct.2022.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Spirito A, Cao D, Mehran R. Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon. Eur Heart J 2022:ehac353. [PMID: 35789263 DOI: 10.1093/eurheartj/ehac353] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Geisler T, Poli S, Huber K, Rath D, Aidery P, Kristensen SD, Storey RF, Ball A, Collet JP, Berg JT. Resumption of Antiplatelet Therapy after Major Bleeding. Thromb Haemost 2022. [PMID: 35785817 DOI: 10.1055/s-0042-1750419] [Reference Citation Analysis]
101 Mplani V, Apostolopoulos D, Koufou E, Spyridonidis T, Tsigkas G, Hahalis G, Alexopoulos D, Davlouros P. Inferior myocardial wall ischemia on SPECT-MPI in patients with non dominant right coronary artery and non significant coronary artery disease. Int J Cardiol 2022;358:8-10. [PMID: 35469935 DOI: 10.1016/j.ijcard.2022.04.058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Thomas D, Sharmila S, Saravana Babu MS, Raman SP, Gadhinglajkar SV, Koshy T. Perioperative cardiovascular outcome in patients with coronary artery disease undergoing major vascular surgery: A retrospective cohort study. Ann Card Anaesth 2022;25:297-303. [PMID: 35799557 DOI: 10.4103/aca.aca_88_21] [Reference Citation Analysis]
103 Dinges SM, Krotz J, Gass F, Treitschke J, Fegers-Wustrow I, Geisberger M, Esefeld K, von Korn P, Duvinage A, Edelmann F, Wolfram O, Brandts J, Winzer EB, Wolfarth B, Freigang F, Neubauer S, Nebling T, Hackenberg B, Amelung V, Mueller S, Halle M. Cardiovascular risk factors, exercise capacity and health literacy in patients with chronic ischaemic heart disease and type 2 diabetes mellitus in Germany: Baseline characteristics of the Lifestyle Intervention in Chronic Ischaemic Heart Disease and Type 2 Diabetes study. Diab Vasc Dis Res 2022;19:14791641221113781. [PMID: 35953083 DOI: 10.1177/14791641221113781] [Reference Citation Analysis]
104 Zhao J, Fan H, Wang T, Yu B, Mao S, Wang X, Zhang W, Wang L, Zhang Y, Ren Z, Liang B. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol 2022;21:123. [PMID: 35778734 DOI: 10.1186/s12933-022-01548-y] [Reference Citation Analysis]
105 Geng Y, Liu H, Wang X, Zhang J, Gong Y, Zheng D, Jiang J, Xia L. Effect of microcirculatory dysfunction on coronary hemodynamics: A pilot study based on computational fluid dynamics simulation. Computers in Biology and Medicine 2022;146:105583. [DOI: 10.1016/j.compbiomed.2022.105583] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Laurikka P, Kivelä L, Kurppa K, Kaukinen K. Review article: Systemic consequences of coeliac disease. Aliment Pharmacol Ther 2022;56 Suppl 1:S64-72. [PMID: 35815828 DOI: 10.1111/apt.16912] [Reference Citation Analysis]
107 Motwani M, Williams MC, Nieman K, Choi AD. Great Debates in Cardiac Computed Tomography: OPINION: "Artificial Intelligence is key to the future of CCTA – the great hope”. Journal of Cardiovascular Computed Tomography 2022. [DOI: 10.1016/j.jcct.2022.07.004] [Reference Citation Analysis]
108 Hachiya S, Kosuge H, Fujita Y, Hida S, Chikamori T. Performance of Hybrid Imaging in the Diagnosis of Coronary Artery Disease. Am J Cardiol 2022;174:34-9. [PMID: 35379453 DOI: 10.1016/j.amjcard.2022.02.043] [Reference Citation Analysis]
109 Tavella R, Beltrame JF. Shortcomings in Managing Patients With Ischemia With Nonobstructed Coronary Arteries. Circ Cardiovasc Qual Outcomes 2022;15:e008746. [PMID: 35861783 DOI: 10.1161/CIRCOUTCOMES.122.008746] [Reference Citation Analysis]
110 Di Serafino L, Esposito G. May FFR-guided PCI save lives?: Commentary on: "Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry". Catheter Cardiovasc Interv 2022;100:49-50. [PMID: 35819145 DOI: 10.1002/ccd.30310] [Reference Citation Analysis]
111 Li Y, Chen L, Shao Y, Zhang M, Zhi L, Lu Y. The effect of apolipoprotein E gene polymorphism and Lp(a) levels on coronary artery disease with atrial fibrillation. J Int Med Res 2022;50:3000605221109387. [PMID: 35850541 DOI: 10.1177/03000605221109387] [Reference Citation Analysis]
112 Hamdan AME, Mohammedsaleh ZM, Aboelnour A, Elkannishy SM. Preclinical study for the ameliorating effect of l-ascorbic acid for the oxidative stress of chronic administration of organic nitrates on myocardial tissue in high sucrose/fat rat model. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.07.001] [Reference Citation Analysis]
113 Villines TC. Improving education and training opportunities in cardiac CT. Journal of Cardiovascular Computed Tomography 2022;16:384-5. [DOI: 10.1016/j.jcct.2022.05.008] [Reference Citation Analysis]
114 Lee CS, Westland H, Faulkner KM, Iovino P, Thompson JH, Sexton J, Farry E, Jaarsma T, Riegel B. The effectiveness of self-care interventions in chronic illness: a meta-analysis of randomized controlled trials. International Journal of Nursing Studies 2022. [DOI: 10.1016/j.ijnurstu.2022.104322] [Reference Citation Analysis]
115 Pezel T, Sanguineti F, Garot P, Unterseeh T, Champagne S, Toupin S, Morisset S, Hovasse T, Faradji A, Ah-Sing T, Nicol M, Hamzi L, Dillinger JG, Henry P, Bousson V, Garot J. Machine-Learning Score Using Stress CMR for Death Prediction in Patients With Suspected or Known CAD. JACC Cardiovasc Imaging 2022:S1936-878X(22)00341-2. [PMID: 35842360 DOI: 10.1016/j.jcmg.2022.05.007] [Reference Citation Analysis]
116 Pohl J, Heintze C, Herrmann WJ. Patients' and GPs' duties and responsibilities in long-term care after myocardial infarction: a qualitative study of patients' perspectives. Fam Pract 2022:cmac073. [PMID: 35770486 DOI: 10.1093/fampra/cmac073] [Reference Citation Analysis]
117 Morris PD, Al-Lamee RK, Berry C; BCIS Research and Development Committee. Coronary physiological assessment in the catheter laboratory: haemodynamics, clinical assessment and future perspectives. Heart 2022:heartjnl-2020-318743. [PMID: 35768192 DOI: 10.1136/heartjnl-2020-318743] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Rozhkov AN, Shchekochikhin DY, Ashikhmin YI, Mitina YO, Evgrafova VV, Zhelankin AV, Gognieva DG, Akselrod AS, Kopylov PY. The Profile of Circulating Blood microRNAs in Outpatients with Vulnerable and Stable Atherosclerotic Plaques: Associations with Cardiovascular Risks. ncRNA 2022;8:47. [DOI: 10.3390/ncrna8040047] [Reference Citation Analysis]
119 Janus SE, Karnib M, Al-Kindi SG. Reimagining Training in Cardiac CT for Cardiology Fellows. J Am Coll Cardiol 2022;79:2543-7. [PMID: 35738717 DOI: 10.1016/j.jacc.2022.02.054] [Reference Citation Analysis]
120 Sliwicka O, Swiderska-Chadaj Z, Snoeren M, Brink M, Salah K, Peters-Bax L, Stille T, van Amerongen MJ, Sechopoulos I, Habets J. Multireader image quality evaluation of dynamic myocardial computed tomography perfusion imaging with a novel four-dimensional noise reduction filter. Acta Radiol 2022;:2841851221108804. [PMID: 35765201 DOI: 10.1177/02841851221108804] [Reference Citation Analysis]
121 Ponticelli F, Giannini F. Coronary sinus reducer for the treatment of chronic refractory angina pectoris. Future Cardiol 2022. [PMID: 35758146 DOI: 10.2217/fca-2021-0064] [Reference Citation Analysis]
122 Yang J, Li C, Zheng Y, Gao J, Liu YP, Wang JJ, Song JJ, Zhou Q, Meng X, Zhang K, Wang W, Shao C, Tang YD. The Association Between High-Sensitivity C-Reactive Protein/Albumin Ratio and Cardiovascular Prognosis in Patients Undergoing Percutaneous Coronary Intervention. Angiology 2022;:33197221110715. [PMID: 35748815 DOI: 10.1177/00033197221110715] [Reference Citation Analysis]
123 Schillemans T, Tragante V, Maitusong B, Gigante B, Cresci S, Laguzzi F, Vikström M, Richards M, Pilbrow A, Cameron V, Foco L, Doughty RN, Kuukasjärvi P, Allayee H, Hartiala JA, Tang WHW, Lyytikäinen L, Nikus K, Laurikka JO, Srinivasan S, Mordi IR, Trompet S, Kraaijeveld A, van Setten J, Gijsberts CM, Maitland-van der Zee AH, Saely CH, Gong Y, Johnson JA, Cooper-dehoff RM, Pepine CJ, Casu G, Leiherer A, Drexel H, Horne BD, van der Laan SW, Marziliano N, Hazen SL, Sinisalo J, Kähönen M, Lehtimäki T, Lang CC, Burkhardt R, Scholz M, Jukema JW, Eriksson N, Åkerblom A, James S, Held C, Hagström E, Spertus JA, Algra A, de Faire U, Åkesson A, Asselbergs FW, Patel RS, Leander K. Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis. Front Physiol 2022;13:909870. [DOI: 10.3389/fphys.2022.909870] [Reference Citation Analysis]
124 Pelliccia F, Gragnano F, Pasceri V, Cesaro A, Zimarino M, Calabrò P. Risk Scores of Bleeding Complications in Patients on Dual Antiplatelet Therapy: How to Optimize Identification of Patients at Risk of Bleeding after Percutaneous Coronary Intervention. JCM 2022;11:3574. [DOI: 10.3390/jcm11133574] [Reference Citation Analysis]
125 Kim H, Kim I, Hwang J, Park H, Lee CH, Cho Y, Yoon H, Nam C, Han S, Hur S. Surveillance of adenosine stress myocardial contrast echocardiography following percutaneous coronary intervention. Int J Cardiovasc Imaging. [DOI: 10.1007/s10554-022-02583-2] [Reference Citation Analysis]
126 Lin S, Yang X, Guo X, Ye J, Hu X, Dong H, Zhou Y, Ye X. Impact of Short-Term Heart Rate Variability in Patients with STEMI Treated by Delayed versus Immediate Stent in Primary Percutaneous Coronary Intervention: A Prospective Cohort Study. Computational and Mathematical Methods in Medicine 2022;2022:1-10. [DOI: 10.1155/2022/2533664] [Reference Citation Analysis]
127 Lancellotti P, Go YY, Nchimi A. Stress imaging versus fractional flow reserve: what comes first-the chicken or the egg? Eur Heart J 2022:ehac287. [PMID: 35713675 DOI: 10.1093/eurheartj/ehac287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Reed SC, Dhir N, Widmer RJ. Optimal cardiovascular medical therapy: current guidelines and new developments. Baylor University Medical Center Proceedings. [DOI: 10.1080/08998280.2022.2083903] [Reference Citation Analysis]
129 Drugescu A, Roca M, Zota IM, Costache AD, Gavril OI, Gavril RS, Vasilcu TF, Mitu O, Esanu IM, Roca IC, Ghiciuc CM, Mitu F. Value of the Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Predicting CPET Performance in Patients with Stable CAD and Recent Elective PCI. Medicina (Kaunas) 2022;58:814. [PMID: 35744077 DOI: 10.3390/medicina58060814] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
130 Wojszel ZB, Kuźma Ł, Rogalska E, Kurasz A, Dobrzycki S, Sobkowicz B, Tomaszuk-Kazberuk A. A Newly Defined CHA2DS2-VA Score for Predicting Obstructive Coronary Artery Disease in Patients with Atrial Fibrillation-A Cross-Sectional Study of Older Persons Referred for Elective Coronary Angiography. J Clin Med 2022;11:3462. [PMID: 35743532 DOI: 10.3390/jcm11123462] [Reference Citation Analysis]
131 Driessen RS, van Diemen PA, Raijmakers PG, Knuuti J, Maaniitty T, Underwood SR, Nagel E, Robbers LFHJ, Demirkiran A, von Bartheld MB, van de Ven PM, Hofstra L, Somsen GA, Tulevski II, Boellaard R, van Rossum AC, Danad I, Knaapen P. Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study. Eur Heart J 2022:ehac286. [PMID: 35708168 DOI: 10.1093/eurheartj/ehac286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
132 Güner A, Özkan M, Kalçık M, Gürsoy MO, Gündüz S, Kılıçgedik A, Bayam E, Kalkan S, Kırma C, Türkmen M, Adademir T, Aksüt M, Fedakar A, Kırali K. Serum Levels of Cholesterol and Lipoproteins in Patients With Symptomatic Paravalvular Leaks. Am J Cardiol 2022;173:112-9. [PMID: 35369933 DOI: 10.1016/j.amjcard.2022.02.050] [Reference Citation Analysis]
133 Liu B, Yu W, Wang J, Shao X, Zhang F, Zhou M, Shi Y, Wang B, Xu Y, Wang Y. A model combining rest-only ECG-gated SPECT myocardial perfusion imaging and cardiovascular risk factors can effectively predict obstructive coronary artery disease. BMC Cardiovasc Disord 2022;22:268. [PMID: 35705898 DOI: 10.1186/s12872-022-02712-8] [Reference Citation Analysis]
134 Yacoub B, Varga-Szemes A, Schoepf UJ, Kabakus IM, Baruah D, Burt JR, Aquino GJ, Sullivan AK, O' Doherty J, Hoelzer P, Sperl J, Emrich T. Impact of Artificial Intelligence Assistance on Chest CT Interpretation Times: A Prospective Randomized Study. AJR Am J Roentgenol 2022. [PMID: 35703413 DOI: 10.2214/AJR.22.27598] [Reference Citation Analysis]
135 Gue YX, Gorog DA, Lip GYH. Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease: Does Less Mean More? JAMA Cardiol 2022. [PMID: 35704350 DOI: 10.1001/jamacardio.2022.1572] [Reference Citation Analysis]
136 Spacek M, Vacha J, Precek J, Hutyra M, Nykl R, Sluka M, Taborsky M. Complete revascularization of multivessel coronary artery disease in patients with ST elevation acute coronary syndrome - for whom and when? A comprehensive review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2022. [PMID: 35703363 DOI: 10.5507/bp.2022.024] [Reference Citation Analysis]
137 Al-Lamee RK, Foley M, Rajkumar CA, Francis DP. Revascularization in stable coronary artery disease. BMJ 2022;377:e067085. [PMID: 35697356 DOI: 10.1136/bmj-2021-067085] [Reference Citation Analysis]
138 Peper J, Becker LM, van den Berg H, Bor WL, Brouwer J, Nijenhuis VJ, van Ginkel DJ, Rensing BJMW, Ten Berg JM, Timmers L, Leiner T, Swaans MJ. Diagnostic Performance of CCTA and CT-FFR for the Detection of CAD in TAVR Work-Up. JACC Cardiovasc Interv 2022;15:1140-9. [PMID: 35680194 DOI: 10.1016/j.jcin.2022.03.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Capodanno D, Baber U, Bhatt DL, Collet JP, Dangas G, Franchi F, Gibson CM, Gwon HC, Kastrati A, Kimura T, Lemos PA, Lopes RD, Mehran R, O'Donoghue ML, Rao SV, Rollini F, Serruys PW, Steg PG, Storey RF, Valgimigli M, Vranckx P, Watanabe H, Windecker S, Angiolillo DJ. P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention. Nat Rev Cardiol 2022. [PMID: 35697777 DOI: 10.1038/s41569-022-00725-6] [Reference Citation Analysis]
140 Xue J, Li J, Sun D, Sheng L, Gong Y, Wang D, Zhang S, Zou Y, Shi J, Xu W, An M, Dai C, Li W, Zheng L, Vinograd A, Liu G, Kong Y, Li Y. Functional evaluation of intermediate coronary lesions with integrated computed tomography angiography and invasive angiography in patients with stable coronary artery disease. Journal of Translational Internal Medicine 2022;0. [DOI: 10.2478/jtim-2022-0018] [Reference Citation Analysis]
141 Van Schalkwijk DL, Widdershoven JWMG, Elias-Smale S, Hartzema-Meijer M, Den Oudsten BL, Slatman J, Mommersteeg PMC. ShareHeart: A patient journey map of patients with ischemia and non-obstructive coronary artery disease based on qualitative research. J Clin Nurs 2022. [PMID: 35689371 DOI: 10.1111/jocn.16409] [Reference Citation Analysis]
142 Edvardsen T, Asch FM, Davidson B, Delgado V, DeMaria A, Dilsizian V, Gaemperli O, Garcia MJ, Kamp O, Lee DC, Neglia D, Neskovic AN, Pellikka PA, Plein S, Sechtem U, Shea E, Sicari R, Villines TC, Lindner JR, Popescu BA. Non-Invasive Imaging in Coronary Syndromes: Recommendations of The European Association of Cardiovascular Imaging and the American Society of Echocardiography, in Collaboration with The American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Cardiovasc Comput Tomogr 2022:S1934-5925(22)00074-0. [PMID: 35729014 DOI: 10.1016/j.jcct.2022.05.006] [Reference Citation Analysis]
143 Butnariu LI, Florea L, Badescu MC, Țarcă E, Costache II, Gorduza EV. Etiologic Puzzle of Coronary Artery Disease: How Important Is Genetic Component? Life (Basel) 2022;12:865. [PMID: 35743896 DOI: 10.3390/life12060865] [Reference Citation Analysis]
144 Marchini F, Pompei G, D'Aniello E, Marrone A, Caglioni S, Biscaglia S, Campo G, Tebaldi M. Shedding Light on Treatment Options for Coronary Vasomotor Disorders: A Systematic Review. Cardiovasc Drugs Ther 2022. [PMID: 35678926 DOI: 10.1007/s10557-022-07351-x] [Reference Citation Analysis]
145 Miller RJH, Hauser MT, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Huang C, Liang JX, Han D, Dey D, Berman DS, Slomka PJ. Machine learning to predict abnormal myocardial perfusion from pre-test features. J Nucl Cardiol . [DOI: 10.1007/s12350-022-03012-6] [Reference Citation Analysis]
146 Ang DTY, Berry C, Kaski J. Phenotype-based management of coronary microvascular dysfunction. J Nucl Cardiol . [DOI: 10.1007/s12350-022-03000-w] [Reference Citation Analysis]
147 Lin J, Tseng W, Lee P, Lee C, Tseng S, Chen P, Chang H, Chao T. A Randomized Controlled Trial Evaluating Outcome Impact of Cilostazol in Patients with Coronary Artery Disease or at a High Risk of Cardiovascular Disease. JPM 2022;12:938. [DOI: 10.3390/jpm12060938] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
148 Birkl K, Beyer C, Plank F, Feuchtner GM, Friedrich G. Evaluation of the Appropriate Use of Coronary Computed Tomography Angiography: A Retrospective, Single-Center Analysis. JCDD 2022;9:180. [DOI: 10.3390/jcdd9060180] [Reference Citation Analysis]
149 Power DA, Rosenson RS. Secondary Prevention of Atherosclerotic Cardiovascular Disease. In: Dangas GD, Di Mario C, Thiele H, Barlis P, Addo T, Claessen B, Hengstenberg C, Kipshidze N, editors. Interventional Cardiology. Wiley; 2022. pp. 475-82. [DOI: 10.1002/9781119697367.ch44] [Reference Citation Analysis]
150 Mortensen MB, Dzaye O, Razavi AC, Jensen JM, Steffensen FH, Bøtker HE, Cainzos-Achirica M, Sørensen HT, Maeng M, Blaha MJ, Nasir K, Nørgaard BL. Association between REDUCE-IT criteria, coronary artery disease severity and cardiovascular events: The Western Denmark Heart Registry. Eur J Prev Cardiol 2022:zwac104. [PMID: 35653637 DOI: 10.1093/eurjpc/zwac104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Prasad A, Gersh BJ. Stable Coronary Artery Disease. In: Dangas GD, Di Mario C, Thiele H, Barlis P, Addo T, Claessen B, Hengstenberg C, Kipshidze N, editors. Interventional Cardiology. Wiley; 2022. pp. 136-45. [DOI: 10.1002/9781119697367.ch11] [Reference Citation Analysis]
152 Jeremias A, Nijjer S, Davies J, Dimario C. Physiologic Assessment and Guidance in the Cardiac Catheterization Laboratory. In: Dangas GD, Di Mario C, Thiele H, Barlis P, Addo T, Claessen B, Hengstenberg C, Kipshidze N, editors. Interventional Cardiology. Wiley; 2022. pp. 75-92. [DOI: 10.1002/9781119697367.ch7] [Reference Citation Analysis]
153 Hamaya R, van de Hoef TP, Lee JM, Hoshino M, Kanaji Y, Murai T, Boerhout CKM, de Waard GA, Jung JH, Lee SH, Mejia Renteria H, Echavarria-Pinto M, Meuwissen M, Matsuo H, Madera-Cambero M, Eftekhari A, Effat MA, Marques K, Doh JH, Christiansen EH, Banerjee R, Nam CW, Niccoli G, Nakayama M, Tanaka N, Shin ES, Sasano T, Chamuleau SAJ, Knaapen P, Escaned J, Koo BK, Piek JJ, Kakuta T. Differential Impact of Coronary Revascularization on Long-Term Clinical Outcome According to Coronary Flow Characteristics: Analysis of the International ILIAS Registry. Circ Cardiovasc Interv 2022;15:e011948. [PMID: 35603622 DOI: 10.1161/CIRCINTERVENTIONS.121.011948] [Reference Citation Analysis]
154 Naeem H, Khan U, Mohsin M, Niazi K, Malik J, Satti DI, Anwar W. Comparison of Invasive Coronary Angiography Versus Computed Tomography Angiography to Assess Mehran Classification of In-Stent Restenosis in Bifurcation Percutaneous Coronary Intervention. Am J Cardiol 2022;172:11-7. [PMID: 35351284 DOI: 10.1016/j.amjcard.2022.02.014] [Reference Citation Analysis]
155 Redberg RF, Guduguntla V. A PROMISE to Reduce Low-Value Testing. JACC: Cardiovascular Imaging 2022. [DOI: 10.1016/j.jcmg.2022.04.018] [Reference Citation Analysis]
156 Villines TC, Williams MC. The Fallacy of the Power of Zero. JACC Cardiovasc Imaging 2022;15:1075-7. [PMID: 35680216 DOI: 10.1016/j.jcmg.2022.02.022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Ilic A, Debeljacki D, Komazec N, Preveden A, Cankovic M, Preveden M. High take-off right coronary artery - computed tomography in the management of acute coronary syndrome. Postepy Kardiol Interwencyjnej 2022;18:173-4. [PMID: 36051831 DOI: 10.5114/aic.2022.118536] [Reference Citation Analysis]
158 Agha AM, Pacor J, Grandhi GR, Mszar R, Khan SU, Parikh R, Agrawal T, Burt J, Blankstein R, Blaha MJ, Shaw LJ, Al-mallah MH, Brackett A, Cainzos-achirica M, Miller EJ, Nasir K. The Prognostic Value of CAC Zero Among Individuals Presenting With Chest Pain. JACC: Cardiovascular Imaging 2022. [DOI: 10.1016/j.jcmg.2022.03.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
159 Uzun F, Güner A, Pusuroglu H, Demir AR, Gündüz S, Gürbak İ, Aslan S, Demirci G, Gültekin Güner E, Arslan E, Erturk M. Association of red blood cell distribution width, systemic-immune-inflammation index and poor cardiovascular outcomes in patients with newly diagnosed hypertension. Clin Exp Hypertens 2022;:1-9. [PMID: 35642501 DOI: 10.1080/10641963.2022.2079668] [Reference Citation Analysis]
160 Jiang J, Li C, Hu Y, Li C, He J, Leng X, Xiang J, Ge J, Wang J. A novel CFD-based computed index of microcirculatory resistance (IMR) derived from coronary angiography to assess coronary microcirculation. Computer Methods and Programs in Biomedicine 2022;221:106897. [DOI: 10.1016/j.cmpb.2022.106897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Rios R, Miller RJ, Manral N, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Van Kriekinge SD, Kavanagh PB, Parekh T, Liang JX, Dey D, Berman DS, Slomka PJ. Handling missing values in machine learning to predict patient-specific risk of adverse cardiac events: Insights from REFINE SPECT registry. Computers in Biology and Medicine 2022;145:105449. [DOI: 10.1016/j.compbiomed.2022.105449] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
162 Rizzetto F, Gnocchi G, Travaglini F, Rocco GD, Rizzo A, Carbonaro LA, Vanzulli A. Impact of COVID-19 pandemic on the workload of diagnostic radiology: a 2-year observational study in a tertiary referral hospital. Academic Radiology 2022. [DOI: 10.1016/j.acra.2022.06.002] [Reference Citation Analysis]
163 Deschepper C, Berwouts D, Cornelis K, Floré V, Beckers R, De Sutter J. SPECT-CCTA: guiding treatment in ischaemic heart disease. Acta Cardiol 2022;77:328-32. [PMID: 34176430 DOI: 10.1080/00015385.2021.1939511] [Reference Citation Analysis]
164 Boettcher M, Düngen HD, Donath F, Mikus G, Werner N, Thuermann PA, Karakas M, Besche N, Koch T, Gurniak M, Becker C. Vericiguat in Combination with Short-Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study. Clin Pharmacol Ther 2022;111:1239-47. [PMID: 35258101 DOI: 10.1002/cpt.2574] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
165 Mergen V, Sartoretti T, Baer-Beck M, Schmidt B, Petersilka M, Wildberger JE, Euler A, Eberhard M, Alkadhi H. Ultra-High-Resolution Coronary CT Angiography With Photon-Counting Detector CT: Feasibility and Image Characterization. Invest Radiol 2022. [PMID: 35640019 DOI: 10.1097/RLI.0000000000000897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Kotalczyk A, Guo Y, Fawzy AM, Wang Y, Lip GYH. Outcomes in elderly Chinese patients with atrial fibrillation and coronary artery disease. A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation ( ChiOTEAF ) registry. Journal of Arrhythmia. [DOI: 10.1002/joa3.12744] [Reference Citation Analysis]
167 Mesnier J, Panagides V, Nuche J, Rodés-cabau J. Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going. JCM 2022;11:3090. [DOI: 10.3390/jcm11113090] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Liga R, Gimelli A. Cardiac Imaging on COVID-19 Pandemic Era: the Stand, The Lost, and Found. Curr Cardiovasc Imaging Rep. [DOI: 10.1007/s12410-022-09565-x] [Reference Citation Analysis]
169 Harris E, Conway D, Jimenez-aranda A, Butts J, Hedley-takhar P, Thomson R, Astin F. Development and user-testing of a digital patient decision aid to facilitate shared decision-making for people with stable angina. BMC Med Inform Decis Mak 2022;22. [DOI: 10.1186/s12911-022-01882-x] [Reference Citation Analysis]
170 Ann SH, Lee H, Park KS, Jeon YJ, Park EJ, Park S, Kim YG, Lee Y, Choi SH, Kwon WJ, Park GM. Marital Status and Subclinical Coronary Atherosclerosis in Asymptomatic Individuals. J Am Heart Assoc 2022;:e024942. [PMID: 35621225 DOI: 10.1161/JAHA.121.024942] [Reference Citation Analysis]
171 Travieso A, Jeronimo-Baza A, Faria D, Shabbir A, Mejia-Rentería H, Escaned J. Invasive evaluation of coronary microvascular dysfunction. J Nucl Cardiol 2022. [PMID: 35618991 DOI: 10.1007/s12350-022-02997-4] [Reference Citation Analysis]
172 Ganesananthan S, Rajkumar CA, Foley M, Thompson D, Nowbar AN, Seligman H, Petraco R, Sen S, Nijjer S, Thom SA, Wensel R, Davies J, Francis D, Shun-Shin M, Howard J, Al-Lamee R. Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial. Eur Heart J 2022:ehac260. [PMID: 35639660 DOI: 10.1093/eurheartj/ehac260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
173 Mair J, Jaffe A, Lindahl B, Mills N, Möckel M, Cullen L, Giannitsis E, Hammarsten O, Huber K, Krychtiuk K, Mueller C, Thygesen K. The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction - from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC). Biomarkers 2022;:1-11. [PMID: 35603440 DOI: 10.1080/1354750X.2022.2055792] [Reference Citation Analysis]
174 Anetta K, Horak A, Wojakowski W, Wita K, Jadczyk T. Deep Learning Analysis of Polish Electronic Health Records for Diagnosis Prediction in Patients with Cardiovascular Diseases. JPM 2022;12:869. [DOI: 10.3390/jpm12060869] [Reference Citation Analysis]
175 Ties D, van Dorp P, Pundziute G, Lipsic E, van der Aalst CM, Oudkerk M, de Koning HJ, Vliegenthart R, van der Harst P. Multi-Modality Imaging for Prevention of Coronary Artery Disease and Myocardial Infarction in the General Population: Ready for Prime Time? J Clin Med 2022;11:2965. [PMID: 35683356 DOI: 10.3390/jcm11112965] [Reference Citation Analysis]
176 Voutilainen A, Brester C, Kolehmainen M, Tuomainen TP. Epidemiological analysis of coronary heart disease and its main risk factors: are their associations multiplicative, additive, or interactive? Ann Med 2022;54:1500-10. [PMID: 35603961 DOI: 10.1080/07853890.2022.2078875] [Reference Citation Analysis]
177 Einstein AJ, Hirschfeld C, Williams MC, Vitola JV, Better N, Villines TC, Cerci R, Shaw LJ, Choi AD, Dorbala S, Karthikeyan G, Lu B, Sinitsyn V, Ansheles AA, Kudo T, Bucciarelli-Ducci C, Nørgaard BL, Maurovich-Horvat P, Campisi R, Milan E, Louw L, Allam AH, Bhatia M, Sewanan L, Malkovskiy E, Cohen Y, Randazzo M, Narula J, Morozova O, Pascual TNB, Pynda Y, Dondi M, Paez D; INCAPS COVID 2 Investigators Group. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19. J Am Coll Cardiol 2022;79:2001-17. [PMID: 35589162 DOI: 10.1016/j.jacc.2022.03.348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
178 Koo BK, Yang S. Doppler vs Thermodilution for Coronary Flow Reserve: Does the End Justify the Means? JACC Cardiovasc Interv 2022;15:1071-3. [PMID: 35589237 DOI: 10.1016/j.jcin.2022.04.012] [Reference Citation Analysis]
179 van de Hoef TP, Lee JM, Boerhout CKM, de Waard GA, Jung JH, Lee SH, Mejía-Rentería H, Hoshino M, Echavarria-Pinto M, Meuwissen M, Matsuo H, Madera-Cambero M, Eftekhari A, Effat MA, Murai T, Marques K, Doh JH, Christiansen EH, Banerjee R, Nam CW, Niccoli G, Nakayama M, Tanaka N, Shin ES, van Royen N, Chamuleau SAJ, Knaapen P, Escaned J, Kakuta T, Koo BK, Piek JJ. Combined Assessment of FFR and CFR for Decision Making in Coronary Revascularization: From the Multicenter International ILIAS Registry. JACC Cardiovasc Interv 2022;15:1047-56. [PMID: 35589234 DOI: 10.1016/j.jcin.2022.03.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Demir OM, Boerhout CKM, de Waard GA, van de Hoef TP, Patel N, Beijk MAM, Williams R, Rahman H, Everaars H, Kharbanda RK, Knaapen P, van Royen N, Piek JJ, Perera D; Oxford Acute Myocardial Infarction (OxAMI) Study. Comparison of Doppler Flow Velocity and Thermodilution Derived Indexes of Coronary Physiology. JACC Cardiovasc Interv 2022;15:1060-70. [PMID: 35589236 DOI: 10.1016/j.jcin.2022.03.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Lee SH, Hong D, Dai N, Shin D, Choi KH, Kim SM, Kim HK, Jeon K, Ha SJ, Lee KY, Park TK, Yang JH, Song YB, Hahn J, Choi S, Choe YH, Gwon H, Ge J, Lee JM. Anatomic and Hemodynamic Plaque Characteristics for Subsequent Coronary Events. Front Cardiovasc Med 2022;9:871450. [DOI: 10.3389/fcvm.2022.871450] [Reference Citation Analysis]
182 Yokoi M, Ito T, Nakayama T, Fujita H, Sugiura T, Seo Y. Effects of hemodialysis and reduced estimated glomerular filtration rate in nonhemodialysis on clinical outcomes after fractional flow reserve-guided deferral of revascularization. Medicine (Baltimore) 2022;101:e29256. [PMID: 35608428 DOI: 10.1097/MD.0000000000029256] [Reference Citation Analysis]
183 Altıparmak IH, Tanrıverdi Z, Taşcanov MB, Güngören F, Biçer A, Fedai H, Toprak K, Elmas AN, Demirbağ R. C-Reactive Protein/Albumin Ratio as a Novel Predictor of Contrast Induced Nephropathy in Patients With Stable Angina Pectoris. Angiology 2022;:33197221103635. [PMID: 35589620 DOI: 10.1177/00033197221103635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Kielb J, Weber J, Shahjerdi K, Saffak S, Baensch L, Glugla S, Polzin A, Zeus T, Kelm M, Dannenberg L. Untapped Potential for Female Patients? Comment on Lucà et al. Update on Management of Cardiovascular Diseases in Women. J. Clin. Med. 2022, 11, 1176. J Clin Med 2022;11:2862. [PMID: 35628988 DOI: 10.3390/jcm11102862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Jourdi G, Marquis-Gravel G, Martin AC, Lordkipanidzé M, Godier A, Gaussem P. Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines. Front Pharmacol 2022;13:878416. [PMID: 35571090 DOI: 10.3389/fphar.2022.878416] [Reference Citation Analysis]
186 Beyene SD, Nikus KC, Lehtimäki TJ, Kähönen MAP, Viik JJ. Evaluation of the QRS score for diagnosing coronary artery disease in women: A Finnish cardiovascular study. Ann Noninvasive Electrocardiol 2022;:e12968. [PMID: 35580147 DOI: 10.1111/anec.12968] [Reference Citation Analysis]
187 Vesterbekkmo EK, Madssen E, Aamot Aksetøy I, Follestad T, Nilsen HO, Hegbom K, Wisløff U, Wiseth R. CENIT (Impact of Cardiac Exercise Training on Lipid Content in Coronary Atheromatous Plaques Evaluated by Near‐Infrared Spectroscopy): A Randomized Trial. JAHA. [DOI: 10.1161/jaha.121.024705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Cheng SQ, Liu NF, Fang LJ, Li M. Factors predicting the occurrence of aortic valve calcification in patients with coronary artery calcification in China. Acta Cardiol 2022;:1-8. [PMID: 35575298 DOI: 10.1080/00015385.2022.2072053] [Reference Citation Analysis]
189 Sharma SP, Manintveld OC, Budde RPJ, Hirsch A, Lenzen MJ, Galema TW. Gender Differences in Patients With Stable Chest Pain. Am J Cardiol 2022;171:84-90. [PMID: 35277254 DOI: 10.1016/j.amjcard.2022.01.054] [Reference Citation Analysis]
190 Palma C, David C, Fernandes RM, Pinto FJ, Costa J, Ferreira JJ, Caldeira D. The sham effect of invasive interventions in chronic coronary syndromes: a systematic review and meta-analysis. BMC Cardiovasc Disord 2022;22:223. [PMID: 35568808 DOI: 10.1186/s12872-022-02658-x] [Reference Citation Analysis]
191 Cattaneo M, Halasz G, Cattaneo MM, Younes A, Gallino C, Sudano I, Gallino A. The Central Nervous System and Psychosocial Factors in Primary Microvascular Angina. Front Cardiovasc Med 2022;9:896042. [DOI: 10.3389/fcvm.2022.896042] [Reference Citation Analysis]
192 Tar B, Ágoston A, Üveges Á, Szabó GT, Szűk T, Komócsi A, Czuriga D, Csippa B, Paál G, Kőszegi Z. Pressure- and 3D-Derived Coronary Flow Reserve with Hydrostatic Pressure Correction: Comparison with Intracoronary Doppler Measurements. JPM 2022;12:780. [DOI: 10.3390/jpm12050780] [Reference Citation Analysis]
193 Fernando H, Mcfadyen JD, Wang X, Shaw J, Stub D, Peter K. P2Y12 Antagonists in Cardiovascular Disease—Finding the Best Balance Between Preventing Ischemic Events and Causing Bleeding. Front Cardiovasc Med 2022;9:854813. [DOI: 10.3389/fcvm.2022.854813] [Reference Citation Analysis]
194 Chen S, Ma C, Feng X, Cui M. Nicorandil Improves Left Ventricular Myocardial Strain in Patients With Coronary Chronic Total Occlusion. Front Cardiovasc Med 2022;9:864223. [DOI: 10.3389/fcvm.2022.864223] [Reference Citation Analysis]
195 Adjedj J, Morelle JF, Saint Etienne C, Fichaux O, Marcollet P, Decomis MP, Motreff P, Chassaing S, Koning R, Range G; all France PCI investigators. Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry. Catheter Cardiovasc Interv 2022. [PMID: 35544784 DOI: 10.1002/ccd.30225] [Reference Citation Analysis]
196 Kawase Y, Matsuo H, Kuramitsu S, Shiono Y, Akasaka T, Tanaka N, Amano T, Kozuma K, Nakamura M, Yokoi H, Kobayashi Y, Ikari Y. Clinical use of physiological lesion assessment using pressure guidewires: an expert consensus document of the Japanese association of cardiovascular intervention and therapeutics-update 2022. Cardiovasc Interv Ther 2022. [PMID: 35543896 DOI: 10.1007/s12928-022-00863-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
197 Bradley C, Berry C. Definition and epidemiology of coronary microvascular disease. J Nucl Cardiol 2022. [PMID: 35534718 DOI: 10.1007/s12350-022-02974-x] [Reference Citation Analysis]
198 Floria M, Burlacu A. Left atrial functional changes as emerging diagnostic and prognostic marker. J Clin Ultrasound 2022;50:455-7. [PMID: 35521927 DOI: 10.1002/jcu.23168] [Reference Citation Analysis]
199 Jávorszky N, Homonnay B, Gerstenblith G, Bluemke D, Kiss P, Török M, Celentano D, Lai H, Lai S, Kolossváry M. Deep learning-based atherosclerotic coronary plaque segmentation on coronary CT angiography. Eur Radiol 2022. [PMID: 35524783 DOI: 10.1007/s00330-022-08801-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
200 Greco A, Buccheri S, Tamburino C, Capodanno D. Risk Stratification Approach to Multivessel Coronary Artery Disease. In: Dangas GD, Di Mario C, Thiele H, Barlis P, Addo T, Claessen B, Hengstenberg C, Kipshidze N, editors. Interventional Cardiology. Wiley; 2022. pp. 195-206. [DOI: 10.1002/9781119697367.ch17] [Reference Citation Analysis]
201 Rowland B, Batty JA, Dangas GD, Mehran R, Kunadian V. Oral Antiplatelet Agents in Percutaneous Coronary Intervention. In: Dangas GD, Di Mario C, Thiele H, Barlis P, Addo T, Claessen B, Hengstenberg C, Kipshidze N, editors. Interventional Cardiology. Wiley; 2022. pp. 420-38. [DOI: 10.1002/9781119697367.ch39] [Reference Citation Analysis]
202 Boucheniata C, Tessier N, Martel C. Editorial: Highlights in Lipids in Cardiovascular Disease: 2021. Front Cardiovasc Med 2022;9:915262. [DOI: 10.3389/fcvm.2022.915262] [Reference Citation Analysis]
203 Bettencourt N. Papel da Tomografia Computorizada na Exclusão de Síndrome Coronária Aguda em Contexto de Urgência: A Anatomia é o Caminho? Arquivos Brasileiros de Cardiologia 2022;118:903-4. [DOI: 10.36660/abc.20220273] [Reference Citation Analysis]
204 Huynh QL, Nghiem S, Byrnes J, Scuffham PA, Marwick T. Application of a risk-guided strategy to secondary prevention of coronary heart disease: analysis from a state-wide data linkage in Queensland, Australia. BMJ Open 2022;12:e057856. [PMID: 35508342 DOI: 10.1136/bmjopen-2021-057856] [Reference Citation Analysis]
205 Ono M, Onuma Y, Kawashima H, Hara H, Gao C, Wang R, O'Leary N, Benit E, Janssens L, Ferrario M, Żurakowski A, Dominici M, Huber K, Buszman P, Garg S, Wykrzykowska JJ, Piek JJ, Jüni P, Hamm C, Windecker S, Vranckx P, Deliargyris EN, Bhatt DL, Storey RF, Valgimigli M, Serruys PW; GLOBAL LEADERS trial investigators. Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial. Catheter Cardiovasc Interv 2022. [PMID: 35500171 DOI: 10.1002/ccd.30217] [Reference Citation Analysis]
206 De Luca L, Cappadona F, Temporelli PL, Gonzini L, Ledda A, Raisaro A, Viazzi F, Gabrielli D, Colivicchi F, Gulizia MM, Pontremoli R; On-Behalf-of-the-START-Investigators. Impact of eGFR rate on 1-year all-cause mortality in patients with stable coronary artery disease. Eur J Intern Med 2022:S0953-6205(22)00164-9. [PMID: 35513990 DOI: 10.1016/j.ejim.2022.04.021] [Reference Citation Analysis]
207 Carrabba N, Pontone G, Andreini D, Buffa V, Cademartiri F, Carbone I, Clemente A, Guaricci AI, Guglielmo M, Indolfi C, La Grutta L, Ligabue G, Liguori C, Mercuro G, Mushtaq S, Neglia D, Palmisano A, Sciagrà R, Seitun S, Vignale D, Francone M, Esposito A. Appropriateness criteria for the use of cardiac computed tomography, SIC-SIRM part 2: acute chest pain evaluation; stent and coronary artery bypass graft patency evaluation; planning of coronary revascularization and transcatheter valve procedures; cardiomyopathies, electrophysiological applications, cardiac masses, cardio-oncology and pericardial diseases evaluation. J Cardiovasc Med (Hagerstown) 2022;23:290-303. [PMID: 35486680 DOI: 10.2459/JCM.0000000000001303] [Reference Citation Analysis]
208 Blankstein R, Shaw LJ, Gulati M, Atalay MK, Bax J, Calnon DA, Dyke CK, Ferencik M, Heitner JF, Henry TD, Hung J, Knuuti J, Lindner JR, Phillips LM, Raman SV, Rao SV, Rybicki FJ, Saraste A, Stainback RF, Thompson RC, Williamson E, Nieman K, Tremmel JA, Woodard PK, Di Carli MF, Chandrashekhar YS. Implications of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline for Cardiovascular Imaging: A Multisociety Viewpoint. JACC Cardiovasc Imaging 2022;15:912-26. [PMID: 35512960 DOI: 10.1016/j.jcmg.2022.02.021] [Reference Citation Analysis]
209 Bastiany A, Pacheco C, Sedlak T, Saw J, Miner SE, Liu S, Lavoie A, Kim DH, Gulati M, Graham MM. A Practical Approach to Invasive Testing in Ischemia with No Obstructive Coronary Arteries (INOCA). CJC Open 2022. [DOI: 10.1016/j.cjco.2022.04.009] [Reference Citation Analysis]
210 Glöckner D, Zeus T, Kelm M, Makimoto H. Recurrent nocturnal ST-T deviation and nonsustained ventricular tachycardias recorded with a smartwatch: A case report. Journal of Cardiology Cases 2022. [DOI: 10.1016/j.jccase.2022.04.006] [Reference Citation Analysis]
211 Seitz A, Pereyra VM, Hubert A, Klingel K, Bekeredjian R, Sechtem U, Ong P. Epicardial and microvascular coronary artery spasm in biopsy-proven viral myocarditis. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.05.008] [Reference Citation Analysis]
212 Barradas MI, Duarte F, Dourado R, Tavares A, Martins D. Double coronary anomaly: A case report. Journal of Cardiology Cases 2022. [DOI: 10.1016/j.jccase.2022.04.007] [Reference Citation Analysis]
213 SEC Working Group for the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice and SEC Guidelines Committee. Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed) 2022;75:364-9. [PMID: 35165071 DOI: 10.1016/j.rec.2021.10.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
214 De Luca L, Rubboli A, Lettino M, Tubaro M, Leonardi S, Casella G, Valente S, Rossini R, Sciahbasi A, Natale E, Trambaiolo P, Navazio A, Cipriani M, Corda M, De Nardo A, Francese GM, Napoletano C, Tizzani E, Nardi F, Roncon L, Caldarola P, Riccio C, Gabrielli D, Oliva F, Massimo Gulizia M, Colivicchi F. ANMCO position paper on antithrombotic treatment of patients with atrial fibrillation undergoing intracoronary stenting and/or acute coronary syndromes. Eur Heart J Suppl 2022;24:C254-71. [PMID: 35663586 DOI: 10.1093/eurheartj/suac020] [Reference Citation Analysis]
215 . Comentarios a la guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica. Revista Española de Cardiología 2022;75:364-9. [DOI: 10.1016/j.recesp.2021.10.015] [Reference Citation Analysis]
216 Sueda S, Sakaue T. Sex-related differences in coronary vasomotor disorders: Comparisons between Western and Japanese populations. Journal of Cardiology 2022. [DOI: 10.1016/j.jjcc.2022.04.002] [Reference Citation Analysis]
217 Zhang J, Li Y, Zheng B, Qiu J, Chen X, Zhou W, Fan Y, Liu M. The Predictive Value of Combining Symptoms, Residual Syntax Score and Non-Invasive Tests in the Diagnosis of Significant Coronary Artery Disease in Elderly Post-PCI Patients. IJGM 2022;Volume 15:4603-12. [DOI: 10.2147/ijgm.s357996] [Reference Citation Analysis]
218 Gallinoro E, Almendarez M, Alvarez-velasco R, Barbato E, Avanzas P. Bioresorbable stents: Is the game over? International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.05.024] [Reference Citation Analysis]
219 Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Rafael Sádaba J, Tribouilloy C, Wojakowski W. Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.11.023] [Reference Citation Analysis]
220 Rasmussen LD, Fordyce CB, Nissen L, Hill CL, Alhanti B, Hoffmann U, Udelson J, Bøttcher M, Douglas PS, Winther S. The PROMISE Minimal Risk Score Improves Risk Classification of Symptomatic Patients With Suspected CAD. JACC: Cardiovascular Imaging 2022. [DOI: 10.1016/j.jcmg.2022.03.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Pezel T, Hovasse T, Lefèvre T, Sanguineti F, Unterseeh T, Champagne S, Benamer H, Neylon A, Toupin S, Garot P, Chevalier B, Garot J. Prognostic Value of Stress CMR in Symptomatic Patients With Coronary Stenosis on CCTA. JACC: Cardiovascular Imaging 2022. [DOI: 10.1016/j.jcmg.2022.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 García AG, Fabregate M, Manzano L, Guillén del Castillo A, Rivas MR, Argibay A, Ballvé AM, Pintó IR, Salas XP, Marí-alfonso B, Moraga EC, Argüelles DC, Comet LS, González-echávarri C, Ortego-centeno N, Hitos JAV, Parra JAT, Martínez LT, Marín MTH, Freire M, Chamorro A, Fraile IP, Vuelta ABM, Trigo SS, Vilella CT, Pla VF, Aznar CPS. Left Ventricular Diastolic Dysfunction in Systemic Sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE Registry. Seminars in Arthritis and Rheumatism 2022. [DOI: 10.1016/j.semarthrit.2022.152033] [Reference Citation Analysis]
223 Shiomi H. Paradigm Shift in Ischemia Evaluation and Accumulating Evidence of Safety of Deferred Coronary Revascularization on the Basis of Invasive Fractional Flow Reserve Measurement. Circ J. [DOI: 10.1253/circj.cj-22-0204] [Reference Citation Analysis]
224 Chua A, Ihdayhid AR, Linde JJ, Sørgaard M, Cameron JD, Seneviratne SK, Ko BS. Diagnostic Performance of CT-Derived Fractional Flow Reserve in Australian Patients Referred for Invasive Coronary Angiography. Heart Lung Circ 2022:S1443-9506(22)00115-9. [PMID: 35501246 DOI: 10.1016/j.hlc.2022.03.008] [Reference Citation Analysis]
225 Tesche C, Giesen A, Korosoglou G. Commentary: Plaque Features and Epicardial Fat Volume for Cardiovascular Risk Assessment—A Key Role With Cardiac Computed Tomography? Front Cardiovasc Med 2022;9:896321. [DOI: 10.3389/fcvm.2022.896321] [Reference Citation Analysis]
226 Maurovich-Horvat P, Bosserdt M, Kofoed KF, Rieckmann N, Benedek T, Donnelly P, Rodriguez-Palomares J, Erglis A, Štěchovský C, Šakalyte G, Čemerlić Adić N, Gutberlet M, Dodd JD, Diez I, Davis G, Zimmermann E, Kępka C, Vidakovic R, Francone M, Ilnicka-Suckiel M, Plank F, Knuuti J, Faria R, Schröder S, Berry C, Saba L, Ruzsics B, Kubiak C, Gutierrez-Ibarluzea I, Schultz Hansen K, Müller-Nordhorn J, Merkely B, Knudsen AD, Benedek I, Orr C, Xavier Valente F, Zvaigzne L, Suchánek V, Zajančkauskiene L, Adić F, Woinke M, Hensey M, Lecumberri I, Thwaite E, Laule M, Kruk M, Neskovic AN, Mancone M, Kuśmierz D, Feuchtner G, Pietilä M, Gama Ribeiro V, Drosch T, Delles C, Matta G, Fisher M, Szilveszter B, Larsen L, Ratiu M, Kelly S, Garcia Del Blanco B, Rubio A, Drobni ZD, Jurlander B, Rodean I, Regan S, Cuéllar Calabria H, Boussoussou M, Engstrøm T, Hodas R, Napp AE, Haase R, Feger S, Serna-Higuita LM, Neumann K, Dreger H, Rief M, Wieske V, Estrella M, Martus P, Dewey M; DISCHARGE Trial Group. CT or Invasive Coronary Angiography in Stable Chest Pain. N Engl J Med 2022;386:1591-602. [PMID: 35240010 DOI: 10.1056/NEJMoa2200963] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 25.0] [Reference Citation Analysis]
227 Jonik S, Marchel M, Huczek Z, Kochman J, Wilimski R, Kuśmierczyk M, Grabowski M, Opolski G, Mazurek T. An Individualized Approach of Multidisciplinary Heart Team for Myocardial Revascularization and Valvular Heart Disease—State of Art. JPM 2022;12:705. [DOI: 10.3390/jpm12050705] [Reference Citation Analysis]
228 d'Entremont MA, Couture ÉL, Connelly K, Walling A, Jolly SS, Valettas N, Tsang MB, Mampuya W, Poirier P, Huynh T. Management of the master endurance athlete with stable coronary artery disease. Can J Cardiol 2022:S0828-282X(22)00263-X. [PMID: 35489669 DOI: 10.1016/j.cjca.2022.04.013] [Reference Citation Analysis]
229 Candemir M, Kiziltunç E, Candemir B, Nurkoç S, Şahinarslan A. Visceral Adiposity Index Is Associated with the Increased Syntax Score in Patients with Type 2 Diabetes Mellitus. Metab Syndr Relat Disord 2022. [PMID: 35483052 DOI: 10.1089/met.2022.0009] [Reference Citation Analysis]
230 Jalasto J, Kauppi P, Luukkonen R, Lindqvist A, Langhammer A, Kankaanranta H, Backman H, Rönmark E, Sovijärvi A, Piirilä P. Self-Reported Physician Diagnosed Asthma with COPD is Associated with Higher Mortality than Self-Reported Asthma or COPD Alone - A Prospective 24-Year Study in the Population of Helsinki, Finland. COPD 2022;19:226-35. [PMID: 35471091 DOI: 10.1080/15412555.2022.2061935] [Reference Citation Analysis]
231 Lee SH, Shin D, Lee JM, van de Hoef TP, Hong D, Choi KH, Hwang D, Boerhout CKM, de Waard GA, Jung JH, Mejia-Renteria H, Hoshino M, Echavarria-Pinto M, Meuwissen M, Matsuo H, Madera-Cambero M, Eftekhari A, Effat MA, Murai T, Marques K, Doh JH, Christiansen EH, Banerjee R, Kim HK, Nam CW, Niccoli G, Nakayama M, Tanaka N, Shin ES, Chamuleau SAJ, van Royen N, Knaapen P, Koo BK, Kakuta T, Escaned J, Piek JJ; ILIAS Registry Investigators †. Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction. J Am Heart Assoc 2022;:e025171. [PMID: 35475358 DOI: 10.1161/JAHA.121.025171] [Reference Citation Analysis]
232 Turck D, Bohn T, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Knutsen HK, Maciuk A, Mangelsdorf I, McArdle HJ, Naska A, Peláez C, Pentieva K, Thies F, Tsabouri S, Vinceti M, Bresson JL, Siani A; EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Scientific advice related to nutrient profiling for the development of harmonised mandatory front-of-pack nutrition labelling and the setting of nutrient profiles for restricting nutrition and health claims on foods. EFSA J 2022;20:e07259. [PMID: 35464873 DOI: 10.2903/j.efsa.2022.7259] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
233 Gröschel J, Trauzeddel RF, Blaszczyk E, Schulz-Menger J. [Role of cardiovascular magnetic resonance in cardiovascular diagnostics]. Dtsch Med Wochenschr 2022;147:528-37. [PMID: 35468634 DOI: 10.1055/a-1554-8382] [Reference Citation Analysis]
234 Yamaura H, Otsuka K, Ishikawa H, Shirasawa K, Fukuda D, Kasayuki N. Determinants of Non-calcified Low-Attenuation Coronary Plaque Burden in Patients Without Known Coronary Artery Disease: A Coronary CT Angiography Study. Front Cardiovasc Med 2022;9:824470. [PMID: 35463764 DOI: 10.3389/fcvm.2022.824470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Lee YJ, Cho JY, Yun KH, Lee SJ, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y, Kim JS. Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month DAPT trial. EuroIntervention 2022:EIJ-D-22-00135. [PMID: 35470799 DOI: 10.4244/EIJ-D-22-00135] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
236 Wei W, Liu J, Chen S, Xu X, Guo D, He Y, Huang Z, Wang B, Huang H, Li Q, Chen J, Chen H, Tan N, Liu Y. Sodium Glucose Cotransporter Type 2 Inhibitors Improve Cardiorenal Outcome of Patients With Coronary Artery Disease: A Meta-Analysis. Front Endocrinol (Lausanne) 2022;13:850836. [PMID: 35330914 DOI: 10.3389/fendo.2022.850836] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
237 Han C, Kang KW, Kim TY, Uhm JS, Park JW, Jung IH, Kim M, Bae S, Lim HS, Yoon D. Artificial Intelligence-Enabled ECG Algorithm for the Prediction of Coronary Artery Calcification. Front Cardiovasc Med 2022;9:849223. [PMID: 35463761 DOI: 10.3389/fcvm.2022.849223] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
238 Meng H, Li L, Ruan J, Chen Y, Yan Z, Liu J, Li X, Mao C, Yang P, Jiang W. Association of Low Expression of NUMB in Peripheral Blood with Acute Myocardial Infarction. Cardiology Research and Practice 2022;2022:1-7. [DOI: 10.1155/2022/7981637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Táborský M, Kautzner J, Fedorco M, Čurila K, Wünschová H, Pyszko J, Novák M, Kozák M, Válek M, Polášek R, Keprt P, Kubíčková M, Plášek J, Gloger V, Bulava A, Vančura V, Skála T, Pařízek P, Daněk J. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Translation of the document prepared by the Czech Society of Cardiology. Cor Vasa 2022;64:7-86. [DOI: 10.33678/cor.2022.024] [Reference Citation Analysis]
240 Diekmann J, Bengel FM. [Clinical use of Cardiac Nuclear Medicine in Germany]. Dtsch Med Wochenschr 2022;147:538-48. [PMID: 35468635 DOI: 10.1055/a-1554-8415] [Reference Citation Analysis]
241 Blaum C, Arnold N, Waldeyer C. Kosten-Nutzen-Analyse neuer Lipidsenker. Herz. [DOI: 10.1007/s00059-022-05116-8] [Reference Citation Analysis]
242 Hu Q, Han Y, Zhou T, Wang X, Zhang Q. Efficacy and Safety of the Reduced Bivalirudin in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention Stratified by Renal Function (REDUCE BOLUS): A Single-Blind, Stratified Randomized, Non-inferiority Trial. Front Cardiovasc Med 2022;9:864048. [DOI: 10.3389/fcvm.2022.864048] [Reference Citation Analysis]
243 Haq TU, Zahoor A, Ali Y, Chen Y, Jalil F, Shah AA. Genetic Variants of MIR27A, MIR196A2 May Impact the Risk for the Onset of Coronary Artery Disease in the Pakistani Population. Genes 2022;13:747. [DOI: 10.3390/genes13050747] [Reference Citation Analysis]
244 Al-Lamee R, Aubiniere-Robb L, Berry C. The British Cardiovascular Society and clinical studies in ischaemic heart disease: from RITA to ORBITA, and beyond. Heart 2022;108:800-6. [PMID: 35459731 DOI: 10.1136/heartjnl-2021-320150] [Reference Citation Analysis]
245 Viscusi MM, Mangiacapra F, Circhetta S, Paolucci L, De Luca R, Nusca A, Melfi R, Ricottini E, Ussia GP, Grigioni F. Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention. J Thromb Thrombolysis 2022. [PMID: 35445902 DOI: 10.1007/s11239-022-02657-x] [Reference Citation Analysis]
246 Evertz R, Lange T, Backhaus SJ, Schulz A, Beuthner BE, Topci R, Toischer K, Puls M, Kowallick JT, Hasenfuß G, Schuster A, Kim MC. Artificial Intelligence Enabled Fully Automated CMR Function Quantification for Optimized Risk Stratification in Patients Undergoing Transcatheter Aortic Valve Replacement. Journal of Interventional Cardiology 2022;2022:1-9. [DOI: 10.1155/2022/1368878] [Reference Citation Analysis]
247 Drapkina OM, Kontsevaya AV, Kalinina AM, Avdeev SM, Agaltsov MV, Alexandrova LM, Antsiferova AA, Aronov DM, Akhmedzhanov NM, Balanova YA, Balakhonova TV, Berns SA, Bochkarev MV, Bochkareva EV, Bubnova MV, Budnevsky AV, Gambaryan MG, Gorbunov VM, Gorny BE, Gorshkov AY, Gumanova NG, Dadaeva VA, Drozdova LY, Egorov VA, Eliashevich SO, Ershova AI, Ivanova ES, Imaeva AE, Ipatov PV, Kaprin AD, Karamnova NS, Kobalava ZD, Konradi AO, Kopylova OV, Korostovtseva LS, Kotova MB, Kulikova MS, Lavrenova EA, Lischenko OV, Lopatina MV, Lukina YV, Lukyanov MM, Mayev IV, Mamedov MN, Markelova SV, Martsevich SY, Metelskaya VA, Meshkov AN, Milushkina OY, Mukaneeva DK, Myrzamatova AO, Nebieridze DV, Orlov DO, Poddubskaya EA, Popovich MV, Popovkina OE, Potievskaya VI, Prozorova GG, Rakovskaya YS, Rotar OP, Rybakov IA, Sviryaev YV, Skripnikova IA, Skoblina NA, Smirnova MI, Starinsky VV, Tolpygina SN, Usova EV, Khailova ZV, Shalnova SA, Shepel RN, Shishkova VN, Yavelov IS. 2022 Prevention of chronic non-communicable diseases in Of the Russian Federation. National guidelines. Cardiovasc Ther Prev 2022;21:3235. [DOI: 10.15829/1728-8800-2022-3235] [Reference Citation Analysis]
248 Koopman MY, Reijnders JJW, Willemsen RTA, van Bruggen R, Doggen CJM, Kietselaer B, Oude Wolcherink MJ, van Ooijen PMA, Gratama JWC, Braam R, Oudkerk M, van der Harst P, Dinant GJ, Vliegenthart R. Coronary calcium scoring as first-line test to detect and exclude coronary artery disease in patients presenting to the general practitioner with stable chest pain: protocol of the cluster-randomised CONCRETE trial. BMJ Open 2022;12:e055123. [PMID: 35440450 DOI: 10.1136/bmjopen-2021-055123] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
249 Cai Y, Hao B, Chen J, Li Y, Liu H. Correlation Between Plasma Proteomics and Adverse Outcomes Among Older Men With Chronic Coronary Syndrome. Front Cardiovasc Med 2022;9:867646. [DOI: 10.3389/fcvm.2022.867646] [Reference Citation Analysis]
250 Budassi S, Biccirè FG, Paoletti G, Marco V, Boi A, Romagnoli E, Fabbiocchi F, Fineschi M, Di Pietro R, Versaci F, Calligaris G, Gatto L, Albertucci M, Ramazzotti V, Burzotta F, Ozaki Y, Arbustini E, Alfonso F, Prati F. The Role of the Association Between Serum C-Reactive Protein Levels and Coronary Plaque Macrophage Accumulation in Predicting Clinical Events - Results from the CLIMA Registry. J Cardiovasc Transl Res 2022. [PMID: 35437619 DOI: 10.1007/s12265-022-10250-z] [Reference Citation Analysis]
251 D’ascenzi F, Baggiano A, Cavigli L, Mandoli GE, Andreini D, Marallo C, Valente S, Focardi M, Cameli M, Pontone G. The role of cardiac computed tomography in sports cardiology: back to the future! European Heart Journal - Cardiovascular Imaging 2022. [DOI: 10.1093/ehjci/jeac069] [Reference Citation Analysis]
252 Liu X, Zhou W, Fan W, Li A, Pang J, Chen Z, Li X, Hu X, Zeng Y, Tang L. The benefit of exercise rehabilitation guided by 6-minute walk test on lipoprotein-associated phospholipase A2 in patients with coronary heart disease undergoing percutaneous coronary intervention: a prospective randomized controlled study. BMC Cardiovasc Disord 2022;22. [DOI: 10.1186/s12872-021-02430-7] [Reference Citation Analysis]
253 Minhas AS, Goerlich E, Corretti MC, Arbab-zadeh A, Kelle S, Leucker T, Lerman A, Hays AG. Imaging Assessment of Endothelial Function: An Index of Cardiovascular Health. Front Cardiovasc Med 2022;9:778762. [DOI: 10.3389/fcvm.2022.778762] [Reference Citation Analysis]
254 von Känel R, Meister-langraf RE, Zuccarella-hackl C, Znoj H, Pazhenkottil AP, Schmid J, Barth J, Schnyder U, Princip M. Association Between Changes in Post-hospital Cardiac Symptoms and Changes in Acute Coronary Syndrome-Induced Symptoms of Post-traumatic Stress. Front Cardiovasc Med 2022;9:852710. [DOI: 10.3389/fcvm.2022.852710] [Reference Citation Analysis]
255 You H, Zhang R, Hu J, Sun Y, Li X, Hou J, Pei Y, Zhao L, Zhang L, Yang B. Performance of Radiomics Models Based on Coronary Computed Tomography Angiography in Predicting The Risk of Major Adverse Cardiovascular Events Within 3 Years: A Comparison Between the Pericoronary Adipose Tissue Model and the Epicardial Adipose Tissue Model. Acad Radiol 2022:S1076-6332(22)00192-1. [PMID: 35431140 DOI: 10.1016/j.acra.2022.03.015] [Reference Citation Analysis]
256 Vergallo R, Volpe M. The DISCHARGE trial: imaging a new strategy for the clinical management of stable chest pain? Eur Heart J 2022:ehac193. [PMID: 35417531 DOI: 10.1093/eurheartj/ehac193] [Reference Citation Analysis]
257 Piao JJ, Wan B, Zhao H, Shang Z, Yan L, Hao Z, Wang Y, Zhang Y, Gu Y. Effects of different brisk walking intensities on adherence and cardiorespiratory endurance of cardiac rehabilitation among patients with CHD after PCI: protocol for a randomised controlled trial. BMJ Open 2022;12:e055437. [PMID: 35418429 DOI: 10.1136/bmjopen-2021-055437] [Reference Citation Analysis]
258 Baskaran L, Neo YP, Lee JK, Yoon YE, Jiang Y, Al'Aref SJ, van Rosendael AR, Han D, Lin FY, Nakanishi R, Maurovich Horvat P, Tan SY, Villines TC, Bittencourt MS, Shaw LJ. Evaluating the Coronary Artery Disease Consortium Model and the Coronary Artery Calcium Score in Predicting Obstructive Coronary Artery Disease in a Symptomatic Mixed Asian Cohort. J Am Heart Assoc 2022;:e022697. [PMID: 35411790 DOI: 10.1161/JAHA.121.022697] [Reference Citation Analysis]
259 Linden F, Frey N, Erbel C. Die polyvaskuläre Erkrankung – eine Übersicht über die Datenlage und Managementstrategien. Aktuelle Kardiologie 2022;11:147-53. [DOI: 10.1055/a-1693-2284] [Reference Citation Analysis]
260 Liu J, Wang X, Li B, Huang S, Sun H, Zhang L, Sun Y, Liu Z, Liu J, Wang L, Zhao X, Wang W, Zhang M, Liu Y. Non-Invasive Quantification of Fraction Flow Reserve Based on Steady-State Geometric Multiscale Models. Front Physiol 2022;13:881826. [DOI: 10.3389/fphys.2022.881826] [Reference Citation Analysis]
261 Mcdermott M, Bing R. Coronary vasospasm and future percutaneous coronary intervention: relax. Heart. [DOI: 10.1136/heartjnl-2022-320974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
262 Nazir MS, Bustin A, Hajhosseiny R, Yazdani M, Ryan M, Vergani V, Neji R, Kunze KP, Nicol E, Masci PG, Perera D, Plein S, Chiribiri A, Botnar R, Prieto C. High-resolution non-contrast free-breathing coronary cardiovascular magnetic resonance ngiography for detection of coronary artery disease: validation against invasive coronary angiography. J Cardiovasc Magn Reson 2022;24:26. [PMID: 35399091 DOI: 10.1186/s12968-022-00858-0] [Reference Citation Analysis]
263 Pogorielova OS, Korniienko VV, Chumachenko YD, Obukhova OA, Martsovenko I, Harbuzova VY, Sun J. Impact of MMP-9 Genetic Polymorphism and Concentration on the Development of Coronary Artery Disease in Ukrainian Population. Cardiology Research and Practice 2022;2022:1-8. [DOI: 10.1155/2022/2067632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
264 De Caterina R, Calabrò P, Campo G, Rossini R, Giubilato S. A Therapeutic Pathway in Patients with Chronic Coronary Syndromes: Proposal for Optimization. JCM 2022;11:2091. [DOI: 10.3390/jcm11082091] [Reference Citation Analysis]
265 Gao F, Rahman F. DOACs and Atherosclerotic Cardiovascular Disease Management: Can We Find the Right Balance Between Efficacy and Harm. Curr Atheroscler Rep 2022. [PMID: 35386093 DOI: 10.1007/s11883-022-01022-w] [Reference Citation Analysis]
266 Dou G, Shan D, Wang K, Wang X, Liu Z, Zhang W, Li D, He B, Jing J, Wang S, Chen Y, Yang J. Integrating Coronary Plaque Information from CCTA by ML Predicts MACE in Patients with Suspected CAD. JPM 2022;12:596. [DOI: 10.3390/jpm12040596] [Reference Citation Analysis]
267 Nazir MS, Rodriguez-Guadarrama Y, Rua T, Bui KH, Buylova Gola A, Chiribiri A, McCrone P, Plein S, Pennington M. Cost-effectiveness in diagnosis of stable angina patients: a decision-analytical modelling approach. Open Heart 2022;9:e001700. [PMID: 35379740 DOI: 10.1136/openhrt-2021-001700] [Reference Citation Analysis]
268 Rocco E, Grimaldi MC, Maino A, Cappannoli L, Pedicino D, Liuzzo G, Biasucci LM. Advances and Challenges in Biomarkers Use for Coronary Microvascular Dysfunction: From Bench to Clinical Practice. JCM 2022;11:2055. [DOI: 10.3390/jcm11072055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
269 Mancia G, Kjeldsen SE, Kreutz R, Pathak A, Grassi G, Esler M. Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines. Hypertension 2022;79:1153-66. [PMID: 35378981 DOI: 10.1161/HYPERTENSIONAHA.122.19020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
270 Rohlfing AK, Kolb K, Sigle M, Ziegler M, Bild A, Münzer P, Sudmann J, Dicenta V, Harm T, Manke MC, Geue S, Kremser M, Chatterjee M, Liang C, von Eysmondt H, Dandekar T, Heinzmann D, Günter M, von Ungern-Sternberg S, Büttcher M, Castor T, Mencl S, Langhauser F, Sies K, Ashour D, Beker MC, Lämmerhofer M, Autenrieth SE, Schäffer TE, Laufer S, Szklanna P, Maguire P, Heikenwalder M, Müller KAL, Hermann DM, Kilic E, Stumm R, Ramos G, Kleinschnitz C, Borst O, Langer HF, Rath D, Gawaz M. ACKR3 regulates platelet activation and ischemia-reperfusion tissue injury. Nat Commun 2022;13:1823. [PMID: 35383158 DOI: 10.1038/s41467-022-29341-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
271 Pahud de Mortanges A, Sinaci E, Salvador D Jr, Bally L, Muka T, Wilhelm M, Bano A. GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events. Front Pharmacol 2022;13:856111. [PMID: 35370744 DOI: 10.3389/fphar.2022.856111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
272 Tabachnikov V, Saliba W, Aker A, Zafrir B. Heart Rate Response to Exercise and Recovery: INDEPENDENT PROGNOSTIC MEASURES IN PATIENTS WITHOUT KNOWN MAJOR CARDIOVASCULAR DISEASE. J Cardiopulm Rehabil Prev 2022. [PMID: 35383665 DOI: 10.1097/HCR.0000000000000679] [Reference Citation Analysis]
273 Jansen TPJ, Konst RE, de Vos A, Paradies V, Teerenstra S, van den Oord SCH, Dimitriu-Leen A, Maas AHEM, Smits PC, Damman P, van Royen N, Elias-Smale SE. Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial. JACC Cardiovasc Imaging 2022:S1936-878X(22)00177-2. [PMID: 35466050 DOI: 10.1016/j.jcmg.2022.03.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
274 Lévy BI, Mourad JJ. Renin Angiotensin Blockers and Cardiac Protection: From Basis to Clinical Trials. Am J Hypertens 2022;35:293-302. [PMID: 34265036 DOI: 10.1093/ajh/hpab108] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
275 L.j. Visseren F, Mach F, M. Smulders Y, Carballo D, C. Koskinas K, Bäck M, Benetos A, Biffi A, Manuel Boavida J, Capodanno D, Cosyns B, Crawford C, H. Davos C, Desormais I, Di Angelantonio E, H. Franco O, Halvorsen S, Richard Hobbs F, Hollander M, A. Jankowska E, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, P. Tsioufis K, van Dis I, C. van Gelder I, Wanner C, Williams B. Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.10.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Wang J, Chen H, Zhou L, Zhang X, Chen B, Chen K, Fang X. Prediction of acute myocardial infarction by multi-parameter coronary computed tomography angiography. Clinical Radiology 2022. [DOI: 10.1016/j.crad.2022.02.021] [Reference Citation Analysis]
277 Sulava EF, Johnson JC. Management of Coronary Artery Disease. Surgical Clinics of North America 2022. [DOI: 10.1016/j.suc.2022.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Hinton J, Bashar H, Curzen N. Atheroma or ischemia: which is more important for managing patients with stable chest pain? Future Cardiol 2022. [PMID: 35360934 DOI: 10.2217/fca-2021-0053] [Reference Citation Analysis]
279 Baptista R, Maricoto T, Monteiro S, Dias J, Gonçalves S, Febra H, Gil V. Practical approach to referral from primary health care to a cardiology hospital consultation in 2021. Revista Portuguesa de Cardiologia 2022. [DOI: 10.1016/j.repc.2022.01.007] [Reference Citation Analysis]
280 Parry M, Van Spall HG, Mullen K, Mulvagh SL, Pacheco C, Colella TJ, Clavel M, Jaffer S, Foulds HJ, Grewal J, Hardy M, Price JA, Levinsson AL, Gonsalves CA, Norris CM. The Canadian Women’s Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of Cardiovascular Disease in Women-Chapter 6: Sex- And Gender-Specific Diagnosis and Treatment. CJC Open 2022. [DOI: 10.1016/j.cjco.2022.04.002] [Reference Citation Analysis]
281 Seitz A, Pereyra VM, Sechtem U, Ong P. Update on coronary artery spasm 2022 – A narrative review. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Hara H, Serruys PW, O'Leary N, Gao C, Murray A, Breslin E, Garg S, Bureau C, Reiber JH, Barbato E, Aminian A, Janssens L, Rosseel L, Benit E, Campo G, Guiducci V, Casella G, Santarelli A, Franzè A, Diaz VAJ, Iñiguez A, Brugaletta S, Sabate M, Amat-Santos IJ, Amoroso G, Wykrzykowska J, von Birgelen C, Somi S, Liu T, Hofma SH, Curzen N, Trillo R, Ocaranza R, Mathur A, Smits PC, Escaned J, Baumbach A, Wijns W, Sharif F, Onuma Y; PIONEER IV trial investigator. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design. Am Heart J 2022;246:32-43. [PMID: 34990582 DOI: 10.1016/j.ahj.2021.12.018] [Reference Citation Analysis]
283 Taylor AJ, Papapostolou S. Finding the Right Pathway for the Assessment of Stable Coronary Artery Disease. JACC Cardiovasc Imaging 2022;15:626-8. [PMID: 35393065 DOI: 10.1016/j.jcmg.2021.12.009] [Reference Citation Analysis]
284 Moschetti K, Kwong RY, Petersen SE, Lombardi M, Garot J, Atar D, Rademakers FE, Sierra-Galan LM, Mavrogeni S, Li K, Fernandes JL, Schneider S, Pinget C, Ge Y, Antiochos P, Deluigi C, Bruder O, Mahrholdt H, Schwitter J. Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR/SPINS Registries. JACC Cardiovasc Imaging 2022;15:607-25. [PMID: 35033498 DOI: 10.1016/j.jcmg.2021.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
285 Roesner C, Goeller M, Raaz-schrauder D, Dey D, Kilian T, Achenbach S, Marwan M, Bittner DO. Differences of inflammatory cytokine profile in patients with vulnerable plaque: A coronary CTA study. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.04.011] [Reference Citation Analysis]
286 Indraratna P, Naoum C, Ben Zekry S, Gransar H, Blanke P, Sellers S, Achenbach S, Al-Mallah MH, Andreini D, Berman DS, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chinnaiyan K, Chow BJW, Cury RC, DeLago A, Feuchtner G, Hadamitzky M, Hausleiter J, Kaufmann PA, Kim YJ, Maffei E, Marques H, Gonçalves PA, Pontone G, Raff GL, Rubinshtein R, Villines TC, Lin FY, Shaw LJ, Narula J, Bax JJ, Leipsic JA. Aspirin and Statin Therapy for Nonobstructive Coronary Artery Disease: Five-year Outcomes from the CONFIRM Registry. Radiol Cardiothorac Imaging 2022;4:e210225. [PMID: 35506137 DOI: 10.1148/ryct.210225] [Reference Citation Analysis]
287 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JG, Coats AJ, Crespo-leiro MG, Farmakis D, Gilard M, Heyman S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CS, Lyon AR, Mcmurray JJ, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GM, Ruschitzka F, Skibelund AK. Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.11.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
288 Meng S, Guo L, Ye Z, Wang J, Ding H, Wu S, Huang R. Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Cohort Study. CIA 2022;Volume 17:331-41. [DOI: 10.2147/cia.s355210] [Reference Citation Analysis]
289 Lourida KG, Louridas GE. Clinical Phenotypes of Cardiovascular and Heart Failure Diseases Can Be Reversed? The Holistic Principle of Systems Biology in Multifaceted Heart Diseases. Cardiogenetics 2022;12:142-69. [DOI: 10.3390/cardiogenetics12020015] [Reference Citation Analysis]
290 Javaid A, Ahmed AI, Han Y, Al Rifai M, Saad JM, Alfawara MS, Alahdab F, El Nihum L, Jimenez Y, Newstorm E, Al-mallah MH. Incremental prognostic value of spect over CCTA. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.04.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
291 Bettencourt N. Estimating the pre-test probability of coronary artery disease according to the ESC guidelines: Are we getting there? Revista Portuguesa de Cardiologia 2022. [DOI: 10.1016/j.repc.2022.02.002] [Reference Citation Analysis]
292 Ahmed KO, Ahmed AM, Wali MB, Ali AH, Azhari MM, Babiker A, Yousef BA, Muddather HF. Optimal Medical Therapy for Secondary Prevention of Acute Coronary Syndrome: A Retrospective Study from a Tertiary Hospital in Sudan. TCRM 2022;Volume 18:391-8. [DOI: 10.2147/tcrm.s361129] [Reference Citation Analysis]
293 Edvardsen T, Asch FM, Davidson B, Delgado V, Demaria A, Dilsizian V, Gaemperli O, Garcia MJ, Kamp O, Lee DC, Neglia D, Neskovic AN, Pellikka PA, Plein S, Sechtem U, Shea E, Sicari R, Villines TC, Lindner JR, Popescu BA. Non-Invasive Imaging in Coronary Syndromes: Recommendations of The European Association of Cardiovascular Imaging and the American Society of Echocardiography, in Collaboration with The American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography 2022;35:329-54. [DOI: 10.1016/j.echo.2021.12.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
294 Miyata K, Asano T, Saito A, Abe K, Tanigaki T, Hoshino M, Kobayashi T, Takaoka Y, Kanie T, Yamasaki M, Yoshino K, Wakabayashi N, Ouchi K, Kodama H, Shiina Y, Tamaki R, Nishihata Y, Masuda K, Suzuki T, Nonaka H, Emori H, Katagiri Y, Miyazaki Y, Sotomi Y, Yasunaga M, Kogame N, Kuramitsu S, Reiber JHC, Okamura T, Higuchi Y, Kakuta T, Misumi H, Komiyama N, Matsuo H, Tanabe K; DECISION QFR investigators. Heart Team risk assessment with angiography-derived fractional flow reserve determining the optimal revascularization strategy in patients with multivessel disease: Trial design and rationale for the DECISION QFR randomized trial. Clin Cardiol 2022. [PMID: 35362109 DOI: 10.1002/clc.23821] [Reference Citation Analysis]
295 Di Lisi D, Madaudo C, Alagna G, Santoro M, Rossetto L, Siragusa S, Novo G. The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity. ESC Heart Fail 2022. [PMID: 35355425 DOI: 10.1002/ehf2.13897] [Reference Citation Analysis]
296 Ji W, Wu L, Pan G, Zou X. Effects and Safety of Non-Pharmacological Therapies of Traditional Chinese Medicine for Coronary Heart Disease: An Overview of Systematic Reviews. Evid Based Complement Alternat Med 2022;2022:8465269. [PMID: 35345620 DOI: 10.1155/2022/8465269] [Reference Citation Analysis]
297 Spione F, Arevalos V, Gabani R, Sabaté M, Brugaletta S. Coronary Microvascular Angina: A State-of-the-Art Review. Front Cardiovasc Med 2022;9:800918. [DOI: 10.3389/fcvm.2022.800918] [Reference Citation Analysis]
298 Hong N, Cho YD, Kim HS, Pang CH, Yoo DH, Kim JE, Kim KM, Cho WS, Lee SH, Kang HS. Is it safe to discontinue antiplatelet medication after stent-assisted coil embolization? If so, when is the best time? J Neuroradiol 2022:S0150-9861(22)00105-5. [PMID: 35364131 DOI: 10.1016/j.neurad.2022.03.009] [Reference Citation Analysis]
299 Lim Y, Kim MC, Ahn Y, Cho KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Baek SH, Her S, Lee KY, Han SH, Rha S, Choi D, Gwon H, Kwon HM, Yang T, Park K, Jo S. Prognostic Impact of Chronic Vasodilator Therapy in Patients With Vasospastic Angina. JAHA. [DOI: 10.1161/jaha.121.023776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
300 Lazar DR, Lazar F, Homorodean C, Cainap C, Focsan M, Cainap S, Olinic DM, El-khazragy N. High-Sensitivity Troponin: A Review on Characteristics, Assessment, and Clinical Implications. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/9713326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
301 Zhang Q, Wang Y, Hu X, Tan Y, Gao C, Chen J, Han F, Chen J, Yang Y. Association of serum cardiac troponin I and severity of coronary stenosis in patients with varied renal functions: a retrospective cohort study. BMJ Open 2022;12:e054722. [DOI: 10.1136/bmjopen-2021-054722] [Reference Citation Analysis]
302 Palau P, Núñez J, Monmeneu JV, Lopez-Lereu MP, Gavara J, Rios-Navarro C, de Dios E, Perez-Sole N, Marcos-Garces V, Domínguez E, Moratal D, Canoves J, Miñana G, Chorro FJ, Bodi V. Sex Effect in the Decision to Perform Invasive Coronary Angiography in Patients With Chronic Coronary Syndrome After Undergoing Vasodilator Stress MRI. J Magn Reson Imaging 2022. [PMID: 35344231 DOI: 10.1002/jmri.28163] [Reference Citation Analysis]
303 Jonik S, Marchel M, Pędzich-Placha E, Pietrasik A, Rdzanek A, Huczek Z, Kochman J, Budnik M, Piątkowski R, Scisło P, Czub P, Wilimski R, Maksym J, Grabowski M, Opolski G, Mazurek T. Optimal Management of Patients with Severe Coronary Artery Disease following Multidisciplinary Heart Team Approach-Insights from Tertiary Cardiovascular Care Center. Int J Environ Res Public Health 2022;19:3933. [PMID: 35409613 DOI: 10.3390/ijerph19073933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 Ooi EL, Rajendran S. Obstructive Sleep Apnea in Coronary Artery Disease. Curr Probl Cardiol 2022;:101178. [PMID: 35341799 DOI: 10.1016/j.cpcardiol.2022.101178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
305 Tan BE, Wong PY, Baibhav B, Thakkar S, Azhar AZ, Rao M, Cheung JW. Clopidogrel Versus Aspirin Monotherapy Following Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis. Curr Probl Cardiol 2022;:101174. [PMID: 35341798 DOI: 10.1016/j.cpcardiol.2022.101174] [Reference Citation Analysis]
306 Wu F, Ma K, Xiang R, Han B, Chang J, Zuo Z, Luo Y, Mao M. Efficacy and safety of a bridging strategy that uses intravenous platelet glycoprotein receptor inhibitors for patients undergoing surgery after coronary stent implantation: a meta-analysis. BMC Cardiovasc Disord 2022;22:125. [PMID: 35331138 DOI: 10.1186/s12872-022-02563-3] [Reference Citation Analysis]
307 Rottura M, Molonia A, Giorgi DA, Marino S, Scoglio R, Pallio G, Irrera N, Imbalzano E, Altavilla D, Squadrito G, Squadrito F, Arcoraci V. Pharmacological Treatment of Diabetic and Non-Diabetic Patients With Coronary Artery Disease in the Real World of General Practice. Front Pharmacol 2022;13:858385. [DOI: 10.3389/fphar.2022.858385] [Reference Citation Analysis]
308 Haba MȘC, Șerban DN, Șerban IL, Tudorancea IM, Haba RM, Mărănducă MA, Tănase DM, Iliescu R, Tudorancea I. Nanocarrier-Based Management of Venous and Arterial Thrombosis. Crystals 2022;12:450. [DOI: 10.3390/cryst12040450] [Reference Citation Analysis]
309 Ngo V, Tavoosi A, Natalis A, Harel F, Jolicoeur EM, Beanlands RSB, Pelletier-Galarneau M. Non-invasive diagnosis of vasospastic angina. J Nucl Cardiol 2022. [PMID: 35322379 DOI: 10.1007/s12350-022-02948-z] [Reference Citation Analysis]
310 Perera D, Berry C, Hoole SP, Sinha A, Rahman H, Morris PD, Kharbanda RK, Petraco R, Channon K. Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership. Heart. [DOI: 10.1136/heartjnl-2021-320718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
311 Wu S, Qiu Z, Lu Y, Wu X, Gao T, Xu J, Li S, Zhou X. Predictive value of ACEF II score for adverse prognosis in patients with coronary heart disease after percutaneous coronary intervention. Postgrad Med J 2022:postgradmedj-2022-141609. [PMID: 35318252 DOI: 10.1136/postgradmedj-2022-141609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
312 Lao M, Cheng Y, Gao X, Ou Q. The interaction among OSA, CPAP, and medications in patients with comorbid OSA and cardiovascular/cerebrovascular disease: a randomized controlled trial. BMC Pulm Med 2022;22:99. [PMID: 35313858 DOI: 10.1186/s12890-022-01879-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
313 Yongguang G, Yibing S, Ping X, Jinyao Z, Yufei F, Yayong H, Yuanshun X, Gutao L. Diagnostic efficacy of CCTA and CT-FFR based on risk factors for myocardial ischemia. J Cardiothorac Surg 2022;17. [DOI: 10.1186/s13019-022-01787-w] [Reference Citation Analysis]
314 Bonanni A, d’Aiello A, Pedicino D, Di Sario M, Vinci R, Ponzo M, Ciampi P, Lo Curto D, Conte C, Cribari F, Canonico F, Russo G, Montone RA, Trani C, Severino A, Crea F, Liuzzo G. Molecular Hallmarks of Ischemia with Non-Obstructive Coronary Arteries: The “INOCA versus Obstructive CCS” Challenge. JCM 2022;11:1711. [DOI: 10.3390/jcm11061711] [Reference Citation Analysis]
315 Mileva N, Nagumo S, Mizukami T, Sonck J, Berry C, Gallinoro E, Monizzi G, Candreva A, Munhoz D, Vassilev D, Penicka M, Barbato E, De Bruyne B, Collet C. Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta-Analysis. J Am Heart Assoc 2022;:e023207. [PMID: 35301851 DOI: 10.1161/JAHA.121.023207] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
316 Ferraro RA, Leucker T, Martin SS, Banach M, Jones SR, Toth PP. Contemporary Management of Dyslipidemia. Drugs 2022. [PMID: 35303294 DOI: 10.1007/s40265-022-01691-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
317 Xu C, Yu B, Zhao X, Lin X, Tang X, Liu Z, Gao P, Ge J, Wang S, Li L. Valosin Containing Protein as a Specific Biomarker for Predicting the Development of Acute Coronary Syndrome and Its Complication. Front Cardiovasc Med 2022;9:803532. [DOI: 10.3389/fcvm.2022.803532] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
318 Fu B, Wei X, Lin Y, Chen J, Yu D. Pathophysiologic Basis and Diagnostic Approaches for Ischemia With Non-obstructive Coronary Arteries: A Literature Review. Front Cardiovasc Med 2022;9:731059. [DOI: 10.3389/fcvm.2022.731059] [Reference Citation Analysis]
319 Alkhalil M, Džavík V, Bhatt DL, Mehran R, Mehta SR. Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention. Curr Cardiol Rep 2022;24:277-93. [PMID: 35294730 DOI: 10.1007/s11886-022-01645-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
320 Boettcher M, Mikus G, Trenk D, Düngen HD, Donath F, Werner N, Karakas M, Besche N, Schulz-Burck D, Gerrits M, Hung J, Becker C. Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR study. Clin Transl Sci 2022. [PMID: 35299288 DOI: 10.1111/cts.13238] [Reference Citation Analysis]
321 Suri JS, Bhagawati M, Paul S, Protogerou AD, Sfikakis PP, Kitas GD, Khanna NN, Ruzsa Z, Sharma AM, Saxena S, Faa G, Laird JR, Johri AM, Kalra MK, Paraskevas KI, Saba L. A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review. Diagnostics 2022;12:722. [DOI: 10.3390/diagnostics12030722] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
322 Negrea MO, Zdrenghea D, Teodoru M, Neamțu B, Cipăian CR, Pop D. Gender Particularities and Prevalence of Atypical Clinical Presentation in Non-ST Elevation Acute Coronary Syndrome. JCDD 2022;9:84. [DOI: 10.3390/jcdd9030084] [Reference Citation Analysis]
323 Nakano S, Kohsaka S, Chikamori T, Fukushima K, Kobayashi Y, Kozuma K, Manabe S, Matsuo H, Nakamura M, Ohno T, Sawano M, Toda K, Ueda Y, Yokoi H, Gatate Y, Kasai T, Kawase Y, Matsumoto N, Mori H, Nakazato R, Niimi N, Saito Y, Shintani A, Watanabe I, Watanabe Y, Ikari Y, Jinzaki M, Kosuge M, Nakajima K, Kimura T; on behalf of the JCS Joint Working Group. JCS 2022 Guideline Focused Update on Diagnosis and Treatment in Patients With Stable Coronary Artery Disease. Circ J. [DOI: 10.1253/circj.cj-21-1041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
324 Santos CDCL, Oliveira RP, Sena J, Oliveira AD, Ferreira MG, Santos A, Guissoni H, Brito JC, Feitosa GS, Feitosa-filho GS. Fatores que Impactam a Decisão de Realizar Ventriculografia Esquerda em Doença Arterial Coronariana. Arquivos Brasileiros de Cardiologia 2022;118:607-13. [DOI: 10.36660/abc.20200217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
325 Zhao L, He R, Liu Y, She F, Xie Y, Zhang P. Report of a patient with refractory atrial tachycardia whose heart rate was controlled using ivabradine. J Int Med Res 2022;50:3000605221081727. [PMID: 35264051 DOI: 10.1177/03000605221081727] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
326 Gao A, Liu J, Liu Y, Hu C, Zhu Y, Zhou Y, Han H, Zhao Y, Liberale L. Serum CTRP9 Reflects Coronary Collateralization in Nondiabetic Patients with Obstructive Coronary Artery Disease. BioMed Research International 2022;2022:1-10. [DOI: 10.1155/2022/8537686] [Reference Citation Analysis]
327 Lo W, Chen W, Lai C, Chen Y, Su C, Chang W, Wang C, Liu T, Liang K, Lee W, Tebaldi M. Rotablation in Patients with Advanced Renal Insufficiency through End-Stage Renal Disease: Short- and Intermediate-Term Results. Journal of Interventional Cardiology 2022;2022:1-10. [DOI: 10.1155/2022/7884401] [Reference Citation Analysis]
328 Del Torto A, Guaricci AI, Pomarico F, Guglielmo M, Fusini L, Monitillo F, Santoro D, Vannini M, Rossi A, Muscogiuri G, Baggiano A, Pontone G. Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med 2022;9:758975. [DOI: 10.3389/fcvm.2022.758975] [Reference Citation Analysis]
329 Yu F, McLean B, Badiwala M, Billia F. Heart Failure and Drug Therapies: A Metabolic Review. Int J Mol Sci 2022;23:2960. [PMID: 35328390 DOI: 10.3390/ijms23062960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
330 Villines TC, Weber LA. Trust us! Time to move on from pretest probability scores for stable chest pain. Heart 2022:heartjnl-2021-320741. [PMID: 35264419 DOI: 10.1136/heartjnl-2021-320741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
331 Crea F. Personalized antithrombotic treatment of cardiovascular disease: a glimpse into the future based on current knowledge. Eur Heart J 2022;43:925-9. [PMID: 35253068 DOI: 10.1093/eurheartj/ehac086] [Reference Citation Analysis]
332 Chang S, Lin J, Wang Y, Wu C, Cheng J, Hwang J, Lin J, Chiang F, Chen Y, Hsu R, Chen W, Chen J, Lien W. The Sequential Change in Left Ventricular Function among Various Cardiovascular Diseases: A 12-Year Study. JPM 2022;12:415. [DOI: 10.3390/jpm12030415] [Reference Citation Analysis]
333 Baumann S, Overhoff D, Tesche C, Korosoglou G, Kelle S, Nassar M, Buss SJ, Andre F, Renker M, Schoepf UJ, Akin I, Waldeck S, Schoenberg SO, Lossnitzer D. [Morphological and functional diagnostics of coronary artery disease by computed tomography]. Herz 2022. [PMID: 35244729 DOI: 10.1007/s00059-022-05098-7] [Reference Citation Analysis]
334 Huang H, Liu J, Bao K, Huang X, Huang D, Wei H, Remutula N, Tuersun T, Lai W, Li Q, Wang B, He Y, Yang H, Chen S, Chen J, Chen K, Tan N, Wang X, Chen L, Liu Y. Prevalence and Mortality of Moderate or Severe Mitral Regurgitation Among Patients Undergoing Percutaneous Coronary Intervention With or Without Heart Failure: Results From CIN Study With 28,358 Patients. Front Cardiovasc Med 2022;9:796447. [DOI: 10.3389/fcvm.2022.796447] [Reference Citation Analysis]
335 Sumin AN, Shcheglova AV. Assessment of Pre-test and Clinical Probability in the Diagnosis of Chronic Coronary Syndrome — What's New? Racionalʹnaâ farmakoterapiâ v kardiologii 2022;18:92-6. [DOI: 10.20996/1819-6446-2022-02-04] [Reference Citation Analysis]
336 Martínez Pereyra V, Seitz A, Sechtem U, Ong P. Prevention of epicardial coronary artery spasm with intracoronary nitroglycerine during acetylcholine testing in a female patient with resting angina—implications for optimal pharmacological management. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5480] [Reference Citation Analysis]
337 Sonck J, Mizukami T, Johnson NP, Nagumo S, Gallinoro E, Candreva A, Mileva N, Munhoz D, Shinke T, Svanerud J, Barbato E, De Bruyne B, Collet C. Development, validation, and reproducibility of the pullback pressure gradient (PPG) derived from manual fractional flow reserve pullbacks. Catheter Cardiovasc Interv 2022. [PMID: 35233906 DOI: 10.1002/ccd.30064] [Reference Citation Analysis]
338 Syed YY. Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use. Am J Cardiovasc Drugs 2022;22:219-30. [PMID: 35257306 DOI: 10.1007/s40256-022-00521-0] [Reference Citation Analysis]
339 Dai JR, Li J, He X, Huang H, Li Y. A relationship among the blood serum levels of interleukin-6, albumin, and 25-hydroxyvitamin D and frailty in elderly patients with chronic coronary syndrome. Aging Med (Milton) 2022;5:17-29. [PMID: 35309153 DOI: 10.1002/agm2.12201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
340 Soschynski M, Hagar MT, Taron J, Krauss T, Ruile P, Hein M, Nührenberg T, Russe MF, Bamberg F, Schlett CL. Update for the Performance of CT Coronary Angiography. Rofo 2022. [PMID: 35231938 DOI: 10.1055/a-1747-3554] [Reference Citation Analysis]
341 Lopes PM, Albuquerque F, Freitas P, Rocha BM, Cunha GJ, Santos AC, Abecasis J, Guerreiro S, Saraiva C, Mendes M, Ferreira AM. The updated pre-test probability model of the 2019 ESC guidelines improves prediction of obstructive coronary artery disease. Revista Portuguesa de Cardiologia 2022. [DOI: 10.1016/j.repc.2021.03.016] [Reference Citation Analysis]
342 Brandt V, Bekeredjian R, Schoepf UJ, Varga-szemes A, Emrich T, Aquino GJ, Decker J, Bayer RR, Ellis L, Ebersberger U, Tesche C. Prognostic value of epicardial adipose tissue volume in combination with coronary plaque and flow assessment for the prediction of major adverse cardiac events. European Journal of Radiology 2022;148:110157. [DOI: 10.1016/j.ejrad.2022.110157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
343 Kolossváry M, Mayrhofer T, Ferencik M, Karády J, Pagidipati NJ, Shah SH, Nanna MG, Foldyna B, Douglas PS, Hoffmann U, Lu MT. Are risk factors necessary for pretest probability assessment of coronary artery disease? A patient similarity network analysis of the PROMISE trial. Journal of Cardiovascular Computed Tomography 2022. [DOI: 10.1016/j.jcct.2022.03.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Towashiraporn K, Krittayaphong R. Current Perspectives on Antithrombotic Therapy for the Treatment of Acute Coronary Syndrome. IJGM 2022;Volume 15:2397-414. [DOI: 10.2147/ijgm.s289295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
345 Aktas H, Gul M. The prognostic role of intra-aortic pulse pressure measured before percutaneous coronary intervention in patients with chronic coronary syndrome: a single-center, retrospective, observational cohort study. Clin Exp Hypertens 2022;:1-8. [PMID: 35229701 DOI: 10.1080/10641963.2022.2043893] [Reference Citation Analysis]
346 Hosono K, Nakanishi R, Koike H, Matsumoto S, Oka Y, Fujii T, Ikeda T. Impact of computed tomography on the diagnosis of Takayasu arteritis with acute coronary syndrome: A case series. Journal of Cardiology Cases 2022. [DOI: 10.1016/j.jccase.2022.03.001] [Reference Citation Analysis]
347 Azarine A, Scalbert F, Garçon P. Cardiac Functional Imaging. La Presse Médicale 2022. [DOI: 10.1016/j.lpm.2022.104119] [Reference Citation Analysis]
348 Nanna MG, Vemulapalli S, Fordyce CB, Mark DB, Patel MR, Al-Khalidi HR, Kelsey M, Martinez B, Yow E, Mullen S, Stone GW, Ben-Yehuda O, Udelson JE, Rogers C, Douglas PS. The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial. Am Heart J 2022;245:136-48. [PMID: 34953768 DOI: 10.1016/j.ahj.2021.12.004] [Reference Citation Analysis]
349 Gabaldón-pérez A, Bonanad C, García-blas S, Gavara J, Ríos-navarro C, Pérez-solé N, de Dios E, Marcos-garcés V, Merenciano-gonzález H, Monmeneu JV, López-lereu MP, Núñez J, Chorro FJ, Bodí V. Resonancia magnética cardiaca de estrés para predecir mortalidad y toma de decisiones: registro de 2.496 pacientes mayores con síndrome coronario crónico. Revista Española de Cardiología 2022;75:223-31. [DOI: 10.1016/j.recesp.2021.06.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
350 Christensen DM, Schjerning AM, Sindet-Pedersen C, Lamberts M, Olesen JB, Barcella CA, Torp-Pedersen C, Gislason G, Strange JE. Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A nationwide registry-based study. Am Heart J 2022;245:81-9. [PMID: 34902311 DOI: 10.1016/j.ahj.2021.11.018] [Reference Citation Analysis]
351 Shalaeva EV, Shadmanov AК, Azizova FL, Mirakhmedova KT, Messerli FH, Franco OH, Saner H. Is Lone Hypertension a Risk Factor for More Severe COVID-19 Outcomes? gh 2022;17. [DOI: 10.5334/gh.1099] [Reference Citation Analysis]
352 Logan JK, Ayers MP. Noninvasive Imaging for the Asymptomatic Patient. Medical Clinics of North America 2022;106:377-88. [DOI: 10.1016/j.mcna.2021.11.012] [Reference Citation Analysis]
353 Gohmann RF, Seitz P, Pawelka K, Majunke N, Schug A, Heiser L, Renatus K, Desch S, Lauten P, Holzhey D, Noack T, Wilde J, Kiefer P, Krieghoff C, Lücke C, Ebel S, Gottschling S, Borger MA, Thiele H, Panknin C, Abdel-Wahab M, Horn M, Gutberlet M. Combined Coronary CT-Angiography and TAVI Planning: Utility of CT-FFR in Patients with Morphologically Ruled-Out Obstructive Coronary Artery Disease. J Clin Med 2022;11:1331. [PMID: 35268422 DOI: 10.3390/jcm11051331] [Reference Citation Analysis]
354 Li Y, Lee I, Chen Y, Lin Y, Liu Y, Lai F. Using Text Content From Coronary Catheterization Reports to Predict 5-Year Mortality Among Patients Undergoing Coronary Angiography: A Deep Learning Approach. Front Cardiovasc Med 2022;9:800864. [DOI: 10.3389/fcvm.2022.800864] [Reference Citation Analysis]
355 Skalsky K, Shiyovich A, Steinmetz T, Kornowski R. Chronic Renal Failure and Cardiovascular Disease: A Comprehensive Appraisal. J Clin Med 2022;11:1335. [PMID: 35268426 DOI: 10.3390/jcm11051335] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
356 Berry C, Ang DTY. Personalizing the Competing Risks for Thrombotic and Bleeding Events in Ischemia With Nonobstructed Coronary Arteries. JACC Cardiovasc Interv 2022;15:440-2. [PMID: 35210050 DOI: 10.1016/j.jcin.2021.12.010] [Reference Citation Analysis]
357 Reis JF, Ramos RB, Marques H, Daniel PM, Aguiar SR, Morais LA, Cruz MC, Moreira RI, Monteiro AV, Cacela D, Figueiredo L, Ferreira RC. Cardiac computed tomographic angiography after abnormal ischemia test as a gatekeeper to invasive coronary angiography. Int J Cardiovasc Imaging. [DOI: 10.1007/s10554-021-02426-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
358 Frank-tewaag J, Bleek J, Günster C, Schneider U, Horenkamp-sonntag D, Marschall U, Franke S, Schlößler K, Donner-banzhoff N, Sundmacher L. Regional variation in coronary angiography rates: the association with supply factors and the role of indication: a spatial analysis. BMC Cardiovasc Disord 2022;22. [DOI: 10.1186/s12872-022-02513-z] [Reference Citation Analysis]
359 Liu J, Huang L, Shi X, Gu C, Xu H, Liu S. Clinical Parameters and Metabolomic Biomarkers That Predict Inhospital Outcomes in Patients With ST-Segment Elevated Myocardial Infarctions. Front Physiol 2021;12:820240. [PMID: 35211029 DOI: 10.3389/fphys.2021.820240] [Reference Citation Analysis]
360 Espinola-Klein C. When and How to Combine Antiplatelet and Anticoagulant Drugs? Hamostaseologie 2022;42:73-9. [PMID: 35196733 DOI: 10.1055/a-1724-4922] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
361 Spicher B, Fischer K, Zimmerli ZA, Yamaji K, Ueki Y, Bertschinger CN, Jung B, Otsuka T, Bigler MR, Gräni C, von Tengg-kobligk H, Räber L, Eberle B, Guensch DP. Combined Analysis of Myocardial Deformation and Oxygenation Detects Inducible Ischemia Unmasked by Breathing Maneuvers in Chronic Coronary Syndrome. Front Cardiovasc Med 2022;9:800720. [DOI: 10.3389/fcvm.2022.800720] [Reference Citation Analysis]
362 Takamura K, Fujimoto S, Mita T, Kawaguchi YO, Kurita M, Kadowaki S, Kamo Y, Aoshima C, Nozaki YO, Takahashi D, Kudo A, Hiki M, Tomizawa N, Ikeda F, Satoh H, Watada H, Minamino T. Identification of Risk Factors for Coronary Artery Disease in Asymptomatic Patients with Type 2 Diabetes Mellitus. J Clin Med 2022;11:1226. [PMID: 35268317 DOI: 10.3390/jcm11051226] [Reference Citation Analysis]
363 Lu X, Liu Z, Cui Q, Liu F, Li J, Niu X, Shen C, Hu D, Huang K, Chen J, Xing X, Zhao Y, Lu F, Liu X, Cao J, Chen S, Ma H, Yu L, Wu X, Wu X, Li Y, Zhang H, Mo X, Zhao L, Huang J, Wang L, Wen W, Shu XO, Takeuchi F, Koh WP, Tai ES, Cheng CY, Wong TY, Chang X, Chan MY, Gao W, Zheng H, Chen K, Chen J, He J, Tang CS, Lam KSL, Tse HF, Cheung CYY, Takahashi A, Kubo M, Kato N, Terao C, Kamatani Y, Sham PC, Heng CK, Hu Z, Chen YE, Wu T, Shen H, Willer CJ, Gu D. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study. Eur Heart J 2022:ehac093. [PMID: 35195259 DOI: 10.1093/eurheartj/ehac093] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
364 Muscogiuri G, Chiesa M, Baggiano A, Spadafora P, De Santis R, Guglielmo M, Scafuri S, Fusini L, Mushtaq S, Conte E, Annoni A, Formenti A, Mancini ME, Ricci F, Ariano FP, Spiritigliozzi L, Babbaro M, Mollace R, Maragna R, Giacari CM, Andreini D, Guaricci AI, Colombo GI, Rabbat MG, Pepi M, Sardanelli F, Pontone G. Diagnostic performance of deep learning algorithm for analysis of computed tomography myocardial perfusion. Eur J Nucl Med Mol Imaging 2022. [PMID: 35194673 DOI: 10.1007/s00259-022-05732-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
365 Calcagno S, Biondizoccai G, Stankovic T, Szabo E, Szabo AB, Kecskes I. Novel tech throws knock-out punch to ECG improving GP referral decisions to cardiology. Open Heart 2022;9:e001852. [DOI: 10.1136/openhrt-2021-001852] [Reference Citation Analysis]
366 Krittayaphong R, Winijkul A, Methavigul K, Sairat P, investigators COOLF, De Luca L. The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry. Cardiovascular Therapeutics 2022;2022:1-10. [DOI: 10.1155/2022/5797257] [Reference Citation Analysis]
367 Reynolds HR, Bairey Merz CN, Berry C, Samuel R, Saw J, Smilowitz NR, de Souza ACDAH, Sykes R, Taqueti VR, Wei J. Coronary Arterial Function and Disease in Women With No Obstructive Coronary Arteries. Circ Res 2022;130:529-51. [PMID: 35175840 DOI: 10.1161/CIRCRESAHA.121.319892] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
368 Sun L, Zhang YN. Compound Danshen dripping pills in treating with coronary heart disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e28927. [PMID: 35363219 DOI: 10.1097/MD.0000000000028927] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
369 Wang X, Han L, Yang J. Evaluation of efficacy and safety of aspirin combination treatment in treating patients with coronary heart disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e28848. [PMID: 35363182 DOI: 10.1097/MD.0000000000028848] [Reference Citation Analysis]
370 Peiró ÓM, Ferrero M, Romeu A, Carrasquer A, Bonet G, Mohandes M, Pernigotti A, Bardají A. Performance of Coronary Angiography in the Detection of Coronary Artery Disease in Patients with Systolic Left Ventricular Dysfunction and No Prior Ischemic Heart Disease. JCM 2022;11:1097. [DOI: 10.3390/jcm11041097] [Reference Citation Analysis]
371 Peteiro J, Bouzas-Mosquera A, Barbeito-Caamaño C, Martin-Alvarez E, Souto-Cainzos B, Vazquez-Rodriguez JM. Additive prognostic and diagnostic value of diastolic exercise parameters in patients referred for exercise echocardiography. Eur Heart J Cardiovasc Imaging 2022:jeac039. [PMID: 35175338 DOI: 10.1093/ehjci/jeac039] [Reference Citation Analysis]
372 Juarez-Orozco LE, Klén R, Niemi M, Ruijsink B, Daquarti G, van Es R, Benjamins JW, Yeung MW, van der Harst P, Knuuti J. Artificial Intelligence to Improve Risk Prediction with Nuclear Cardiac Studies. Curr Cardiol Rep 2022. [PMID: 35171443 DOI: 10.1007/s11886-022-01649-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
373 Topf A, Mirna M, Dienhart C, Jirak P, Bacher N, Boxhammer E, Gharibeh SX, Motloch LJ, Hoppe UC, Lichtenauer M. Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome. Biomedicines 2022;10:464. [DOI: 10.3390/biomedicines10020464] [Reference Citation Analysis]
374 Essa H, Sankaranarayanan R, Walker L. Triple antithrombotic therapy and dual therapy - What is the evidence base? Br J Clin Pharmacol 2022. [PMID: 35172379 DOI: 10.1111/bcp.15257] [Reference Citation Analysis]
375 Liu M, Zhao C, Wang S, Jia H, Yu B. Artificial Intelligence—A Good Assistant to Multi-Modality Imaging in Managing Acute Coronary Syndrome. Front Cardiovasc Med 2022;8:782971. [DOI: 10.3389/fcvm.2021.782971] [Reference Citation Analysis]
376 Guo H, Li J, Liu H, He J. Learning dynamic treatment strategies for coronary heart diseases by artificial intelligence: real-world data-driven study. BMC Med Inform Decis Mak 2022;22:39. [PMID: 35168623 DOI: 10.1186/s12911-022-01774-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
377 Si-Mohamed SA, Boccalini S, Lacombe H, Diaw A, Varasteh M, Rodesch PA, Dessouky R, Villien M, Tatard-Leitman V, Bochaton T, Coulon P, Yagil Y, Lahoud E, Erhard K, Riche B, Bonnefoy E, Rioufol G, Finet G, Bergerot C, Boussel L, Greffier J, Douek PC. Coronary CT Angiography with Photon-counting CT: First-In-Human Results. Radiology 2022;:211780. [PMID: 35166583 DOI: 10.1148/radiol.211780] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
378 Griffin WF, Choi AD, Riess JS, Marques H, Chang HJ, Choi JH, Doh JH, Her AY, Koo BK, Nam CW, Park HB, Shin SH, Cole J, Gimelli A, Khan MA, Lu B, Gao Y, Nabi F, Nakazato R, Schoepf UJ, Driessen RS, Bom MJ, Thompson R, Jang JJ, Ridner M, Rowan C, Avelar E, Généreux P, Knaapen P, de Waard GA, Pontone G, Andreini D, Earls JP. AI Evaluation of Stenosis on Coronary CT Angiography, Comparison With Quantitative Coronary Angiography and Fractional Flow Reserve: A CREDENCE Trial Substudy. JACC Cardiovasc Imaging 2022:S1936-878X(22)00001-8. [PMID: 35183478 DOI: 10.1016/j.jcmg.2021.10.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
379 Ortega-paz L, Galli M, Capodanno D, Brugaletta S, Angiolillo DJ. The Role of Antiplatelet Therapy in Patients With MINOCA. Front Cardiovasc Med 2022;8:821297. [DOI: 10.3389/fcvm.2021.821297] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
380 Jonik S, Marchel M, Grabowski M, Opolski G, Mazurek T. Gastrointestinal Incretins-Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary Artery Disease-State of the Art. Biology (Basel) 2022;11:288. [PMID: 35205155 DOI: 10.3390/biology11020288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
381 Kallio M, Korkeila J, Malmberg M, Gunn J, Rautava P, Korhonen P, Kytö V. Impaired long-term outcomes of patients with schizophrenia spectrum disorder after coronary artery bypass surgery: nationwide case-control study. BJPsych Open 2022;8:e48. [PMID: 35144708 DOI: 10.1192/bjo.2022.10] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
382 Bertolone DT, Gallinoro E, Esposito G, Paolisso P, Bermpeis K, De Colle C, Fabbricatore D, Mileva N, Valeriano C, Munhoz D, Belmonte M, Vanderheyden M, Bartunek J, Sonck J, Wyffels E, Collet C, Mancusi C, Morisco C, De Luca N, De Bruyne B, Barbato E. Contemporary Management of Stable Coronary Artery Disease. High Blood Press Cardiovasc Prev 2022. [PMID: 35147890 DOI: 10.1007/s40292-021-00497-z] [Reference Citation Analysis]
383 Schwemmlein J, Maack C, Bertero E. Mitochondria as Therapeutic Targets in Heart Failure. Curr Heart Fail Rep 2022. [PMID: 35147851 DOI: 10.1007/s11897-022-00539-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
384 Gili S, Galli S, Teruzzi G, Santagostino Baldi G, Ravagnani P, Fabbiocchi F, Bartorelli A, Montorsi P, Trabattoni D. Gender-Associated Outcomes Following Percutaneous Coronary Intervention With a Third-Generation, Ultrathin-Strut Drug-Eluting Stent: A Real-World, Single-Center Experience. Front Cardiovasc Med 2022;8:796604. [DOI: 10.3389/fcvm.2021.796604] [Reference Citation Analysis]
385 Akbar MR, Adiputro DL, Tiksnadi BB, Soeriadi EA, Hasan M, Muttaqien F, Raharjo PP, Nurazizah E, Tarsidin NF. Case Series: Extracorporeal Shockwave Myocardial Revascularization Therapy Improves Ischemic Response, Functional Capacity, and Quality of Life in Indicated CABG-Stable Angina Pectoris Patients. Front Cardiovasc Med 2022;9:799834. [DOI: 10.3389/fcvm.2022.799834] [Reference Citation Analysis]
386 Shibata K, Wakabayashi K, Ishinaga T, Morimura M, Aizawa N, Suzuki T, Furuya T, Sato C, Nishikura T, Ikeda N, Kikuchi M, Tanno K, Shinke T, Izumizaki M. Feasibility, Safety, and Long-Term Outcomes of Zero-Contrast Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease. Circ J. [DOI: 10.1253/circj.cj-21-0905] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
387 Tan M, Ma J, Yang X, You Q, Guo X, Li Y, Wang R, Han G, Chen Y, Qiu X, Wang X, Zhang L. Quantitative proteomics reveals differential immunoglobulin-associated proteome (IgAP) in patients of acute myocardial infarction and chronic coronary syndromes. J Proteomics 2022;252:104449. [PMID: 34890869 DOI: 10.1016/j.jprot.2021.104449] [Reference Citation Analysis]
388 Carbone A, Santelli F, Bottino R, Attena E, Mazzone C, Parisi V, D'Andrea A, Golino P, Nigro G, Russo V. Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation. Eur J Clin Pharmacol 2022. [PMID: 35138442 DOI: 10.1007/s00228-022-03286-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
389 Sechtem U, Seitz A, Mcchord J, Ong P. Ist die weibliche koronare Mikrovaskulatur anders? Aktuelle Kardiologie 2022;11:24-9. [DOI: 10.1055/a-1631-4314] [Reference Citation Analysis]
390 Halbach M, Baldus S, Nitschmann S, Nitschmann S, Halbach M, Baldus S. [Shortening and de-escalation of dual antiplatelet therapy]. Internist (Berl) 2022. [PMID: 35137263 DOI: 10.1007/s00108-022-01262-7] [Reference Citation Analysis]
391 Kott KA, Bishop M, Yang CHJ, Plasto TM, Cheng DC, Kaplan AI, Cullen L, Celermajer DS, Meikle PJ, Vernon ST, Figtree GA. Biomarker Development in Cardiology: Reviewing the Past to Inform the Future. Cells 2022;11:588. [PMID: 35159397 DOI: 10.3390/cells11030588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
392 Samorodskaya IV, Chernyavskaya TK, Kakorina EP, Semyonov VY. Ischemic heart disease: medical certificate of cause of death analysis. Russ J Cardiol 2022;27:4637. [DOI: 10.15829/1560-4071-2022-4637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
393 Huang P, Tseng Y, Tsai C, Chen J, Yang S, Chiu F, Chen Z, Hwang J, Chuang EY, Wang Y, Tsai C. An Artificial Intelligence-Enabled ECG Algorithm for the Prediction and Localization of Angiography-Proven Coronary Artery Disease. Biomedicines 2022;10:394. [DOI: 10.3390/biomedicines10020394] [Reference Citation Analysis]
394 Monda E, Palmiero G, Lioncino M, Rubino M, Cirillo A, Fusco A, Caiazza M, Verrillo F, Diana G, Mauriello A, Iavarone M, Losi MA, De Rimini ML, Dellegrottaglie S, D'Andrea A, Bossone E, Pacileo G, Limongelli G. Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes. J Clin Med 2022;11:868. [PMID: 35160323 DOI: 10.3390/jcm11030868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
395 Myrbakk IN, Friborg O, Høye A, Steigen T, Bergvik S. Psychometric evaluation of the Coronary Revascularisation Outcome Questionnaire (CROQ) in Norwegian patients admitted to elective coronary angiography and possible percutaneous coronary intervention. Health Qual Life Outcomes 2022;20. [DOI: 10.1186/s12955-022-01927-9] [Reference Citation Analysis]
396 Zhang J, Xu K, Hu Y, Yang L, Leng X, Jin H, Tang Y, Liu X, Ye C, Guo Y, Wang L, Zhang J, Feng Y, Mou C, Tang L, Xiang J, Du C. Diagnostic performance of deep learning and computational fluid dynamics-based instantaneous wave-free ratio derived from computed tomography angiography. BMC Cardiovasc Disord 2022;22:33. [PMID: 35120463 DOI: 10.1186/s12872-022-02469-0] [Reference Citation Analysis]
397 Echavarría-Pinto M, Van de Hoef TP, Pacheco-Beltran N, Reyes-Carrera JE, Rangel-Alvarado E, Ledezma-Ledezma E, Aguilar-Castillo LA, Tovar-Becerra AI, Arellano JEM, Ramírez MNM, Muruaga M, Ibarra-Rangel AM, Montes-Collantes CA, Castrejon-Mora JL, Chong-Benitez IH, Vargas-Torrrescano LH, García-García HM. Diagnostic agreement of quantitative flow ratio with fractional flow reserve in a Latin-American population. Int J Cardiovasc Imaging 2022. [PMID: 35122581 DOI: 10.1007/s10554-022-02547-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
398 Dai X, Lu Z, Yu Y, Yu L, Xu H, Zhang J. The use of lesion-specific calcium morphology to guide the appropriate use of dynamic CT myocardial perfusion imaging and CT fractional flow reserve. Quant Imaging Med Surg 2022;12:1257-69. [PMID: 35111621 DOI: 10.21037/qims-21-491] [Reference Citation Analysis]
399 Ošťádal P, Táborský M, Linhart A, Vrablík M, Češka R, Cífková R, Králíková E, Adámková V, Prázný M, Jojko Z. 2022 Summary of recommendations for long-term secondary prevention after myocardial infarction. Cor Vasa 2022;64:7-28. [DOI: 10.33678/cor.2021.140] [Reference Citation Analysis]
400 Fordyce CB, Hill CL, Mark DB, Alhanti B, Pellikka PA, Hoffmann U, Patel MR, Douglas PS; PROMISE Investigators. Physician judgement in predicting obstructive coronary artery disease and adverse events in chest pain patients. Heart 2022:heartjnl-2021-320275. [PMID: 35110385 DOI: 10.1136/heartjnl-2021-320275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
401 Xu X, Zhou J, Zhang Y, Li Q, Guo L, Mao Y, He L, Nguyen TN. Evaluate the Correlation between the TIMI Frame Count, IMR, and CFR in Coronary Microvascular Disease. Journal of Interventional Cardiology 2022;2022:1-7. [DOI: 10.1155/2022/6361398] [Reference Citation Analysis]
402 Ishii M, Kuramitsu S, Yamanaga K, Matsuo H, Horie K, Takashima H, Terai H, Kikuta Y, Ishihara T, Saigusa T, Sakamoto T, Suematsu N, Shiono Y, Asano T, Masamura K, Doijiri T, Toyota F, Ogita M, Kurita T, Matsuo A, Harada K, Yaginuma K, Kanemura N, Sonoda S, Yokoi H, Tanaka N, Tsujita K; J- CONFIRM Registry Investigators . Association of Guideline-Directed Medical Therapy Adherence with Outcomes After Fractional Flow Reserve-Based Deferral of Revascularization. Eur Heart J Cardiovasc Pharmacother 2022:pvac008. [PMID: 35108383 DOI: 10.1093/ehjcvp/pvac008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
403 Orsini E, Marzilli M, Zito GB, Carbone V, Latina L, Oliviero U, Rizzo U; ARCA Registry Investigators. Clinical outcomes of newly diagnosed, stable angina patients managed according to current guidelines. The ARCA (Arca Registry for Chronic Angina) Registry: A prospective, observational, nationwide study. Int J Cardiol 2022:S0167-5273(22)00182-6. [PMID: 35120946 DOI: 10.1016/j.ijcard.2022.01.056] [Reference Citation Analysis]
404 Rodriguez EA. GATA2 promotes human vascular smooth muscle cell proliferation via mitofusin2- mediated Ras/Raf/MEK/ERK signaling pathway. New target in vascular medicine. Int J Cardiol 2022:S0167-5273(22)00188-7. [PMID: 35120945 DOI: 10.1016/j.ijcard.2022.01.062] [Reference Citation Analysis]
405 Schuijf JD, Lima JA, Boedeker KL, Takagi H, Tanaka R, Yoshioka K, Arbab-zadeh A. CT imaging with ultra-high-resolution: opportunities for cardiovascular imaging in clinical practice. Journal of Cardiovascular Computed Tomography 2022. [DOI: 10.1016/j.jcct.2022.02.003] [Reference Citation Analysis]
406 Akimaru K, Iwabuchi M, Ishida A, Uehara H, Higa N, Kakazu M, Wake M, Maeda T, Maeda T, Arima H, Ohya Y, Tokashiki S, Wakugawa H, Miyagi A, Shiohira S, Zaima S, Shiohira T, Toma Y, Ikemiyagi H. Comparative evaluation of standard maintenance-dose clopidogrel versus low-dose prasugrel in patients with stable coronary artery disease after percutaneous coronary intervention. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.02.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
407 Tzimas G, Gulsin GS, Takagi H, Mileva N, Sonck J, Muller O, Leipsic JA, Collet C. Coronary CT Angiography to Guide Percutaneous Coronary Intervention. Radiology: Cardiothoracic Imaging 2022;4:e210171. [DOI: 10.1148/ryct.210171] [Reference Citation Analysis]
408 Mortensen MB, Caínzos-Achirica M, Steffensen FH, Bøtker HE, Jensen JM, Sand NPR, Maeng M, Bruun JM, Blaha MJ, Sørensen HT, Pareek M, Nasir K, Nørgaard BL. Association of Coronary Plaque With Low-Density Lipoprotein Cholesterol Levels and Rates of Cardiovascular Disease Events Among Symptomatic Adults. JAMA Netw Open 2022;5:e2148139. [PMID: 35147685 DOI: 10.1001/jamanetworkopen.2021.48139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
409 Huang K, Yao W, Du J, Wang F, Han Y, Chang Y, Liu R, Ye R, Zhu W, Tu S, Liu X. Functional Assessment of Cerebral Artery Stenosis by Angiography-Based Quantitative Flow Ratio: A Pilot Study. Front Aging Neurosci 2022;14:813648. [DOI: 10.3389/fnagi.2022.813648] [Reference Citation Analysis]
410 Al-mohaissen MA. Echocardiographic Assessment of Primary Microvascular Angina and Primary Coronary Microvascular Dysfunction. Trends in Cardiovascular Medicine 2022. [DOI: 10.1016/j.tcm.2022.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
411 Kawashima H, Kogame N, Ono M, Hara H, Takahashi K, Reiber JH, Thomsen B, de Winter RJ, Tanaka K, La Meir M, de Mey J, Schneider U, Doenst T, Teichgräber U, Wijns W, Mushtaq S, Pompilio G, Bartorelli AL, Andreini D, Serruys PW, Onuma Y. Diagnostic Concordance and Discordance Between Angiography-Based Quantitative Flow Ratio and Fractional Flow Reserve Derived from Computed Tomography in Complex Coronary Artery Disease. Journal of Cardiovascular Computed Tomography 2022. [DOI: 10.1016/j.jcct.2022.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
412 Li L, Meng H, Wang X, Ruan J, Tian X, Meng F. Low ZCCHC9 Gene Expression in Peripheral Blood May Be an Acute Myocardial Infarction Genetic Molecular Marker in Patients with Stable Coronary Atherosclerotic Disease. IJGM 2022;Volume 15:1795-804. [DOI: 10.2147/ijgm.s346335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
413 Pundziute G, Vliegenthart R, Fairbairn TA. FFRCT and QFR: Ready to be Used in Clinical Decision Making? Journal of Cardiovascular Computed Tomography 2022. [DOI: 10.1016/j.jcct.2022.02.007] [Reference Citation Analysis]
414 Dorval JF, Richer LP, Soucie L, McSpadden LC, Hoopai A, Tan S, West NEJ, Jolicoeur EM. Electroanatomical Navigation to Minimize Contrast Medium or X-Rays During Stenting: Insights From an Experimental Model. JACC Basic Transl Sci 2022;7:131-42. [PMID: 35257040 DOI: 10.1016/j.jacbts.2021.11.001] [Reference Citation Analysis]
415 Meng Y, Ding P, Wang H, Yang X, Wang Z, Nie D, Liu J, Huang Y, Su G, Hu J, Su Y, Du X, Dong N, Jia H, Zhang H, Zhang J, Li J. Ca2+/calmodulin-dependent protein kinase II inhibition reduces myocardial fatty acid uptake and oxidation after myocardial infarction. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2022. [DOI: 10.1016/j.bbalip.2022.159120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
416 Antonopoulos AS, Simantiris S, Benetos G, Vlachopoulos C, Tsioufis K, Tousoulis D. Screening of asymptomatic patients with elevated lipoprotein(a) levels by coronary computed tomography angiography. Eur J Prev Cardiol 2022:zwab217. [PMID: 35104322 DOI: 10.1093/eurjpc/zwab217] [Reference Citation Analysis]
417 Boden WE, Kaski JC, Al-lamee R, Weintraub WS. What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation? The Lancet 2022;399:691-4. [DOI: 10.1016/s0140-6736(21)02045-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
418 Xiong X, Luo Z, Zhou H, Duan Z, Niu L, Zhang K, Huang G, Li W. Downregulation of TIGIT Expression in FOXP3+Regulatory T Cells in Acute Coronary Syndrome. JIR 2022;Volume 15:1195-207. [DOI: 10.2147/jir.s351364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
419 Cainzos-achirica M, Nasir K. Debates in Cardiac CT: The Force of Data Is with CAC — And It’s Rock Solid. Journal of Cardiovascular Computed Tomography 2022. [DOI: 10.1016/j.jcct.2022.02.002] [Reference Citation Analysis]
420 Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabés JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJ, Deharo J, Delgado V, Diller G, Israel CW, Keren A, Knops RE, Kotecha D, Leclercq C, Merkely B, Starck C, Thylén I, Tolosana JM. Grupo de trabajo sobre estimulación cardiaca y terapia de resincronización cardiaca de la Sociedad Europea de Cardiología (ESC). Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.10.025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
421 Mangner N, Farah A, Ohlow MA, Möbius-Winkler S, Weilenmann D, Wöhrle J, Linke A, Stachel G, Markovic S, Leibundgut G, Rickenbacher P, Cattaneo M, Gilgen N, Kaiser C, Scheller B, Jeger RV; BASKET-SMALL 2 Investigators. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2. Circ Cardiovasc Interv 2022;15:e011325. [PMID: 35000455 DOI: 10.1161/CIRCINTERVENTIONS.121.011325] [Reference Citation Analysis]
422 Yildiz BS, Cetin N, Gunduz R, Bilge A, Ozgur S, Orman MN. Effect of Coronary Thrombus Aspiration in Non ST Elevation Acute Coronary Syndrome Patients on Three-Year Survival- Does it add any Benefit? Angiology 2022;:33197211053404. [PMID: 35104154 DOI: 10.1177/00033197211053404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
423 Monteiro-Henriques I, Rocha-Sousa A, Barbosa-Breda J. Optical coherence tomography angiography changes in cardiovascular systemic diseases and risk factors: A Review. Acta Ophthalmol 2022;100:e1-e15. [PMID: 33783129 DOI: 10.1111/aos.14851] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
424 Koshy AN, Dinh DT, Fulcher J, Brennan AL, Murphy AC, Duffy SJ, Reid CM, Ajani AE, Freeman M, Hiew C, Oqueli E, Farouque O, Yudi MB, Clark DJ. Long-term mortality in asymptomatic patients with stable ischemic heart disease undergoing percutaneous coronary intervention. Am Heart J 2022;244:77-85. [PMID: 34780716 DOI: 10.1016/j.ahj.2021.10.190] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
425 Zhou F, Chen Q, Luo X, Cao W, Li Z, Zhang B, Schoepf UJ, Gill CE, Guo L, Gao H, Li Q, Shi Y, Tang T, Liu X, Wu H, Wang D, Xu F, Jin D, Huang S, Li H, Pan C, Gu H, Xie L, Wang X, Ye J, Jiang J, Zhao H, Fang X, Xu Y, Xing W, Li X, Yin X, Lu GM, Zhang LJ. Prognostic Value of Coronary CT Angiography-Derived Fractional Flow Reserve in Non-obstructive Coronary Artery Disease: A Prospective Multicenter Observational Study. Front Cardiovasc Med 2022;8:778010. [DOI: 10.3389/fcvm.2021.778010] [Reference Citation Analysis]
426 Engelen SE, Robinson AJB, Zurke Y, Monaco C. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Nat Rev Cardiol. [DOI: 10.1038/s41569-021-00668-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
427 Kaplan A, Amin G, Abidi E, Altara R, Booz GW, Zouein FA. Role of ranolazine in heart failure: From cellular to clinic perspective. Eur J Pharmacol 2022;:174787. [PMID: 35114190 DOI: 10.1016/j.ejphar.2022.174787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
428 Pluta K, Porębska K, Urbanowicz T, Gąsecka A, Olasińska-Wiśniewska A, Targoński R, Krasińska A, Filipiak KJ, Jemielity M, Krasiński Z. Platelet-Leucocyte Aggregates as Novel Biomarkers in Cardiovascular Diseases. Biology (Basel) 2022;11:224. [PMID: 35205091 DOI: 10.3390/biology11020224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
429 Szarpak L, Mierzejewska M, Jurek J, Kochanowska A, Gasecka A, Truszewski Z, Pruc M, Blek N, Rafique Z, Filipiak KJ, Denegri A, Jaguszewski MJ. Effect of Coronary Artery Disease on COVID-19-Prognosis and Risk Assessment: A Systematic Review and Meta-Analysis. Biology (Basel) 2022;11:221. [PMID: 35205088 DOI: 10.3390/biology11020221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
430 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; Authors/Task Force Members:., ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4-131. [PMID: 35083827 DOI: 10.1002/ejhf.2333] [Cited by in Crossref: 174] [Cited by in F6Publishing: 56] [Article Influence: 174.0] [Reference Citation Analysis]
431 Jourdi G, Godier A, Lordkipanidzé M, Marquis-gravel G, Gaussem P. Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches. Front Cardiovasc Med 2022;9:805525. [DOI: 10.3389/fcvm.2022.805525] [Reference Citation Analysis]
432 Rodriguez-Zanella H, Arbucci R, Fritche-Salazar JF, Ortiz-Leon XA, Tuttolomondo D, Lowenstein DH, Wierzbowska-Drabik K, Ciampi Q, Kasprzak JD, Gaibazzi N, Lowenstein J, Posada-Martinez EL, Arias-Godinez JA, de la Fuente-Mancera JC, Picano E, On Behalf Of The Stress Echo Study Group Of The Italian Society Of Echocardiography And Cardiovascular Imaging Siecvi. Vasodilator Strain Stress Echocardiography in Suspected Coronary Microvascular Angina. J Clin Med 2022;11:711. [PMID: 35160163 DOI: 10.3390/jcm11030711] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
433 Puteri MU, Azmi NU, Kato M, Saputri FC. PCSK9 Promotes Cardiovascular Diseases: Recent Evidence about Its Association with Platelet Activation-Induced Myocardial Infarction. Life 2022;12:190. [DOI: 10.3390/life12020190] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
434 Spadarella G, Perillo T, Ugga L, Cuocolo R. Radiomics in Cardiovascular Disease Imaging: from Pixels to the Heart of the Problem. Curr Cardiovasc Imaging Rep. [DOI: 10.1007/s12410-022-09563-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
435 Angeli F, Verdecchia P, Savonitto S, Cavallini S, Santucci A, Coiro S, Sclafani R, Riccini C, De Servi S, Cavallini C. Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention. Clin Chem Lab Med 2022;60:118-26. [PMID: 34714987 DOI: 10.1515/cclm-2021-0817] [Reference Citation Analysis]
436 Stomby A, Strömberg S, Theodorsson E, Olsen Faresjö Å, Jones M, Faresjö T. Standard Modifiable Cardiovascular Risk Factors Mediate the Association Between Elevated Hair Cortisol Concentrations and Coronary Artery Disease. Front Cardiovasc Med 2022;8:765000. [DOI: 10.3389/fcvm.2021.765000] [Reference Citation Analysis]
437 Vinci R, Pedicino D, Bonanni A, d'Aiello A, Pisano E, Ponzo M, Severino A, Ciampi P, Canonico F, Russo G, Di Sario M, Vergallo R, Filomia S, Montone RA, Flego D, Stefanini L, Piacentini R, Conte C, Cribari F, Massetti M, Crea F, Liuzzo G. Monocyte-Platelet Aggregates Triggered by CD31 Molecule in Non-ST Elevation Myocardial Infarction: Clinical Implications in Plaque Rupture. Front Cardiovasc Med 2022;8:741221. [DOI: 10.3389/fcvm.2021.741221] [Reference Citation Analysis]
438 Zhao J, Wang S, Zhao P, Huo Y, Li C, Zhou J, Kleczynski P. Comparison of Risk Assessment Strategies for Patients with Diabetes Mellitus and Stable Chest Pain: A Coronary Computed Tomography Angiography Study. Journal of Diabetes Research 2022;2022:1-10. [DOI: 10.1155/2022/8183487] [Reference Citation Analysis]
439 Beauchamp A, Talevski J, Niebauer J, Gutenberg J, Kefalianos E, Mayr B, Sareban M, Kulnik ST. Health literacy interventions for secondary prevention of coronary artery disease: a scoping review. Open Heart 2022;9:e001895. [PMID: 35064057 DOI: 10.1136/openhrt-2021-001895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
440 Li W, Diao K, Wen Y, Shuai T, You Y, Zhao J, Liao K, Lu C, Yu J, He Y, Li Z. High-strength deep learning image reconstruction in coronary CT angiography at 70-kVp tube voltage significantly improves image quality and reduces both radiation and contrast doses. Eur Radiol. [DOI: 10.1007/s00330-021-08424-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
441 Pedersen E, Primicerio R, Halvorsen KH, Eggen AE, Garcia BH, Schirmer H, Waaseth M. Medication adherence among persons with coronary heart disease and associations with blood pressure and low-density-lipoprotein-cholesterol. Eur J Clin Pharmacol. [DOI: 10.1007/s00228-022-03276-4] [Reference Citation Analysis]
442 Song PS, Kim MJ, Seong SW, Choi SW, Gwon HC, Hur SH, Rha SW, Yoon CH, Jeong MH, Jeong JO, Kamir-Nih Investigators. Gender Differences in All-Cause Mortality after Acute Myocardial Infarction: Evidence for a Gender-Age Interaction. J Clin Med 2022;11:541. [PMID: 35159993 DOI: 10.3390/jcm11030541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
443 Wang Y, Xu Y, Zhang L, Huang S, Dou L, Yang J, Fu W, Zhou P, Wan H. Comparison of Buyang Huanwu granules and Naoxintong capsules in the treatment of stable angina pectoris: rationale and design of a randomized, blinded, multicentre clinical trial. Trials 2022;23:65. [PMID: 35062988 DOI: 10.1186/s13063-021-05914-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
444 Wang X, Luo P, Du H, Li S, Wang Y, Guo X, Wan L, Zhao B, Ren J. Ultrasound Radiomics Nomogram Integrating Three-Dimensional Features Based on Carotid Plaques to Evaluate Coronary Artery Disease. Diagnostics 2022;12:256. [DOI: 10.3390/diagnostics12020256] [Reference Citation Analysis]
445 Karlsen S, Melichova D, Dahlslett T, Grenne B, Sjøli B, Smiseth O, Edvardsen T, Brunvand H. Increased deformation of the left ventricle during exercise test measured by global longitudinal strain can rule out significant coronary artery disease in patients with suspected unstable angina pectoris. Echocardiography 2022. [PMID: 35043455 DOI: 10.1111/echo.15295] [Reference Citation Analysis]
446 Tveit SH, Myhre PL, Hanssen TA, Forsdahl SH, Iqbal A, Omland T, Schirmer H. Cardiac troponin I and T for ruling out coronary artery disease in suspected chronic coronary syndrome. Sci Rep 2022;12:945. [PMID: 35042885 DOI: 10.1038/s41598-022-04850-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
447 Baggiano A, Italiano G, Guglielmo M, Fusini L, Guaricci AI, Maragna R, Giacari CM, Mushtaq S, Conte E, Annoni AD, Formenti A, Mancini ME, Andreini D, Rabbat M, Pepi M, Pontone G. Changing Paradigms in the Diagnosis of Ischemic Heart Disease by Multimodality Imaging. JCM 2022;11:477. [DOI: 10.3390/jcm11030477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
448 Desperak P, Desperak A, Szyguła-jurkiewicz B, Rozentryt P, Lekston A, Gąsior M. The Impact of Short-Term Outdoor Air Pollution on Clinical Status and Prognosis of Hospitalized Patients with Coronary Artery Disease Treated with Percutaneous Coronary Intervention. JCM 2022;11:484. [DOI: 10.3390/jcm11030484] [Reference Citation Analysis]
449 Yong J, Tian J, Zhao X, Yang X, Zhang M, Zhou Y, He Y, Song X. Revascularization or medical therapy for stable coronary artery disease patients with different degrees of ischemia: a systematic review and meta-analysis of the role of myocardial perfusion. Therapeutic Advances in Chronic Disease 2022;13:204062232110567. [DOI: 10.1177/20406223211056713] [Reference Citation Analysis]
450 Brandt V, Decker J, Schoepf UJ, Varga-Szemes A, Emrich T, Aquino G, Bayer RR 2nd, Carson L, Sullivan A, Ellis L, von Knebel Doeberitz PL, Ebersberger U, Bekeredjian R, Tesche C. Additive value of epicardial adipose tissue quantification to coronary CT angiography-derived plaque characterization and CT fractional flow reserve for the prediction of lesion-specific ischemia. Eur Radiol 2022. [PMID: 35037968 DOI: 10.1007/s00330-021-08481-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
451 Vriz O, Palatini P, Rudski L, Frumento P, Kasprzak JD, Ferrara F, Cocchia R, Gargani L, Wierzbowska-drabik K, Capone V, Ranieri B, Salzano A, Stanziola AA, Marra AM, Annunziata R, Chianese S, Rega S, Saltalamacchia T, Maramaldi R, Sepe C, Limongelli G, Cademartiri F, D’andrea A, D’alto M, Izzo R, Ferrara N, Mauro C, Cittadini A, Ekkehard G, Guazzi M, Bossone E. Right Heart Pulmonary Circulation Unit Response to Exercise in Patients with Controlled Systemic Arterial Hypertension: Insights from the RIGHT Heart International NETwork (RIGHT-NET). JCM 2022;11:451. [DOI: 10.3390/jcm11020451] [Reference Citation Analysis]
452 Silverio A, Di Maio M, Buccheri S, De Luca G, Esposito L, Sarno G, Vecchione C, Galasso G. Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients. Int J Cardiol 2021:S0167-5273(21)01784-8. [PMID: 34774882 DOI: 10.1016/j.ijcard.2021.11.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
453 Jansen TPJ, van Keeken K, Konst RE, Dimitriu-leen A, Maas AHEM, van Royen N, Damman P, Elias-smale S. Relation Between Coronary Tortuosity and Vasomotor Dysfunction in Patients Without Obstructed Coronaries? Front Cardiovasc Med 2022;8:804731. [DOI: 10.3389/fcvm.2021.804731] [Reference Citation Analysis]
454 Haider A, Bengs S, Portmann A, Rossi A, Ahmed H, Etter D, Warnock GI, Mikail N, Grämer M, Meisel A, Gisler L, Jie C, Keller C, Kozerke S, Weber B, Schibli R, Mu L, Kaufmann PA, Regitz-Zagrosek V, Ametamey SM, Gebhard C. Role of sex hormones in modulating myocardial perfusion and coronary flow reserve. Eur J Nucl Med Mol Imaging 2022. [PMID: 35024889 DOI: 10.1007/s00259-022-05675-2] [Reference Citation Analysis]
455 Seraphim A, Knott KD, Augusto JB, Menacho K, Tyebally S, Dowsing B, Bhattacharyya S, Menezes LJ, Jones DA, Uppal R, Moon JC, Manisty C. Non-invasive Ischaemia Testing in Patients With Prior Coronary Artery Bypass Graft Surgery: Technical Challenges, Limitations, and Future Directions. Front Cardiovasc Med 2021;8:795195. [PMID: 35004905 DOI: 10.3389/fcvm.2021.795195] [Reference Citation Analysis]
456 Nusca A, Bernardini F, Mangiacapra F, Maddaloni E, Melfi R, Ricottini E, Piccirillo F, Manfrini S, Ussia GP, Grigioni F. Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study. J Diabetes Res 2021;2021:4952447. [PMID: 35005029 DOI: 10.1155/2021/4952447] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
457 Wienemann H, Meyer A, Mauri V, Baar T, Adam M, Baldus S, Halbach M. Comparison of Resting Full-Cycle Ratio and Fractional Flow Reserve in a German Real-World Cohort. Front Cardiovasc Med 2021;8:744181. [PMID: 35004875 DOI: 10.3389/fcvm.2021.744181] [Reference Citation Analysis]
458 Seitz A, Feenstra R, Konst RE, Martínez Pereyra V, Beck S, Beijk M, van de Hoef T, van Royen N, Bekeredjian R, Sechtem U, Damman P, Piek JJ, Ong P. Acetylcholine Rechallenge: A First Step Toward Tailored Treatment in Patients With Coronary Artery Spasm. JACC Cardiovasc Interv 2022;15:65-75. [PMID: 34991826 DOI: 10.1016/j.jcin.2021.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
459 Cimci M, Polad J, Mamas M, Iniguez-Romo A, Chevalier B, Abhaichand R, Aminian A, Roguin A, Maluenda G, Angioi M, Cassel G, Kuramitsu S, Jacobs L, Debrus R, Malik F, Hildick-Smith D, Laanmets P, Roffi M. Outcomes and regional differences in practice in a worldwide coronary stent registry. Heart 2022:heartjnl-2021-320116. [PMID: 35012960 DOI: 10.1136/heartjnl-2021-320116] [Reference Citation Analysis]
460 Asher C, Puyol-Antón E, Rizvi M, Ruijsink B, Chiribiri A, Razavi R, Carr-White G. The Role of AI in Characterizing the DCM Phenotype. Front Cardiovasc Med 2021;8:787614. [PMID: 34993240 DOI: 10.3389/fcvm.2021.787614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
461 Park H, Kang DY, Lee CW. Functional Angioplasty: Definitions, Historical Overview, and Future Perspectives. Korean Circ J 2022;52:34-46. [PMID: 34989193 DOI: 10.4070/kcj.2021.0363] [Reference Citation Analysis]
462 Angeli F, Verdecchia P, Balestrino A, Bruschi C, Ceriana P, Chiovato L, Dalla Vecchia LA, Fanfulla F, La Rovere MT, Perego F, Scalvini S, Spanevello A, Traversi E, Visca D, Vitacca M, Bachetti T. Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry. JCDD 2022;9:15. [DOI: 10.3390/jcdd9010015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
463 Pandya A, Yu YJ, Ge Y, Nagel E, Kwong RY, Bakar RA, Grizzard JD, Merkler AE, Ntusi N, Petersen SE, Rashedi N, Schwitter J, Selvanayagam JB, White JA, Carr J, Raman SV, Simonetti OP, Bucciarelli-Ducci C, Sierra-Galan LM, Ferrari VA, Bhatia M, Kelle S. Evidence-based cardiovascular magnetic resonance cost-effectiveness calculator for the detection of significant coronary artery disease. J Cardiovasc Magn Reson 2022;24:1. [PMID: 34986851 DOI: 10.1186/s12968-021-00833-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
464 Xanthopoulos A, Tryposkiadis K, Giamouzis G, Dimos A, Bourazana A, Papamichalis M, Zagouras A, Iakovis N, Kitai T, Skoularigis J, Starling RC, Triposkiadis F. Coexisting Morbidity Burden in Hospitalized Elderly Patients with New-Onset Heart Failure vs Acutely Decompensated Chronic Heart Failure. Angiology. [DOI: 10.1177/00033197211062661] [Reference Citation Analysis]
465 Maehl N, Bleckwenn M, Riedel-Heller SG, Mehlhorn S, Lippmann S, Deutsch T, Schrimpf A. The Impact of the COVID-19 Pandemic on Avoidance of Health Care, Symptom Severity, and Mental Well-Being in Patients With Coronary Artery Disease. Front Med (Lausanne) 2021;8:760265. [PMID: 34977066 DOI: 10.3389/fmed.2021.760265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
466 Ybarra LF, Piazza N. Expanding the Role of Coronary Computed Tomography Angiography in Interventional Cardiology. Circulation 2022;145:5-7. [PMID: 34965167 DOI: 10.1161/CIRCULATIONAHA.121.053038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
467 Picano E. Coronary flow velocity at rest: a speed limit for a safe prognostic journey? Acta Cardiol 2022;:1-3. [PMID: 34979869 DOI: 10.1080/00015385.2021.2020483] [Reference Citation Analysis]
468 Jamthikar A, Gupta D, Johri AM, Mantella LE, Saba L, Suri JS. A machine learning framework for risk prediction of multi-label cardiovascular events based on focused carotid plaque B-Mode ultrasound: A Canadian study. Comput Biol Med 2022;140:105102. [PMID: 34973521 DOI: 10.1016/j.compbiomed.2021.105102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
469 Karam N, Pechmajou L, Narayanan K, Bougouin W, Sharifzadehgan A, Anys S, Weizman O, Perrot D, Waldmann V, Beganton F, Perier M, Rischard J, Loeb T, Agostinucci J, Lecarpentier E, Jabre P, Jost D, Dumas F, Cariou A, Jouven X, Marijon E. Evolution of Incidence, Management, and Outcomes Over Time in Sports-Related Sudden Cardiac Arrest. Journal of the American College of Cardiology 2022;79:238-46. [DOI: 10.1016/j.jacc.2021.11.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
470 Motiejunaite J, Vidal-Petiot E. Does exercise stress testing carry an incremental prognostic value beyond resting office blood pressure? J Hypertens 2022;40:24-6. [PMID: 34857701 DOI: 10.1097/HJH.0000000000003016] [Reference Citation Analysis]
471 Shen L, Qiu L, Liu J, Li N, Shu H, Zhou N. Clinical Implications of Nicorandil Combined with Trimetazidine in Patients with Coronary Heart Disease: A Real-World Observational Study. Adv Ther 2022;39:655-73. [PMID: 34846710 DOI: 10.1007/s12325-021-01987-1] [Reference Citation Analysis]
472 Nguyen HD, Oh H, Kim MS. The association between curry-rice consumption and hypertension, type 2 diabetes, and depression: The findings from KNHANES 2012-2016. Diabetes Metab Syndr 2022;16:102378. [PMID: 34974329 DOI: 10.1016/j.dsx.2021.102378] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
473 Abeel M, Gupta A, Constance C. Concomitant Treatment of Hypertensive Patients with Bisoprolol and Perindopril in Routine Clinical Practice: A Post Hoc Analysis of the CONFIDENCE II, PROTECT I, and PROTECT III Observational Studies. Adv Ther 2022;39:391-404. [PMID: 34755324 DOI: 10.1007/s12325-021-01958-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
474 van Beek KA, van Steenbergen GJ, Vervaat FE, Mulders B, van Straten BH, van Nunen LX, Wijnbergen IF. Single center experience in the treatment of hemodynamically significant diffuse coronary artery disease of the left anterior descending. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.01.048] [Reference Citation Analysis]
475 Zhou J, Li C. The Authors Reply. JACC Cardiovasc Imaging 2022;15:175-6. [PMID: 34991893 DOI: 10.1016/j.jcmg.2021.11.018] [Reference Citation Analysis]
476 Yamaguchi M, Hoshino M, Sugiyama T, Kanaji Y, Nagamine T, Misawa T, Hada M, Araki M, Hamaya R, Usui E, Murai T, Lee T, Yonetsu T, Sasano T, Kakuta T. Association of near-infrared spectroscopy-defined lipid rich plaque with lesion morphology and peri-coronary inflammation on computed tomography angiography. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.01.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
477 Yu Y, Ding X, Yu L, Dai X, Wang Y, Zhang J. Increased coronary pericoronary adipose tissue attenuation in diabetic patients compared to non-diabetic controls: a propensity score matching analysis. Journal of Cardiovascular Computed Tomography 2022. [DOI: 10.1016/j.jcct.2022.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
478 Zafrir B, Aker A, Asaf Y, Saliba W. Blood pressure response during treadmill exercise testing and the risk for future cardiovascular events and new-onset hypertension. J Hypertens 2022;40:143-52. [PMID: 34857707 DOI: 10.1097/HJH.0000000000002991] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
479 Blankstein R, Gulati M, Jaber WA, Bullock-Palmer RP, Bhatt DL, Shaw LJ. The 2021 Chest Pain Guideline: A Revolutionary New Paradigm for Cardiac Testing. JACC Cardiovasc Imaging 2022;15:140-4. [PMID: 34991889 DOI: 10.1016/j.jcmg.2021.10.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
480 Kőszegi Z, Berta B, Tóth GG, Tar B, Üveges Á, Ágoston A, Szücs A, Szabó GT, Barta J, Szük T, Czuriga D, Komócsi A, Ruzsa Z. Anatomical Assessment vs. Pullback REsting full-cycle rAtio (RFR) Measurement for Evaluation of Focal and Diffuse CoronarY Disease: Rationale and Design of the "READY Register". Front Cardiovasc Med 2021;8:784220. [PMID: 34966799 DOI: 10.3389/fcvm.2021.784220] [Reference Citation Analysis]
481 Sato Y, Kawai H, Hoshino M, Matsumoto S, Hayakawa M, Sadato A, Sarai M, Motoyama S, Takahashi H, Naruse H, Ishii J, Toyama H, Ozaki Y, Nakahara I, Hirose Y, Izawa H. Relationship between epicardial adipose tissue and coronary artery stenoses on computed tomography in patients scheduled for carotid artery revascularization. J Cardiol 2021:S0914-5087(21)00363-4. [PMID: 34974941 DOI: 10.1016/j.jjcc.2021.12.008] [Reference Citation Analysis]
482 Nakanishi R, Osawa K, Kurata A, Miyoshi T. Role of coronary computed tomography angiography (CTA) post the ISCHEMIA trial: Precision prevention based on coronary CTA-derived coronary atherosclerosis. J Cardiol 2021:S0914-5087(21)00362-2. [PMID: 34974937 DOI: 10.1016/j.jjcc.2021.12.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
483 Chen W, Li H, Lu Z, Guo Q, Liu X, Sun R, Zhang J, Huang J, Chen Q, Wang J, Shen J, Zhang Y. The ratio of the max-to-mean coronary artery calcium score in the most calcified vessel is associated with the presence of coronary artery disease. Eur J Radiol 2021;147:110134. [PMID: 34979296 DOI: 10.1016/j.ejrad.2021.110134] [Reference Citation Analysis]
484 Huang H, Yu Y, Chen L, Chen S, Tang R, Li Q, Wei W, Bao K, Huang Z, Lai W, Wang B, Tan N, Chen J, Liu J, Liu Y. Independent and joint effects of high-sensitivity c-reactive protein and hypoalbuminemia on long-term all-cause mortality among coronary artery disease: a prospective and multicenter cohort study. BMC Cardiovasc Disord 2021;21:613. [PMID: 34961476 DOI: 10.1186/s12872-021-02431-6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
485 Teragawa H, Oshita C, Uchimura Y, Akazawa R, Orita Y. Coronary Microvascular Vasodilatory Function: Related Clinical Features and Differences According to the Different Coronary Arteries and Types of Coronary Spasm. J Clin Med 2021;11:130. [PMID: 35011869 DOI: 10.3390/jcm11010130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
486 Lopatin Y, Petrova P; MODUS VIVENDI investigators. Effectiveness and Tolerability of Trimetazidine 80 Mg Once Daily in Patients with Stable Angina Uncontrolled with Bisoprolol-Based Therapy: The Modus Vivendi Observational Study. Cardiol Ther 2021. [PMID: 34958427 DOI: 10.1007/s40119-021-00249-z] [Reference Citation Analysis]
487 Vilela EM, Ladeiras-Lopes R, Joao A, Braga J, Torres S, Viamonte S, Ribeiro J, Teixeira M, Nunes JP, Fontes-Carvalho R. Current role and future perspectives of cardiac rehabilitation in coronary heart disease. World J Cardiol 2021; 13(12): 695-709 [DOI: 10.4330/wjc.v13.i12.695] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
488 Liao M, Lai C, Wang T, Lin J, Ho Y, Chan KA. Red Cell Distribution Width and Mortality in Patients Undergoing Percutaneous Coronary Intervention. Biomedicines 2022;10:45. [DOI: 10.3390/biomedicines10010045] [Reference Citation Analysis]
489 Ang DTY, Berry C. What an Interventionalist Needs to Know About INOCA. Interv Cardiol 2021;16:e32. [PMID: 34950239 DOI: 10.15420/icr.2021.16] [Reference Citation Analysis]
490 Marwarha G, Røsand Ø, Scrimgeour N, Slagsvold KH, Høydal MA. miR-210 Regulates Apoptotic Cell Death during Cellular Hypoxia and Reoxygenation in a Diametrically Opposite Manner. Biomedicines 2021;10:42. [PMID: 35052722 DOI: 10.3390/biomedicines10010042] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
491 Aldiwani H, Mahdai S, Alhatemi G, Bairey Merz CN. Microvascular Angina: Diagnosis and Management. Eur Cardiol 2021;16:e46. [PMID: 34950242 DOI: 10.15420/ecr.2021.15] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
492 Dalli Peydró E, Sanz Sevilla N, Tuzón Segarra MT, Miró Palau V, Sánchez Torrijos J, Cosín Sales J. A randomized controlled clinical trial of cardiac telerehabilitation with a prolonged mobile care monitoring strategy after an acute coronary syndrome. Clin Cardiol 2021. [PMID: 34952989 DOI: 10.1002/clc.23757] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
493 Peper J, Becker LM, van Kuijk JP, Leiner T, Swaans MJ. Fractional Flow Reserve: Patient Selection and Perspectives. Vasc Health Risk Manag 2021;17:817-31. [PMID: 34934324 DOI: 10.2147/VHRM.S286916] [Reference Citation Analysis]
494 Zhang Y, Zhang X, Dong Q, Chen D, Xu Y, Jiang J. Duration of Dual Antiplatelet Therapy After Implantation of Drug-Coated Balloon. Front Cardiovasc Med 2021;8:762391. [PMID: 34926613 DOI: 10.3389/fcvm.2021.762391] [Reference Citation Analysis]
495 Vassilev D, Mileva N, Collet C, Nikolov P, Sokolova K, Karamfiloff K, Naunov V, Sonck J, Rigatelli G, Kassab GS, Gil RJ. Bifurcation functional significance score as predictor of mortality: a validating study. Sci Rep 2021;11:24308. [PMID: 34934122 DOI: 10.1038/s41598-021-03815-6] [Reference Citation Analysis]
496 . Quantitative plaque assessment by coronary computed tomography angiography: An up-to-date review. Imaging 2021;13:98-105. [DOI: 10.1556/1647.2021.00033] [Reference Citation Analysis]
497 Savarimuthu S, Philip B, Harky A. Coronary Sinus Reducer: A Solution for patients with Refractory Angina. Curr Probl Cardiol 2021;:101085. [PMID: 34936909 DOI: 10.1016/j.cpcardiol.2021.101085] [Reference Citation Analysis]
498 van den Boogert TPW, Claessen BEPM, Boekholdt SM, Leiner T, Vliegenthart R, Schuiling SF, Timmer JR, Bekkers SCAM, Voskuil M, Siebelink HJ, van Es W, Lamb HJ, Prokop M, Damman P, Stoker J, Willems HC, Henriques JP, Planken RN. The impact and challenges of implementing CTCA according to the 2019 ESC guidelines on chronic coronary syndromes: a survey and projection of CTCA services in the Netherlands. Insights Imaging 2021;12:186. [PMID: 34921633 DOI: 10.1186/s13244-021-01122-2] [Reference Citation Analysis]
499 Parker WAE, Sagar R, Kurdee Z, Hawkins F, Naseem KM, Grant PJ, Storey RF, Ajjan RA. A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control. Cardiovasc Diabetol 2021;20:238. [PMID: 34920734 DOI: 10.1186/s12933-021-01427-y] [Reference Citation Analysis]
500 Ochs A, Nippes M, Salatzki J, Weberling LD, Riffel J, Müller-Hennessen M, Giannitsis E, Osman N, Stehning C, André F, Katus HA, Frey N, Friedrich MG, Ochs MM. Dynamic Handgrip Exercise: Feasibility and Physiologic Stress Response of a Potential Needle-Free Cardiac Magnetic Resonance Stress Test. Front Cardiovasc Med 2021;8:755759. [PMID: 34912862 DOI: 10.3389/fcvm.2021.755759] [Reference Citation Analysis]
501 Yin H, Cheng X, Liang Y, Liu A, Wang H, Liu F, Guo L, Ma H, Geng Q. High Perceived Stress May Shorten Activated Partial Thromboplastin Time and Lead to Worse Clinical Outcomes in Patients With Coronary Heart Disease. Front Cardiovasc Med 2021;8:769857. [PMID: 34912866 DOI: 10.3389/fcvm.2021.769857] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
502 Mehilli J, Winhard M. The CHADS-P2A2RC score: ready to guide the selection of treatment? Eur Heart J 2021:ehab864. [PMID: 34918038 DOI: 10.1093/eurheartj/ehab864] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
503 Cesaro A, Gragnano F, Calabrò P, Moscarella E, Santelli F, Fimiani F, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Pelliccia F, Bossone E, Pengo V, Gresele P, Marcucci R; START-ANTIPLATELET collaborators. Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry. Int J Cardiol 2021;345:7-13. [PMID: 34695525 DOI: 10.1016/j.ijcard.2021.10.138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
504 Caselli C, De Caterina R, Ragusa R, Liga R, Gimelli A, Scholte AJHA, Clerico A, Knuuti J, Neglia D. Association of Circulating Heme Oxygenase-1, Lipid Profile and Coronary Disease Phenotype in Patients with Chronic Coronary Syndrome. Antioxidants (Basel) 2021;10:2002. [PMID: 34943105 DOI: 10.3390/antiox10122002] [Reference Citation Analysis]
505 Elzieny AA, Montaser SS, Emara AM, Ahmed MK. Left Ventricular Twist and Untwist in Patients Undergoing Elective Percutaneous Coronary Intervention. J Cardiovasc Echogr 2021;31:137-43. [PMID: 34900548 DOI: 10.4103/jcecho.jcecho_121_20] [Reference Citation Analysis]
506 Conte E, Mushtaq S, Mancini ME, Annoni A, Formenti A, Muscogiuri G, Gaudenzi Asinelli M, Gigante C, Collet C, Sonck J, Guglielmo M, Baggiano A, Cosentino N, Denora M, Belmonte M, Agalbato C, Esposito AA, Assanelli E, Bartorelli AL, Pepi M, Pontone G, Andreini D. Cardiac Care of Non-COVID-19 Patients During the SARS-CoV-2 Pandemic: The Pivotal Role of CCTA. Front Cardiovasc Med 2021;8:775115. [PMID: 34901235 DOI: 10.3389/fcvm.2021.775115] [Reference Citation Analysis]
507 Zhou H, Zhao Y, Peng W, Han W, Wang Z, Ren X, Wang D, Pan G, Lin Q, Wang X. Effect of Sodium Tanshinone IIA Sulfonate Injection on Blood Lipid in Patients With Coronary Heart Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front Cardiovasc Med 2021;8:770746. [PMID: 34901229 DOI: 10.3389/fcvm.2021.770746] [Reference Citation Analysis]
508 Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, Carver J, Dent S, Ky B, Lyon AR, López-Fernández T, Fradley MG, Ganatra S, Curigliano G, Mitchell JD, Minotti G, Lang NN, Liu JE, Neilan TG, Nohria A, O'Quinn R, Pusic I, Porter C, Reynolds KL, Ruddy KJ, Thavendiranathan P, Valent P. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J 2021:ehab674. [PMID: 34904661 DOI: 10.1093/eurheartj/ehab674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
509 Sato S, Matsumoto H, Li D, Ohya H, Mori H, Sakai K, Ogura K, Oishi Y, Masaki R, Tanaka H, Kondo S, Tsujita H, Tsukamoto S, Isodono K, Kitamura R, Komori Y, Yoshii N, Sato I, Christodoulou AG, Xie Y, Shinke T. Coronary High-Intensity Plaques at T1-weighted MRI in Stable Coronary Artery Disease: Comparison with Near-Infrared Spectroscopy Intravascular US. Radiology 2021;:211463. [PMID: 34904874 DOI: 10.1148/radiol.211463] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
510 Friebel J, Moritz E, Witkowski M, Jakobs K, Strässler E, Dörner A, Steffens D, Puccini M, Lammel S, Glauben R, Nowak F, Kränkel N, Haghikia A, Moos V, Schutheiss HP, Felix SB, Landmesser U, Rauch BH, Rauch U. Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation. Cells 2021;10:3517. [PMID: 34944024 DOI: 10.3390/cells10123517] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
511 Kim M, Jang AY, Oh PC, Suh SY, Lee K, Kang WC, Ahn T, Han SH. Diagnostic and prognostic role of nitroglycerin-induced dilation in patients with suspected vasospastic angina, combined with ergonovine provocation test. Sci Rep 2021;11:23834. [PMID: 34903772 DOI: 10.1038/s41598-021-03338-0] [Reference Citation Analysis]
512 Stumpf MJ, Schahab N, Nickenig G, Skowasch D, Schaefer CA. Therapy of Pseudoxanthoma Elasticum: Current Knowledge and Future Perspectives. Biomedicines 2021;9:1895. [DOI: 10.3390/biomedicines9121895] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
513 Kuchynka P, Adla T, Baxa J, Zemánek D, Kamínek M, Línková H, Kočková R. (Appropriate indications to cardiac computed tomography (CT): expert consensus statement of the Section of Cardiac Computed Tomography of the Czech Association of Cardiovascular Imaging Methods of the Czech Society of Cardiology). Cor Vasa 2021;63:745-7. [DOI: 10.33678/cor.2021.122] [Reference Citation Analysis]
514 Gonzalez-Jaramillo N, Marcin T, Matter S, Eser P, Berlin C, Bano A, Heg D, Franco OH, Windecker S, Räber L, Wilhelm M. Clinical outcomes and cardiac rehabilitation in underrepresented groups after percutaneous coronary intervention: an observational study. Eur J Prev Cardiol 2021:zwab204. [PMID: 34894217 DOI: 10.1093/eurjpc/zwab204] [Reference Citation Analysis]
515 Yang S, Koo BK, Narula J. Interactions Between Morphological Plaque Characteristics and Coronary Physiology: From Pathophysiological Basis to Clinical Implications. JACC Cardiovasc Imaging 2021:S1936-878X(21)00775-0. [PMID: 34922863 DOI: 10.1016/j.jcmg.2021.10.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
516 Suzuki Y, Matsumoto N, Yoda S, Amano Y, Okumura Y. Coronary artery calcium score: Current status of clinical application and how to handle the results. J Cardiol 2021:S0914-5087(21)00340-3. [PMID: 34895980 DOI: 10.1016/j.jjcc.2021.11.020] [Reference Citation Analysis]
517 Sakellarios AI, Siogkas P, Kigka V, Tsompou P, Pleouras D, Kyriakidis S, Karanasiou G, Pelosi G, Nikopoulos S, Naka KK, Rocchiccioli S, Michalis LK, Fotiadis DI. Error Propagation in the Simulation of Atherosclerotic Plaque Growth and the Prediction of Atherosclerotic Disease Progression. Diagnostics (Basel) 2021;11:2306. [PMID: 34943545 DOI: 10.3390/diagnostics11122306] [Reference Citation Analysis]
518 Liu C, Liu L, Gao J, Wang J, Liu Y. Identification of Two Long Non-Coding RNAs AC010082.1 and AC011443.1 as Biomarkers of Coronary Heart Disease Based on Logistic Stepwise Regression Prediction Model. Front Genet 2021;12:780431. [PMID: 34868268 DOI: 10.3389/fgene.2021.780431] [Reference Citation Analysis]
519 Wahrenberg A, Kuja-Halkola R, Magnusson PKE, Häbel H, Warnqvist A, Hambraeus K, Jernberg T, Svensson P. Cardiovascular Family History Increases the Risk of Disease Recurrence After a First Myocardial Infarction. J Am Heart Assoc 2021;10:e022264. [PMID: 34845931 DOI: 10.1161/JAHA.121.022264] [Reference Citation Analysis]
520 Palmisano A, Vignale D, Tadic M, Moroni F, De Stefano D, Gatti M, Boccia E, Faletti R, Oppizzi M, Peretto G, Slavich M, Sala S, Montorfano M, Agricola E, Margonato A, De Cobelli F, Gentile F, Robella M, Cortese G, Esposito A. Myocardial Late Contrast Enhancement CT in Troponin-Positive Acute Chest Pain Syndrome. Radiology 2021;:211288. [PMID: 34874200 DOI: 10.1148/radiol.211288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
521 Xie L, Zhang Z, Wang Q, Chen Y, Lu D, Wu W. COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy. Front Endocrinol (Lausanne) 2021;12:772865. [PMID: 34867819 DOI: 10.3389/fendo.2021.772865] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
522 Pezel T, Unterseeh T, Hovasse T, Asselin A, Lefèvre T, Chevalier B, Neylon A, Benamer H, Champagne S, Sanguineti F, Toupin S, Garot P, Garot J. Phenotypic Clustering of Patients With Newly Diagnosed Coronary Artery Disease Using Cardiovascular Magnetic Resonance and Coronary Computed Tomography Angiography. Front Cardiovasc Med 2021;8:760120. [PMID: 34869675 DOI: 10.3389/fcvm.2021.760120] [Reference Citation Analysis]
523 Lee YH, Tsai TH, Chen JH, Huang CJ, Chiang CE, Chen CH, Cheng HM. Machine learning of treadmill exercise test to improve selection for testing for coronary artery disease. Atherosclerosis 2022;340:23-7. [PMID: 34871817 DOI: 10.1016/j.atherosclerosis.2021.11.028] [Reference Citation Analysis]
524 Steen H, Montenbruck M, Kelle S, Esch S, Schwarz AK, Giusca S, Korosoglou G. Fast-Strain Encoded Cardiac Magnetic Resonance During Vasodilator Perfusion Stress Testing. Front Cardiovasc Med 2021;8:765961. [PMID: 34869679 DOI: 10.3389/fcvm.2021.765961] [Reference Citation Analysis]
525 Würtz M, Olesen KKW, Mortensen MB, Eikelboom JW, Mohammad MA, Erlinge D, Kristensen SD, Maeng M. Dual antithrombotic treatment in chronic coronary syndrome: European Society of Cardiology criteria vs. CHADS-P2A2RC score. Eur Heart J 2021:ehab785. [PMID: 34871376 DOI: 10.1093/eurheartj/ehab785] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
526 Kelion AD. Stable Chest Pain: Are We Investigating a Symptom or Screening for Coronary Disease? JACC Cardiovasc Imaging 2021:S1936-878X(21)00777-4. [PMID: 34922864 DOI: 10.1016/j.jcmg.2021.10.011] [Reference Citation Analysis]
527 Vilela EM, Fontes-Carvalho R. Inflammation and ischemic heart disease: The next therapeutic target? Rev Port Cardiol (Engl Ed) 2021;40:785-96. [PMID: 34857118 DOI: 10.1016/j.repce.2021.10.010] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
528 Fontes JP, Vilela EM, Durazzo A, Teixeira M. Current state of cardiac rehabilitation in Portugal: Results of the 2019 national survey. Rev Port Cardiol (Engl Ed) 2021;40:877-87. [PMID: 34857162 DOI: 10.1016/j.repce.2021.10.024] [Reference Citation Analysis]
529 Kang SH, Baek H, Cho J, Kim S, Hwang H, Lee W, Park JJ, Yoon YE, Yoon CH, Cho YS, Youn TJ, Cho GY, Chae IH, Choi DJ, Yoo S, Suh JW. Management of cardiovascular disease using an mHealth tool: a randomized clinical trial. NPJ Digit Med 2021;4:165. [PMID: 34862449 DOI: 10.1038/s41746-021-00535-z] [Reference Citation Analysis]
530 Di Mitri C, Arcoleo G, Mazzuca E, Camarda G, Farinella EM, Soresi M, Carroccio A; IMUSG. COVID-19 and non-COVID-19 pneumonia: a comparison. Ann Med 2021;53:2321-31. [PMID: 34854790 DOI: 10.1080/07853890.2021.2010797] [Reference Citation Analysis]
531 Gowdak LHW. The Role of Ivabradine in Managing Symptomatic Patients with Chronic Coronary Syndromes: A Clinically Oriented Approach. Cardiol Ther 2021. [PMID: 34860357 DOI: 10.1007/s40119-021-00247-1] [Reference Citation Analysis]
532 Godo S, Takahashi J, Yasuda S, Shimokawa H. Endothelium in Coronary Macrovascular and Microvascular Diseases. J Cardiovasc Pharmacol 2021;78:S19-29. [PMID: 34840261 DOI: 10.1097/FJC.0000000000001089] [Reference Citation Analysis]
533 Lemesle G, Bauters C, Bonello L, Fauchier L, Cayla G, Marijon E, Guenoun M, Schurtz G, Ninni S, Richardson M, Albert F, Cohen S, Lamblin N, Danchin N. Management of antithrombotics in situations with a gap in evidence: A national French survey focusing on patients with coronary artery disease and atrial fibrillation. Int J Cardiol 2021:S0167-5273(21)01966-5. [PMID: 34864080 DOI: 10.1016/j.ijcard.2021.11.077] [Reference Citation Analysis]
534 Task Force for the management of COVID-19 of the European Society of Cardiology . ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Cardiovasc Res 2021:cvab343. [PMID: 34864876 DOI: 10.1093/cvr/cvab343] [Reference Citation Analysis]
535 Bettencourt N, Mendes L, Fontes JP. Estudo da doença coronária em Portugal: haverá vida para além da Covid? Revista Portuguesa de Cardiologia 2021. [DOI: 10.1016/j.repc.2021.06.013] [Reference Citation Analysis]
536 Nef HM, Achenbach S, Birkemeyer R, Bufe A, Dörr O, Elsässer A, Gaede L, Gori T, Hoffmeister HM, Hofmann FJ, Katus HA, Liebetrau C, Massberg S, Pauschinger M, Schmitz T, Süselbeck T, Voelker W, Wiebe J, Zahn R, Hamm C, Zeiher AM, Möllmann H. Manual der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (DGK): Teil 2: „Durchführung der perkutanen Koronarintervention“. Kardiologe 2021;15:542-84. [DOI: 10.1007/s12181-021-00504-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
537 Rijlaarsdam-Hermsen D, van Domburg RT, Deckers JW, Kuijpers D, van Dijkman PRM. Comparison of guidelines for diagnosing suspected stable angina and the additional value of the calcium score. Int J Cardiol 2021;344:1-7. [PMID: 34555447 DOI: 10.1016/j.ijcard.2021.09.039] [Reference Citation Analysis]
538 Tsujita K. Realistic detection of natural history of early coronary atherosclerosis: Best part of computed tomography-derived fractional flow reserve? Int J Cardiol 2021;344:34-5. [PMID: 34655675 DOI: 10.1016/j.ijcard.2021.10.016] [Reference Citation Analysis]
539 Xing D, Zhu M, Liu C, Wang H. Outcome measures in clinical trials of traditional Chinese medicine for stable angina pectoris. Acupuncture and Herbal Medicine 2021;1:99-106. [DOI: 10.1097/hm9.0000000000000014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
540 Simons R, Maire R, Van Drongelen A, Valk P. Grounding of Pilots: Medical Reasons and Recommendations for Prevention. Aerosp Med Hum Perform 2021;92:950-5. [PMID: 34986933 DOI: 10.3357/AMHP.5985.2021] [Reference Citation Analysis]
541 Marazzato J, Masnaghetti S, De Ponti R, Verdecchia P, Blasi F, Ferrarese S, Trapasso M, Spanevello A, Angeli F. Long-Term Survival in Patients with Post-Operative Atrial Fibrillation after Cardiac Surgery: Analysis from a Prospective Cohort Study. J Cardiovasc Dev Dis 2021;8:169. [PMID: 34940524 DOI: 10.3390/jcdd8120169] [Reference Citation Analysis]
542 Brouwers RWM, van der Poort EKJ, Kemps HMC, van den Akker-van Marle ME, Kraal JJ. Cost-effectiveness of Cardiac Telerehabilitation With Relapse Prevention for the Treatment of Patients With Coronary Artery Disease in the Netherlands. JAMA Netw Open 2021;4:e2136652. [PMID: 34854907 DOI: 10.1001/jamanetworkopen.2021.36652] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
543 Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, Diercks DB, Gentile F, Greenwood JP, Hess EP, Hollenberg SM, Jaber WA, Jneid H, Joglar JA, Morrow DA, O'Connor RE, Ross MA, Shaw LJ; Writing Committee Members. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Cardiovasc Comput Tomogr 2021:S1934-5925(21)00469-X. [PMID: 34955448 DOI: 10.1016/j.jcct.2021.11.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
544 Alexander KP, Douglas PS. Chest Pain Redux: Updated and Patient Centered. Circulation 2021;144:1735-7. [PMID: 34709930 DOI: 10.1161/CIRCULATIONAHA.121.056714] [Reference Citation Analysis]
545 Calmac L, Popa-Fotea NM, Bataila V, Ploscaru V, Turea A, Tache IA, Stoian D, Itu L, Badila E, Scafa-Udriste A, Dorobantu M. Importance of Visual Estimation of Coronary Artery Stenoses and Use of Functional Evaluation for Appropriate Guidance of Coronary Revascularization-Multiple Operator Evaluation. Diagnostics (Basel) 2021;11:2241. [PMID: 34943478 DOI: 10.3390/diagnostics11122241] [Reference Citation Analysis]
546 Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, Diercks DB, Gentile F, Greenwood JP, Hess EP, Hollenberg SM, Jaber WA, Jneid H, Joglar JA, Morrow DA, O'Connor RE, Ross MA, Shaw LJ; Writing Committee Members. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021;78:e187-285. [PMID: 34756653 DOI: 10.1016/j.jacc.2021.07.053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 51] [Article Influence: 2.0] [Reference Citation Analysis]
547 Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, Diercks DB, Gentile F, Greenwood JP, Hess EP, Hollenberg SM, Jaber WA, Jneid H, Joglar JA, Morrow DA, O'Connor RE, Ross MA, Shaw LJ. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021;144:e368-454. [PMID: 34709879 DOI: 10.1161/CIR.0000000000001029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
548 Saxer S, Calendo LR, Lichtblau M, Carta A, Müller J, Gautschi F, Berlier C, Furian M, Schwarz EI, Bloch KE, Greutmann M, Ulrich S. Effect of oxygen therapy on exercise performance in patients with cyanotic congenital heart disease: Randomized-controlled trial. Int J Cardiol 2021:S0167-5273(21)01956-2. [PMID: 34856290 DOI: 10.1016/j.ijcard.2021.11.066] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
549 Yang J, Zheng Y, Li C, Liu YP, Zhou Q, Gao J, Meng X, Zhang K, Wang W, Shao C, Tang YD. The impact of subclinical hyperthyroidism on cardiovascular prognosis in patients undergoing PCI. J Clin Endocrinol Metab 2021:dgab855. [PMID: 34850030 DOI: 10.1210/clinem/dgab855] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
550 Liga R, Gimelli A. Radial artery access for invasive coronary angiography: Is going distal the new frontier? Int J Cardiol 2021:S0167-5273(21)01954-9. [PMID: 34856295 DOI: 10.1016/j.ijcard.2021.11.064] [Reference Citation Analysis]
551 Tamargo J, Lopez-Sendon J. Ranolazine: a better understanding of pathophysiology and patient profile to guide treatment of chronic stable angina. Future Cardiol 2021. [PMID: 34841884 DOI: 10.2217/fca-2021-0058] [Reference Citation Analysis]
552 Kokozheva MA, Mardanov BU, Poddubskaya EA, Kutsenko VA, Umetov MA, Mamedov MN. Assessment of structural and functional myocardial characteristics in patients with chronic coronary artery disease and various glycemic status. Cardiovasc Ther Prev 2021;20:3077. [DOI: 10.15829/1728-8800-2021-3077] [Reference Citation Analysis]
553 Drapkina OM, Samorodskaya IV, Yavelov IS, Kashtalap VV, Barbarash OI. Regional differences in cardiac mortality rates in Russia: the role of statistical features. Cardiovasc Ther Prev 2021;20:2928. [DOI: 10.15829/1728-8800-2021-2928] [Reference Citation Analysis]
554 Liang B, Zhang XX, Li R, Gu N. Guanxin V protects against ventricular remodeling after acute myocardial infarction through the interaction of TGF-β1 and Vimentin. Phytomedicine 2021;95:153866. [PMID: 34883417 DOI: 10.1016/j.phymed.2021.153866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
555 Murphy E, Curneen JMG, McEvoy JW. Aspirin in the Modern Era of Cardiovascular Disease Prevention. Methodist Debakey Cardiovasc J 2021;17:36-47. [PMID: 34824680 DOI: 10.14797/mdcvj.293] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
556 Abouelnour A, Gori T. Vasomotor Dysfunction in Patients with Ischemia and Non-Obstructive Coronary Artery Disease: Current Diagnostic and Therapeutic Strategies. Biomedicines 2021;9:1774. [PMID: 34944590 DOI: 10.3390/biomedicines9121774] [Reference Citation Analysis]
557 Jang KM, Choi HH, Nam TK, Byun JS. Clinical outcomes of first-pass effect after mechanical thrombectomy for acute ischemic stroke: A systematic review and meta-analysis. Clin Neurol Neurosurg 2021;211:107030. [PMID: 34823155 DOI: 10.1016/j.clineuro.2021.107030] [Reference Citation Analysis]
558 Rajtik T, Galis P, Bartosova L, Paulis L, Goncalvesova E, Klimas J. Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19. Int J Mol Sci 2021;22:12800. [PMID: 34884604 DOI: 10.3390/ijms222312800] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
559 Kurzelowski R, Barański K, Caluori G, Szot W, Grabowski K, Michalewska-Włudarczyk A, Syzdół M, Kuczmik W, Błach A, Ochała B, Hudziak D, Wilczek J, Gołba KS, Starek Z, Tendera M, Wojakowski W, Jadczyk T. Correlation between electromechanical parameters (NOGA XP) and changes of myocardial ischemia in patients with refractory angina. Postepy Kardiol Interwencyjnej 2021;17:281-9. [PMID: 34819964 DOI: 10.5114/aic.2021.109168] [Reference Citation Analysis]
560 Beltrame JF, Tavella R, Jones D, Zeitz C. Management of ischaemia with non-obstructive coronary arteries (INOCA). BMJ 2021;375:e060602. [PMID: 34836873 DOI: 10.1136/bmj-2021-060602] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
561 Tan JWC, Chew DP, Tsui KL, Tan D, Duplyakov D, Hammoudeh A, Zhang B, Li Y, Xu K, Ong PJ, Firman D, Gamra H, Almahmeed W, Dalal J, Tam LW, Steg G, Nguyen QN, Ako J, Al Suwaidi J, Chan M, Sobhy M, Shehab A, Buddhari W, Wang Z, Fong AYY, Karadag B, Kim BK, Baber U, Chin CT, Han YL. 2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y12 Receptor Antagonists in the Asia-Pacific Region: Special Populations. Eur Cardiol 2021;16:e43. [PMID: 34815751 DOI: 10.15420/ecr.2021.35] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
562 Thakkar A, Agarwala A, Michos ED. Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap. Eur Cardiol 2021;16:e41. [PMID: 34815749 DOI: 10.15420/ecr.2021.24] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
563 Kelshiker MA, Seligman H, Howard JP, Rahman H, Foley M, Nowbar AN, Rajkumar CA, Shun-Shin MJ, Ahmad Y, Sen S, Al-Lamee R, Petraco R. Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J 2021:ehab775. [PMID: 34849697 DOI: 10.1093/eurheartj/ehab775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
564 Chedea VS, Tomoiagǎ LL, Macovei ŞO, Mǎgureanu DC, Iliescu ML, Bocsan IC, Buzoianu AD, Voşloban CM, Pop RM. Antioxidant/Pro-Oxidant Actions of Polyphenols From Grapevine and Wine By-Products-Base for Complementary Therapy in Ischemic Heart Diseases. Front Cardiovasc Med 2021;8:750508. [PMID: 34805304 DOI: 10.3389/fcvm.2021.750508] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
565 Calegari L, Moreira I, Falkowski A, Reolão JBC, Karsten M, Deresz LF. Agreement between heart rate at first ventilatory threshold on treadmill and at 6-min walk test in coronary artery disease patients on β-blockers treatment. J Exerc Rehabil 2021;17:362-8. [PMID: 34805026 DOI: 10.12965/jer.2142488.244] [Reference Citation Analysis]
566 Mechelinck M, Peschel M, Habigt MA, Kroy D, Lehrke M, Helmedag MJ, Rossaint R, Barton M, Hein M. Serum from Patients with Severe Alcoholic Liver Cirrhosis Inhibits Proliferation and Migration of Human Coronary Artery Smooth Muscle Cells. J Clin Med 2021;10:5471. [PMID: 34884173 DOI: 10.3390/jcm10235471] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
567 Li X, Lyu L, Yang W, Pan J, Dong M, Zhang M, Zhang P. Identification of Flow-Limiting Coronary Stenosis With PCS: A New Cost-Effective Index Derived From the Product of Corrected TIMI Frame Count and Percent Diameter Stenosis. Front Cardiovasc Med 2021;8:718935. [PMID: 34805299 DOI: 10.3389/fcvm.2021.718935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
568 Fan Y, Yu M, Li J, Zhang H, Liu Q, Zhao L, Wang T, Xu H. Efficacy and Safety of Resistance Training for Coronary Heart Disease Rehabilitation: A Systematic Review of Randomized Controlled Trials. Front Cardiovasc Med 2021;8:754794. [PMID: 34805309 DOI: 10.3389/fcvm.2021.754794] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
569 Martins J, Afreixo V, Santos L, Fernandes L, Briosa A. Enxerto de Bypass de Artéria Coronária Guiado por Angiografia ou Fisiologia: Uma Metanálise. Arquivos Brasileiros de Cardiologia 2021;117:1115-23. [DOI: 10.36660/abc.20200763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
570 Bailly M, Ribeiro MJ, Angoulvant D. Combining flow and reserve measurement during myocardial perfusion imaging: A new era for myocardial perfusion scintigraphy? Arch Cardiovasc Dis 2021;114:818-27. [PMID: 34801410 DOI: 10.1016/j.acvd.2021.10.006] [Reference Citation Analysis]
571 Di Giorgi N, Michelucci E, Smit JM, Scholte AJHA, El Mahdiui M, Knuuti J, Buechel RR, Teresinska A, Pizzi MN, Roque A, Poddighe R, Parodi O, Pelosi G, Caselli C, Neglia D, Rocchiccioli S. A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome. Atherosclerosis 2021;339:1-11. [PMID: 34801858 DOI: 10.1016/j.atherosclerosis.2021.11.013] [Reference Citation Analysis]
572 Wester M, Koll F, Lüdde M, Langer C, Resch M, Luchner A, Frey N, Müller K, Zeman F, Koller M, Maier LS, Sossalla S. Effects of Visualization of Revascularization on Symptomatic Outcomes in Patients With Chronic Coronary Syndrome. JACC Cardiovasc Interv 2021;14:2525-7. [PMID: 34794658 DOI: 10.1016/j.jcin.2021.09.031] [Reference Citation Analysis]
573 Linder M, Andersen M. Patient characteristics and safety outcomes in new users of ticagrelor and clopidogrel-An observational cohort study in Sweden. Pharmacoepidemiol Drug Saf 2021. [PMID: 34802175 DOI: 10.1002/pds.5387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
574 Kim JS, Kim YJ, Shin YS, Ahn S, Kim WY. Use of Coronary CT Angiography to Predict Obstructive Lesions in Patients with Chest Pain without Enzyme and ST-Segment Elevation. J Clin Med 2021;10:5442. [PMID: 34830723 DOI: 10.3390/jcm10225442] [Reference Citation Analysis]
575 de Silva R, Cheng K. Microvascular angina: quo tendimus? Eur Heart J 2021;42:4601-4. [PMID: 34480544 DOI: 10.1093/eurheartj/ehab534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
576 Vecsey-Nagy M, Jermendy ÁL, Suhai FI, Panajotu A, Csőre J, Borzsák S, Fontanini DM, Kolossváry M, Vattay B, Boussoussou M, Csobay-Novák C, Merkely B, Maurovich-Horvat P, Szilveszter B. Model-based adaptive filter for a dedicated cardiovascular CT scanner: Assessment of image noise, sharpness and quality. Eur J Radiol 2021;145:110032. [PMID: 34800835 DOI: 10.1016/j.ejrad.2021.110032] [Reference Citation Analysis]
577 Talic S, Marquina C, Zomer E, Asenso RO, Petrova M, Vargas-Torres S, Abushana D, Wolfe R, Lybrand S, Thomson D, Stratton G, Liew D, Ademi Z. Attainment of low-density lipoprotein cholesterol goals in statin treated patients: real-world evidence from Australia. Curr Probl Cardiol 2021;:101068. [PMID: 34818528 DOI: 10.1016/j.cpcardiol.2021.101068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
578 Bálint G, Slezáková Z, Miklovičová E. Tobacco Profile and Evaluation of the DS14 Scale in Patients with Coronary Syndrome. Psych 2021;3:694-702. [DOI: 10.3390/psych3040044] [Reference Citation Analysis]
579 Meeder JG, Hartzema-Meijer MJ, Jansen TPJ, Konst RE, Damman P, Elias-Smale SE. Outpatient Management of Patients With Angina With No Obstructive Coronary Arteries: How to Come to a Proper Diagnosis and Therapy. Front Cardiovasc Med 2021;8:716319. [PMID: 34796207 DOI: 10.3389/fcvm.2021.716319] [Reference Citation Analysis]
580 Wang M, Shan Y, Sun W, Han J, Tong H, Fan M, Chen J, Yu P, Shen L, Chen X. Effects of Shexiang Baoxin Pill for Coronary Microvascular Function: A Systematic Review and Meta-Analysis. Front Pharmacol 2021;12:751050. [PMID: 34795585 DOI: 10.3389/fphar.2021.751050] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
581 Fan W, Zhang Y, Liu Y, Ding Z, Si Y, Shi F, Liu J, Sun L. Nomograms Based on the Advanced Lung Cancer Inflammation Index for the Prediction of Coronary Artery Disease and Calcification. Clin Appl Thromb Hemost 2021;27:10760296211060455. [PMID: 34786986 DOI: 10.1177/10760296211060455] [Reference Citation Analysis]
582 Feuchtner GM, Beyer C, Langer C, Bleckwenn S, Senoner T, Barbieri F, Luger A, Spitaler P, Widmann G, Adukauskaite A, Dichtl W, Friedrich G, Plank F. The Atherosclerotic Profile of a Young Symptomatic Population between 19 and 49 Years: Coronary Computed Tomography Angiography or Coronary Artery Calcium Score? J Cardiovasc Dev Dis 2021;8:157. [PMID: 34821710 DOI: 10.3390/jcdd8110157] [Reference Citation Analysis]
583 Han Y. Chinese expert consensus statement on dual antiplatelet therapy in patients with coronary artery disease. Eur Heart J 2021:ehab741. [PMID: 34792118 DOI: 10.1093/eurheartj/ehab741] [Reference Citation Analysis]
584 Preda A, Liberale L, Montecucco F. Imaging techniques for the assessment of adverse cardiac remodeling in metabolic syndrome. Heart Fail Rev 2021. [PMID: 34796433 DOI: 10.1007/s10741-021-10195-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
585 Tsaban G, Zahger D, Abramowitz Y. The COURAGE to face ISCHEMIA: Applying data from randomized studies to real-life. Trends Cardiovasc Med 2021:S1050-1738(21)00137-7. [PMID: 34801663 DOI: 10.1016/j.tcm.2021.11.003] [Reference Citation Analysis]
586 Schill F, Persson M, Engström G, Melander O, Enhörning S. Copeptin as a marker of atherosclerosis and arteriosclerosis. Atherosclerosis 2021;338:64-8. [PMID: 34785062 DOI: 10.1016/j.atherosclerosis.2021.10.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
587 Haring B, Schmidt A, Frantz S. [Acute Chest Pain: A Stepwise Approach to Management]. Pneumologie 2021;75:901-9. [PMID: 34788891 DOI: 10.1055/a-1238-5254] [Reference Citation Analysis]
588 Zampella E, Assante R, Acampa W, Gaudieri V, Nappi C, Mannarino T, D'Antonio A, Buongiorno P, Panico M, Mainolfi CG, Spinelli L, Petretta M, Cuocolo A. Incremental value of 18F-FDG cardiac PET imaging over dobutamine stress echocardiography in predicting myocardial ischemia in patients with suspected coronary artery disease. J Nucl Cardiol 2021. [PMID: 34791621 DOI: 10.1007/s12350-021-02852-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
589 Błaszczyk M, Adamczewski Z, Płachcińska A. Capabilities of Modern Semiconductor Gamma Cameras in Radionuclide Diagnosis of Coronary Artery Disease. Diagnostics (Basel) 2021;11:2130. [PMID: 34829477 DOI: 10.3390/diagnostics11112130] [Reference Citation Analysis]
590 Task Force for the management of COVID-19 of the European Society of Cardiology . ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J 2021:ehab697. [PMID: 34791154 DOI: 10.1093/eurheartj/ehab697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
591 Salinas P, Vilchez-Tschischke JP, Noriega F, Macaya F, Rosillo S, García-Camarero T, de la Torre-Hernández JM, de Tapia B, Jiménez-Kockar M, Regueiro A, Flores-Umanzor E, García-Blas S, González-D'Gregorio J, Gómez-Menchero AE, Díaz-Fernandez JF, Rondán J, Amat-Santos I, Ojeda S, Diez-Gil JL, de Miguel Castro A, Lozano Ruiz-Poveda F, Fernández-Diaz JA, Manzano MC, Cruz-González I, Pascual Tejerina V, García Pérez-Velasco J, Serra A, Poveda-Andrés JL, Macaya C, Escaned J. Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study. Cardiovasc Revasc Med 2021:S1553-8389(21)00742-9. [PMID: 34857473 DOI: 10.1016/j.carrev.2021.11.015] [Reference Citation Analysis]
592 Garot J, Pezel T. What if a patient has CAD? Go to CMR! Arch Cardiovasc Dis 2021;114:765-7. [PMID: 34776368 DOI: 10.1016/j.acvd.2021.10.002] [Reference Citation Analysis]
593 Kexin W, Yaodong D, Wen G, Rui W, Jiaxin Y, Xiaoli L, Hua S, Hailong G. Association of Increased Remnant Cholesterol and the Risk of Coronary Artery Disease: A Retrospective Study. Front Cardiovasc Med 2021;8:740596. [PMID: 34778402 DOI: 10.3389/fcvm.2021.740596] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
594 Pontone G, Mushtaq S, Narula J. Dynamic Perfusion With CT Angiography: Adding Another Feather to a Heavily Decorated Cap. J Am Coll Cardiol 2021;78:1950-3. [PMID: 34763771 DOI: 10.1016/j.jacc.2021.09.016] [Reference Citation Analysis]
595 Kitagawa K, Nakamura S, Ota H, Ogawa R, Shizuka T, Kubo T, Yi Y, Ito T, Nagasawa N, Omori T, Nakamori S, Kurita T, Sugisawa J, Hatori N, Nakashima H, Wang Y, Kido T, Watanabe K, Matsumoto Y, Dohi K, Sakuma H. Diagnostic Performance of Dynamic Myocardial Perfusion Imaging Using Dual-Source Computed Tomography. J Am Coll Cardiol 2021;78:1937-49. [PMID: 34763770 DOI: 10.1016/j.jacc.2021.08.067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
596 Schroder J, Prescott E. Doppler Echocardiography Assessment of Coronary Microvascular Function in Patients With Angina and No Obstructive Coronary Artery Disease. Front Cardiovasc Med 2021;8:723542. [PMID: 34778394 DOI: 10.3389/fcvm.2021.723542] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
597 Winkler MA, Patel R, Fu W, Arora V, Weintraub NL. Three Technologies That Will Guide Revascularization of Chronic Coronary Syndrome Patients into the 21st Century: A Review. Int J Angiol 2021;30:212-20. [PMID: 34776821 DOI: 10.1055/s-0041-1735201] [Reference Citation Analysis]
598 Neglia D, Maroz-Vadalazhskaya N, Carrabba N, Liga R. Coronary Revascularization in Patients With Stable Coronary Artery Disease: The Role of Imaging. Front Cardiovasc Med 2021;8:716832. [PMID: 34778391 DOI: 10.3389/fcvm.2021.716832] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
599 Franks R, Plein S, Chiribiri A. Clinical Application of Dynamic Contrast Enhanced Perfusion Imaging by Cardiovascular Magnetic Resonance. Front Cardiovasc Med 2021;8:768563. [PMID: 34778420 DOI: 10.3389/fcvm.2021.768563] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
600 Polzin A, Dannenberg L, Helten C, Pöhl M, Metzen D, Mourikis P, Dücker C, Marschall U, L'Hoest H, Hennig B, Zako S, Trojovsky K, Petzold T, Jung C, Levkau B, Zeus T, Schrör K, Hohlfeld T, Kelm M. Excess Mortality in Aspirin and Dipyrone (Metamizole) Co-Medicated in Patients With Cardiovascular Disease: A Nationwide Study. J Am Heart Assoc 2021;10:e022299. [PMID: 34726072 DOI: 10.1161/JAHA.121.022299] [Reference Citation Analysis]
601 Siegersma KR, Onland-Moret NC, Appelman Y, van der Harst P, Tulevski II, Somsen GA, Narula J, den Ruijter HM, Hofstra L. Outcomes in patients with a first episode of chest pain undergoing early coronary CT imaging. Heart 2021:heartjnl-2021-319747. [PMID: 34782405 DOI: 10.1136/heartjnl-2021-319747] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
602 Seitz A, Sechtem U. Pericoronary adipose tissue attenuation by computed tomography: A novel indicator for coronary microvascular dysfunction? Int J Cardiol 2021;343:12-3. [PMID: 34481837 DOI: 10.1016/j.ijcard.2021.08.046] [Reference Citation Analysis]
603 Indraratna P, Khasanova E, Gulsin GS, Tzimas G, Takagi H, Park KH, Lin FY, Shaw LJ, Lee SE, Narula J, Bax JJ, Chang HJ, Leipsic J; PARADIGM investigators. Plaque progression: Where, why, and how fast? A review of what we have learned from the analysis of patient data from the PARADIGM registry. J Cardiovasc Comput Tomogr 2021:S1934-5925(21)00464-0. [PMID: 34824029 DOI: 10.1016/j.jcct.2021.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
604 Duband B, Motreff P. [Coronary angiography my false friend]. Ann Cardiol Angeiol (Paris) 2021;70:410-5. [PMID: 34772481 DOI: 10.1016/j.ancard.2021.10.014] [Reference Citation Analysis]
605 Martin-Piedra L, Alcala-Diaz JF, Gutierrez-Mariscal FM, Arenas de Larriva AP, Romero-Cabrera JL, Torres-Peña JD, Caballero-Villarraso J, Luque RM, Perez-Martinez P, Lopez-Miranda J, Delgado-Lista J. Evolution of Metabolic Phenotypes of Obesity in Coronary Patients after 5 Years of Dietary Intervention: From the CORDIOPREV Study. Nutrients 2021;13:4046. [PMID: 34836298 DOI: 10.3390/nu13114046] [Reference Citation Analysis]
606 Brown DL. Optimal Medical Therapy as First-Line Therapy for Chronic Coronary Syndromes: Lessons from COURAGE, BARI 2D, FAME 2, and ISCHEMIA. Cardiovasc Drugs Ther 2021. [PMID: 34767134 DOI: 10.1007/s10557-021-07289-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
607 Ambari AM, Lilihata G, Zuhri E, Ekawati E, Wijaya SA, Dwiputra B, Sukmawan R, Radi B, Haryana SM, Adiarto S, Hanafy DA, Zamroni D, Elen E, Mangkuanom AS, Santoso A. External Counterpulsation Improves Angiogenesis by Preserving Vascular Endothelial Growth Factor-A and Vascular Endothelial Growth Factor Receptor-2 but Not Regulating MicroRNA-92a Expression in Patients With Refractory Angina. Front Cardiovasc Med 2021;8:761112. [PMID: 34760951 DOI: 10.3389/fcvm.2021.761112] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
608 Pan E, Nielsen SJ, Mennander A, Björklund E, Martinsson A, Lindgren M, Hansson EC, Pivodic A, Jeppsson A. Statins for secondary prevention and major adverse events after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2021:S0022-5223(21)01536-1. [PMID: 34893327 DOI: 10.1016/j.jtcvs.2021.08.088] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
609 Breuckmann F, Settelmeier S, Rassaf T, Post F, Haerer W, Bauersachs J, Mudra H, Voigtländer T, Senges J, Münzel T, Giannitsis E. Survey of clinical practice pattern in Germany's certified chest pain units : Adherence to the European Society of Cardiology guidelines on non-ST-segment elevation acute coronary syndrome. Herz 2021. [PMID: 34755215 DOI: 10.1007/s00059-021-05079-2] [Reference Citation Analysis]
610 Meng H, Ruan J, Chen Y, Yan Z, Shi K, Li X, Yang P, Meng F. Investigation of Specific Proteins Related to Different Types of Coronary Atherosclerosis. Front Cardiovasc Med 2021;8:758035. [PMID: 34746269 DOI: 10.3389/fcvm.2021.758035] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
611 Rioufol G, Dérimay F, Roubille F, Perret T, Motreff P, Angoulvant D, Cottin Y, Meunier L, Cetran L, Cayla G, Harbaoui B, Wiedemann JY, Van Belle É, Pouillot C, Noirclerc N, Morelle JF, Soto FX, Caussin C, Bertrand B, Lefèvre T, Dupouy P, Lesault PF, Albert F, Barthelemy O, Koning R, Leborgne L, Barnay P, Chapon P, Armero S, Lafont A, Piot C, Amaz C, Vaz B, Benyahya L, Varillon Y, Ovize M, Mewton N, Finet G; FUTURE Trial Investigators. Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease. J Am Coll Cardiol 2021;78:1875-85. [PMID: 34736563 DOI: 10.1016/j.jacc.2021.08.061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
612 Wong CCY, Nishi T, Yong ASC, Murai T, Kakuta T, Waseda K, Amano T, Hirohata A, Barbato E, Ng MKC, Fearon WF. Discordance Between the Index of Microcirculatory Resistance and Coronary Flow Reserve After Percutaneous Coronary Intervention. JACC Cardiovasc Interv 2021;14:2412-4. [PMID: 34736742 DOI: 10.1016/j.jcin.2021.07.053] [Reference Citation Analysis]
613 Zhao X, Wang J, Li Q, Ye Y, Zeng Y. Impact of Pancreatic β-Cell Function on Clopidogrel Responsiveness and Outcomes in Chinese Nondiabetic Patients Undergoing Elective Percutaneous Coronary Intervention. Cardiovasc Drugs Ther 2021. [PMID: 34748146 DOI: 10.1007/s10557-021-07272-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
614 Yamamoto T, Toshimitsu I, Ishida A. Healed plaque erosion as a cause of recurrent vasospastic angina: a case report. Eur Heart J Case Rep 2021;5:ytab349. [PMID: 34738054 DOI: 10.1093/ehjcr/ytab349] [Reference Citation Analysis]
615 O'Sullivan KJ, Kermavnar T, Gorski KA, Arnous S, O'Sullivan LW. Warmed contrast media temperature loss in traditional manifold systems during angiographic procedures. Acta Radiol 2021;:2841851211055393. [PMID: 34747192 DOI: 10.1177/02841851211055393] [Reference Citation Analysis]
616 Villines TC. The perils of tribalism in cardiovascular imaging. J Cardiovasc Comput Tomogr 2021;15:513-4. [PMID: 34736553 DOI: 10.1016/j.jcct.2021.09.010] [Reference Citation Analysis]
617 Dibben G, Faulkner J, Oldridge N, Rees K, Thompson DR, Zwisler AD, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2021;11:CD001800. [PMID: 34741536 DOI: 10.1002/14651858.CD001800.pub4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
618 Scatteia A, Silverio A, Padalino R, De Stefano F, America R, Cappelletti AM, Dalla Vecchia LA, Guarini P, Donatelli F, Caiazza F, Dellegrottaglie S. Non-Invasive Assessment of Left Ventricle Ejection Fraction: Where Do We Stand? J Pers Med 2021;11:1153. [PMID: 34834505 DOI: 10.3390/jpm11111153] [Reference Citation Analysis]
619 Liu W, Zhou L, Feng L, Zhang D, Zhang C, Gao Y; behalf of the BOSS Group. BuqiTongluo Granule for Ischemic Stroke, Stable Angina Pectoris, Diabetic Peripheral Neuropathy with Qi Deficiency and Blood Stasis Syndrome: Rationale and Novel Basket Design. Front Pharmacol 2021;12:764669. [PMID: 34733163 DOI: 10.3389/fphar.2021.764669] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
620 . „Baby-ASS“ ohne Nachteile. Dtsch Med Wochenschr 2021;146:1440-1. [DOI: 10.1055/a-1531-1127] [Reference Citation Analysis]
621 Kotanidis CP, Nikolaidou C. Stratifying the risk in chronic coronary syndromes: a ray of hope for ischaemia? Eur J Prev Cardiol 2021:zwab182. [PMID: 34739046 DOI: 10.1093/eurjpc/zwab182] [Reference Citation Analysis]
622 Ammon F, Moshage M, Smolka S, Goeller M, Bittner DO, Achenbach S, Marwan M. Influence of reconstruction kernels on the accuracy of CT-derived fractional flow reserve. Eur Radiol 2021. [PMID: 34735608 DOI: 10.1007/s00330-021-08348-0] [Reference Citation Analysis]
623 Loukianov MM, Martsevich SY, Andrenko EY, Yakushin SS, Vorobiev AN, Pereverzeva KG, Zagrebelny AV, Okshina ЕY, Yakusevich VV, Yakusevich VV, Pozdnyakova EM, Gomova TA, Fedotova EE, Valiakhmetov MM, Mikhin VP, Maslennikova YV, Belova EN, Klyashtorny VG, Kudryashov EV, Makoveeva AN, Tatsii JE, Boytsov SA, Drapkina OM. Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries). Racionalʹnaâ farmakoterapiâ v kardiologii 2021;17:702-11. [DOI: 10.20996/1819-6446-2021-10-03] [Reference Citation Analysis]
624 Byrne RA, McGovern L. Angiography-derived quantitative flow ratio guidance of coronary intervention: measure twice, cut once. Lancet 2021:S0140-6736(21)02397-7. [PMID: 34742371 DOI: 10.1016/S0140-6736(21)02397-7] [Reference Citation Analysis]
625 Bershtein LL, Zbyshevskaya EV, Gumerova VE. Optimum Treatment Strategy in Chronic Coronary Syndromes: the New Trials vs the Current Guidelines. Racionalʹnaâ farmakoterapiâ v kardiologii 2021;17:761-70. [DOI: 10.20996/1819-6446-2021-10-02] [Reference Citation Analysis]
626 Roehl AB, Hein M, Kroencke J, Kork F, Koch A, Andert A, Becker M, Schmöe J, Reinartz SD. Cardiovascular Evaluation of Liver Transplant Patients by Using Coronary Calcium Scoring in ECG-Synchronized Computed Tomographic Scans. J Clin Med 2021;10:5148. [PMID: 34768667 DOI: 10.3390/jcm10215148] [Reference Citation Analysis]
627 Fröbert O, Götberg M, Erlinge D, Akhtar Z, Christiansen EH, MacIntyre CR, Oldroyd KG, Motovska Z, Erglis A, Moer R, Hlinomaz O, Jakobsen L, Engstrøm T, Jensen LO, Fallesen CO, Jensen SE, Angerås O, Calais F, Kåregren A, Lauermann J, Mokhtari A, Nilsson J, Persson J, Stalby P, Islam AKMM, Rahman A, Malik F, Choudhury S, Collier T, Pocock SJ, Pernow J. Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Circulation 2021;144:1476-84. [PMID: 34459211 DOI: 10.1161/CIRCULATIONAHA.121.057042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
628 Dai N, Che W, Liu L, Zhang W, Yin G, Xu B, Xu Y, Duan S, Yu H, Li C, Yao K, Huang D, Ge J. Diagnostic Value of Angiography-Derived IMR for Coronary Microcirculation and Its Prognostic Implication After PCI. Front Cardiovasc Med 2021;8:735743. [PMID: 34722667 DOI: 10.3389/fcvm.2021.735743] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
629 Jansen TPJ, Elias-Smale SE, van den Oord S, Gehlmann H, Dimitiriu-Leen A, Maas AHEM, Konst RE, van Royen N, Damman P. Sex Differences in Coronary Function Test Results in Patient With Angina and Nonobstructive Disease. Front Cardiovasc Med 2021;8:750071. [PMID: 34722680 DOI: 10.3389/fcvm.2021.750071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
630 Escobar C, Aranda U, Palacios B, Capel M, Sicras A, Sicras A, Hormigo A, Alcázar R, Manito N, Botana M. Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain. Nefrología (English Edition) 2021;41:670-88. [DOI: 10.1016/j.nefroe.2022.01.008] [Reference Citation Analysis]
631 Ya'qoub L, Elgendy IY, Pepine CJ. Syndrome of Nonobstructive Coronary Artery Diseases: A Comprehensive Overview of Open Artery Ischemia. Am J Med 2021;134:1321-9. [PMID: 34343507 DOI: 10.1016/j.amjmed.2021.06.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
632 Dzaye O, Razavi AC, Blaha MJ, Mortensen MB. Evaluation of coronary stenosis versus plaque burden for atherosclerotic cardiovascular disease risk assessment and management. Curr Opin Cardiol 2021;36:769-75. [PMID: 34620792 DOI: 10.1097/HCO.0000000000000911] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
633 Fontes JP, Vilela EM, Durazzo A, Teixeira M. Current state of cardiac rehabilitation in Portugal: Results of the 2019 national survey. Revista Portuguesa de Cardiologia 2021;40:877-87. [DOI: 10.1016/j.repc.2021.01.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
634 Andreini D, Conte E, Serruys PW. Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events. Curr Opin Cardiol 2021;36:784-92. [PMID: 34620793 DOI: 10.1097/HCO.0000000000000917] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
635 Arero AG, Vasheghani-Farahani A, Soltani D. Meta-Analysis of the Usefulness of Beta-Blockers to Reduce the Risk of Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease Without Prior Myocardial Infarction or Left Ventricular Dysfunction. Am J Cardiol 2021;158:23-9. [PMID: 34462051 DOI: 10.1016/j.amjcard.2021.08.005] [Reference Citation Analysis]
636 Tai CJ, Wu CC, Lee KT, Tseng TG, Wang HC, Chang FR, Yang YH. The Impact of Urate-Lowering Therapy in Post-Myocardial Infarction Patients: Insights from a Population-Based, Propensity Score-Matched Analysis. Clin Pharmacol Ther 2021. [PMID: 34719019 DOI: 10.1002/cpt.2473] [Reference Citation Analysis]
637 Bytyçi I, Bengrid TM, Henein MY. Longitudinal myocardial function is more compromised in cardiac syndrome X compared to insignificant CAD: Role of stress echocardiography and calcium scoring. Clin Physiol Funct Imaging 2021. [PMID: 34716983 DOI: 10.1111/cpf.12733] [Reference Citation Analysis]
638 Volleberg R, Mol JQ, van der Heijden D, Meuwissen M, van Leeuwen M, Escaned J, Holm N, Adriaenssens T, van Geuns RJ, Tu S, Filippo C, Stone G, van Royen N. Optical coherence tomography and coronary revascularization: from indication to procedural optimization. Trends Cardiovasc Med 2021:S1050-1738(21)00124-9. [PMID: 34728349 DOI: 10.1016/j.tcm.2021.10.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
639 Vinci R, Pedicino D, Bonanni A, D'Aiello A, Severino A, Pisano E, Ponzo M, Canonico F, Ciampi P, Russo G, Di Sario M, Montone RA, Trani C, Conte C, Grimaldi MC, Cribari F, Massetti M, Crea F, Liuzzo G. A Novel Monocyte Subset as a Unique Signature of Atherosclerotic Plaque Rupture. Front Cell Dev Biol 2021;9:753223. [PMID: 34712669 DOI: 10.3389/fcell.2021.753223] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
640 Ferencik M, Choi AD, Branch KR, Arbab-Zadeh A, Blankstein R, Shaw LJ, Villines TC. The U.S. multi-societal chest pain guideline - A quick look into a long-awaited document. J Cardiovasc Comput Tomogr 2021:S1934-5925(21)00455-X. [PMID: 34732333 DOI: 10.1016/j.jcct.2021.10.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
641 Huang JY, Huang CK, Yen RF, Chien KL, Wu YW. Diagnostic Effect of Attenuation Correction in Myocardial Perfusion Imaging in Different Coronary Arteries: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2021;8:756060. [PMID: 34712715 DOI: 10.3389/fcvm.2021.756060] [Reference Citation Analysis]
642 Ihdayhid AR, Fairbairn TA, Gulsin GS, Tzimas G, Danehy E, Updegrove A, Jensen JM, Taylor CA, Bax JJ, Sellers SL, Leipsic JA, Nørgaard BL. Cardiac computed tomography-derived coronary artery volume to myocardial mass. J Cardiovasc Comput Tomogr 2021:S1934-5925(21)00452-4. [PMID: 34740557 DOI: 10.1016/j.jcct.2021.10.007] [Reference Citation Analysis]
643 Świątkiewicz I, Di Somma S, De Fazio L, Mazzilli V, Taub PR. Effectiveness of Intensive Cardiac Rehabilitation in High-Risk Patients with Cardiovascular Disease in Real-World Practice. Nutrients 2021;13:3883. [PMID: 34836144 DOI: 10.3390/nu13113883] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
644 Ninke T, Kilger E. [Proper Perioperative Handling of Continuous Medication in Patients with Cardiac Comorbidities]. Anasthesiol Intensivmed Notfallmed Schmerzther 2021;56:666-78. [PMID: 34704244 DOI: 10.1055/a-1226-4720] [Reference Citation Analysis]
645 Mortensen MB, Gaur S, Frimmer A, Bøtker HE, Sørensen HT, Kragholm KH, Niels Peter SR, Steffensen FH, Jensen RV, Mæng M, Kanstrup H, Blaha MJ, Shaw LJ, Dzaye O, Leipsic J, Nørgaard BL, Jensen JM. Association of Age With the Diagnostic Value of Coronary Artery Calcium Score for Ruling Out Coronary Stenosis in Symptomatic Patients. JAMA Cardiol 2021. [PMID: 34705022 DOI: 10.1001/jamacardio.2021.4406] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 20.0] [Reference Citation Analysis]
646 Kuźma Ł, Tomaszuk-Kazberuk A, Kurasz A, Dobrzycki S, Koziński M, Sobkowicz B, Lip GYH. Predicting Mortality in Patients with Atrial Fibrillation and Obstructive Chronic Coronary Syndrome: The Bialystok Coronary Project. J Clin Med 2021;10:4949. [PMID: 34768472 DOI: 10.3390/jcm10214949] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
647 Biener M, Giannitsis E, Hogrefe K, Mueller-Hennessen M, Fröhlich H, Katus HA, Frey N, Frankenstein L, Täger T. Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study. Clin Res Cardiol 2021. [PMID: 34694435 DOI: 10.1007/s00392-021-01952-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
648 Aktaa S, Gencer B, Arbelo E, Davos CH, Désormais I, Hollander M, Abreu A, Ambrosetti M, Bäck M, Carballo D, Crawford C, Deaton C, Dendale P, Eijsvogels TMH, Galbraith M, Piepoli MF, Salzwedel A, Smulders Y, Wilhelm M, Biondi-Zoccai G, Mach F, Visseren FLJ, Gale CP. European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol 2021:zwab160. [PMID: 34687540 DOI: 10.1093/eurjpc/zwab160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
649 Zhang HW, Jin JL, Cao YX, Guo YL, Wu NQ, Zhu CG, Xu RX, Dong Q, Li JJ. Association of diabetes mellitus with clinical outcomes in patients with different coronary artery stenosis. Cardiovasc Diabetol 2021;20:214. [PMID: 34688289 DOI: 10.1186/s12933-021-01403-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
650 Boerhout CKM, Feenstra RGT, Somsen GA, Appelman Y, Ong P, Beijk MAM, Hofstra L, van de Hoef TP, Piek JJ. Coronary computed tomographic angiography as gatekeeper for new-onset stable angina. Neth Heart J 2021;29:551-6. [PMID: 34676522 DOI: 10.1007/s12471-021-01639-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
651 Szilveszter B, Vattay B, Bossoussou M, Vecsey-Nagy M, Simon J, Merkely B, Maurovich-Horvat P, Kolossváry M. CAD-RADS may underestimate coronary plaque progression as detected by serial CT angiography. Eur Heart J Cardiovasc Imaging 2021:jeab215. [PMID: 34687544 DOI: 10.1093/ehjci/jeab215] [Reference Citation Analysis]
652 Zhang J, Yu Y, Pan L, Yu T, Luo G. C Deletion at the re74650330 Locus of the SLC39A8 Gene (rs74650330) Increases the Risk of Coronary Artery Disease in Individuals with Low-Density Lipoprotein Cholesterol Levels. Genet Test Mol Biomarkers 2021;25:660-7. [PMID: 34672770 DOI: 10.1089/gtmb.2021.0083] [Reference Citation Analysis]
653 Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2021;60:727-800. [PMID: 34453161 DOI: 10.1093/ejcts/ezab389] [Cited by in Crossref: 15] [Cited by in F6Publishing: 70] [Article Influence: 15.0] [Reference Citation Analysis]
654 Nørgaard BL, Gaur S, Fairbairn TA, Douglas PS, Jensen JM, Patel MR, Ihdayhid AR, Ko BSH, Sellers SL, Weir-McCall J, Matsuo H, Sand NPR, Øvrehus KA, Rogers C, Mullen S, Nieman K, Parner E, Leipsic J, Abdulla J. Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis. Heart 2021:heartjnl-2021-319773. [PMID: 34686567 DOI: 10.1136/heartjnl-2021-319773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
655 Lv WH, Dong JZ, Du X, Hu R, He L, Long DY, Sang CH, Jia CQ, Feng L, Li X, Ning M, Chen X, Cui YK, Tang RB, Ma CS. Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndrome. J Thromb Thrombolysis 2021. [PMID: 34677727 DOI: 10.1007/s11239-021-02588-z] [Reference Citation Analysis]
656 Keykhaei M, Ashraf H, Rashedi S, Farrokhpour H, Heidari B, Zokaei S, Bagheri S, Foroumadi R, Asgarian S, Amirian A, Saleh SK, James S. Differences in the 2020 ESC Versus 2015 ESC and 2014 ACC/AHA Guidelines on the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation. Curr Atheroscler Rep 2021;23:77. [PMID: 34671860 DOI: 10.1007/s11883-021-00976-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
657 Caselli C, De Caterina R, Smit JM, Campolo J, El Mahdiui M, Ragusa R, Clemente A, Sampietro T, Clerico A, Liga R, Pelosi G, Rocchiccioli S, Parodi O, Scholte A, Knuuti J, Neglia D; EVINCI and SMARTool. Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina. Sci Rep 2021;11:20714. [PMID: 34671067 DOI: 10.1038/s41598-021-00020-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
658 Zhang Y, Zhang Y, Shi Y, Dong W, Mu Y, Wang J, Gao Y, Hu R, Xu Y, Chen Y, Ma J. Influence of Waist-to-Hip Ratio on the Prognosis of Heart Failure Patients With Revascularized Coronary Heart Disease. Front Cardiovasc Med 2021;8:732200. [PMID: 34660733 DOI: 10.3389/fcvm.2021.732200] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
659 Pezel T, Garot P, Kinnel M, Hovasse T, Champagne S, Sanguineti F, Toupin S, Unterseeh T, Garot J. Long-term prognostic value of ischaemia and cardiovascular magnetic resonance-related revascularization for stable coronary disease, irrespective of patient's sex: a large retrospective study. Eur Heart J Cardiovasc Imaging 2021;22:1321-31. [PMID: 34542596 DOI: 10.1093/ehjci/jeab186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
660 Baweja P, Sweeney MJ, López-Candales A. A Reminder That Stress Echocardiography Is Useful in Diagnosing Myocardial Ischemia in Nonobstructive Coronary Artery Disease: Case Series. Cureus 2021;13:e17763. [PMID: 34659974 DOI: 10.7759/cureus.17763] [Reference Citation Analysis]
661 Tækker Madsen K, Veien KT, Larsen P, Husain M, Deibjerg L, Junker A, Kusk MW, Thomsen KK, Rohold A, Jensen LO, Sand NPR. Coronary CT angiography-derived fractional flow reserve in-stable angina: association with recurrent chest pain. Eur Heart J Cardiovasc Imaging 2021:jeab198. [PMID: 34661645 DOI: 10.1093/ehjci/jeab198] [Reference Citation Analysis]
662 Al Said S, Ellscheid M, Beltsios ET, Frey N. Non-Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease. Hamostaseologie 2021. [PMID: 34662918 DOI: 10.1055/a-1606-7523] [Reference Citation Analysis]
663 Santucci A, Cavallini C. The ISCHEMIA trial: optimal medical therapy against PTCA in the stable patient: the endless story. Eur Heart J Suppl 2021;23:E55-8. [PMID: 34650355 DOI: 10.1093/eurheartj/suab088] [Reference Citation Analysis]
664 Patti G, Ghiglieno C. Prevention of ischaemic events in subjects with polydistrict vascular disease. Eur Heart J Suppl 2021;23:E103-8. [PMID: 34650366 DOI: 10.1093/eurheartj/suab102] [Reference Citation Analysis]
665 Oknińska M, Paterek A, Zambrowska Z, Mackiewicz U, Mączewski M. Effect of Ivabradine on Cardiac Ventricular Arrhythmias: Friend or Foe? J Clin Med 2021;10:4732. [PMID: 34682854 DOI: 10.3390/jcm10204732] [Reference Citation Analysis]
666 Gao Z, Zuo Y, Jia L, Yin Y, Yang X, Fan Y, Liu H. Association between epicardial adipose tissue density and characteristics of coronary plaques assessed by coronary computed tomographic angiography. Int J Cardiovasc Imaging 2021. [PMID: 34652589 DOI: 10.1007/s10554-021-02428-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
667 Lee MT, Mahtta D, Dlouhy L, Shahab H, Al Rifai M, Virani SS. Highlights of Cardiovascular Disease Studies Presented at the 2021 European Society of Cardiology Congress. Curr Atheroscler Rep 2021;23:76. [PMID: 34648072 DOI: 10.1007/s11883-021-00975-8] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
668 Bèze NE, Millien V, Lefèvre T, Chevalier B, Garot P, Hovasse T, Unterseeh T, Champagne S, Sanguineti F, Neylon A, Benamer H. [Methergin pour le diagnostic de l'angor spastique : voie intraveineuse ou intracoronaire ?]. Ann Cardiol Angeiol (Paris) 2021;70:446-50. [PMID: 34635330 DOI: 10.1016/j.ancard.2021.09.008] [Reference Citation Analysis]
669 Maragna R, Giacari CM, Guglielmo M, Baggiano A, Fusini L, Guaricci AI, Rossi A, Rabbat M, Pontone G. Artificial Intelligence Based Multimodality Imaging: A New Frontier in Coronary Artery Disease Management. Front Cardiovasc Med 2021;8:736223. [PMID: 34631834 DOI: 10.3389/fcvm.2021.736223] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
670 Wu R, Gao W, Dong Z, Su Y, Ji Y, Liao J, Ma Y, Dai Y, Yao K, Ge J. Plasma Heat Shock Protein 70 Is Associated With the Onset of Acute Myocardial Infarction and Total Occlusion in Target Vessels. Front Cardiovasc Med 2021;8:688702. [PMID: 34631810 DOI: 10.3389/fcvm.2021.688702] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
671 Kähkönen O, Oikarinen A, Vähänikkilä H, Kyngäs H. Association between perceived health and adherence to treatment after percutaneous coronary intervention: A long-term follow-up study. J Adv Nurs 2021. [PMID: 34636444 DOI: 10.1111/jan.15069] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
672 De Bruyne B, Pijls NHJ, Gallinoro E, Candreva A, Fournier S, Keulards DCJ, Sonck J, Van't Veer M, Barbato E, Bartunek J, Vanderheyden M, Wyffels E, De Vos A, El Farissi M, Tonino PAL, Muller O, Collet C, Fearon WF. Microvascular Resistance Reserve for Assessment of Coronary Microvascular Function: JACC Technology Corner. J Am Coll Cardiol 2021;78:1541-9. [PMID: 34620412 DOI: 10.1016/j.jacc.2021.08.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
673 Ma H, Lin S, Li X, Dou K, Yang W, Feng W, Liu S, Wu Y, Peng B, Zheng Z. Exploring optimal heart team protocol to improve decision-making stability for complex coronary artery disease: a sequential explanatory mixed method study. Eur Heart J Qual Care Clin Outcomes 2021:qcab074. [PMID: 34634101 DOI: 10.1093/ehjqcco/qcab074] [Reference Citation Analysis]
674 Liang B, Cai XY, Gu N. Marine Natural Products and Coronary Artery Disease. Front Cardiovasc Med 2021;8:739932. [PMID: 34621803 DOI: 10.3389/fcvm.2021.739932] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
675 Pelliccia F, Marzilli M, Boden WE, Camici PG. Why the Term MINOCA Does Not Provide Conceptual Clarity for Actionable Decision-Making in Patients with Myocardial Infarction with No Obstructive Coronary Artery Disease. J Clin Med 2021;10:4630. [PMID: 34682754 DOI: 10.3390/jcm10204630] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
676 Pezel T, Unterseeh T, Garot P, Hovasse T, Sanguineti F, Toupin S, Morisset S, Champagne S, Garot J. Long-Term Prognostic Value of Stress Cardiovascular Magnetic Resonance-Related Coronary Revascularization to Predict Death: A Large Registry With >200 000 Patient-Years of Follow-Up. Circ Cardiovasc Imaging 2021;14:e012789. [PMID: 34612046 DOI: 10.1161/CIRCIMAGING.121.012789] [Reference Citation Analysis]
677 Nasir K, Ziffer JA, Cainzos-Achirica M, Ali SS, Feldman DI, Arias L, Saxena A, Feldman T, Cury R, Budoff MJ, Fialkow J. The Miami Heart Study (MiHeart) at Baptist Health South Florida, A prospective study of subclinical cardiovascular disease and emerging cardiovascular risk factors in asymptomatic young and middle-aged adults: The Miami Heart Study: Rationale and Design. Am J Prev Cardiol 2021;7:100202. [PMID: 34611641 DOI: 10.1016/j.ajpc.2021.100202] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
678 Grandhi GR, Mszar R, Cainzos-Achirica M, Rajan T, Latif MA, Bittencourt MS, Shaw LJ, Batlle JC, Blankstein R, Blaha MJ, Cury RC, Nasir K. Coronary Calcium to Rule Out Obstructive Coronary Artery Disease in Patients With Acute Chest Pain. JACC Cardiovasc Imaging 2021:S1936-878X(21)00625-2. [PMID: 34656462 DOI: 10.1016/j.jcmg.2021.06.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
679 Ahmed AI, Han Y, Al Rifai M, Alnabelsi T, Nabi F, Chang SM, Cocker M, Schwemmer C, Ramirez-Giraldo JC, Kleiman NS, Zoghbi WA, Mahmarian JJ, Al-Mallah MH. Prognostic Value of Computed Tomography-Derived Fractional Flow Reserve Comparison With Myocardial Perfusion Imaging. JACC Cardiovasc Imaging 2021:S1936-878X(21)00691-4. [PMID: 34656489 DOI: 10.1016/j.jcmg.2021.09.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
680 Heger LA, Glück T, Kaier K, Hortmann M, Rieder M, Siegel PM, Diehl P, Wengenmayer T, Olivier CB, Bode C, Busch HJ, Duerschmied D, Ahrens I. Medical history of coronary artery disease and time to electrocardiogram in the emergency department: a real-life, single-center, retrospective analysis. BMC Cardiovasc Disord 2021;21:480. [PMID: 34620090 DOI: 10.1186/s12872-021-02274-1] [Reference Citation Analysis]
681 Zhou J, Li C, Cong H, Duan L, Wang H, Wang C, Tan Y, Liu Y, Zhang Y, Zhou X, Zhang H, Wang X, Ma Y, Yang J, Chen Y, Guo Z. Comparison of Different Investigation Strategies to Defer Cardiac Testing in Patients With Stable Chest Pain. JACC Cardiovasc Imaging 2021:S1936-878X(21)00690-2. [PMID: 34656487 DOI: 10.1016/j.jcmg.2021.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
682 Flögel U, Temme S, Jacoby C, Oerther T, Keul P, Flocke V, Wang X, Bönner F, Nienhaus F, Peter K, Schrader J, Grandoch M, Kelm M, Levkau B. Multi-targeted 1H/19F MRI unmasks specific danger patterns for emerging cardiovascular disorders. Nat Commun 2021;12:5847. [PMID: 34615876 DOI: 10.1038/s41467-021-26146-6] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
683 Lee KK, Bularga A, O'Brien R, Ferry AV, Doudesis D, Fujisawa T, Kelly S, Stewart S, Wereski R, Cranley D, van Beek EJR, Lowe DJ, Newby DE, Williams MC, Gray AJ, Mills NL. Troponin-Guided Coronary Computed Tomographic Angiography After Exclusion of Myocardial Infarction. J Am Coll Cardiol 2021;78:1407-17. [PMID: 34593122 DOI: 10.1016/j.jacc.2021.07.055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
684 Cheng K, de Silva R. TCT Connect 2020 Trial Update: FORECAST, COMBINE OCT-FFR and DEFINE-PCI. Eur Cardiol 2021;16:e22. [PMID: 34603509 DOI: 10.15420/ecr.2021.07] [Reference Citation Analysis]
685 Jansen TPJ, Konst RE, Elias-Smale SE, van den Oord SC, Ong P, de Vos AMJ, van de Hoef TP, Paradies V, Smits PC, van Royen N, Damman P. Assessing Microvascular Dysfunction in Angina With Unobstructed Coronary Arteries: JACC Review Topic of the Week. J Am Coll Cardiol 2021;78:1471-9. [PMID: 34593129 DOI: 10.1016/j.jacc.2021.08.028] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
686 Korosoglou G, Giusca S. Contrast agent volume in coronary computer tomography angiography-where are the limits? Quant Imaging Med Surg 2021;11:4511-3. [PMID: 34604006 DOI: 10.21037/qims-21-488] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
687 Takahashi J, Suda A, Nishimiya K, Godo S, Yasuda S, Shimokawa H. Pathophysiology and Diagnosis of Coronary Functional Abnormalities. Eur Cardiol 2021;16:e30. [PMID: 34603510 DOI: 10.15420/ecr.2021.23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
688 Lopez-Sendon J, Moreno R, Tamargo J. ISCHEMIA Trial: Key Questions and Answers. Eur Cardiol 2021;16:e34. [PMID: 34603514 DOI: 10.15420/ecr.2021.16] [Reference Citation Analysis]
689 Bossone E, Cademartiri F, AlSergani H, Chianese S, Mehta R, Capone V, Ruotolo C, Tarrar IH, Frangiosa A, Vriz O, Maffei V, Annunziata R, Galzerano D, Ranieri B, Sepe C, Salzano A, Cocchia R, Majolo M, Russo G, Longo G, Muto M, Fedelini P, Esposito C, Perrella A, Guggino G, Raiola E, Catalano M, De Palma M, Romano L, Romano G, Coppola C, Mauro C, Mehta RH. Preoperative Assessment and Management of Cardiovascular Risk in Patients Undergoing Non-Cardiac Surgery: Implementing a Systematic Stepwise Approach during the COVID-19 Pandemic Era. J Cardiovasc Dev Dis 2021;8:126. [PMID: 34677195 DOI: 10.3390/jcdd8100126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
690 Huang Z, Zhang S, Jin N, Hu Y, Xiao J, Li Z, Yang Y, Sun R, Wang Z, Li X, Xie Y, Wang X. Prognostic value of CAD-RADS classification by coronary CTA in patients with suspected CAD. BMC Cardiovasc Disord 2021;21:476. [PMID: 34602055 DOI: 10.1186/s12872-021-02286-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
691 Chen X, Huang W, Sun A, Wang L, Mo F, Guo W. Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis. Thromb J 2021;19:69. [PMID: 34600549 DOI: 10.1186/s12959-021-00322-6] [Reference Citation Analysis]
692 Jurga J, Szummer KE, Lewinter C, Mellbin L, Götberg M, Zwackman S, Nilsson J, Völz S, Erlinge D, Persson J, Omerovic E, Jernberg T, Venetsanos D. Pretreatment With P2Y12 Inhibitors in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the Swedish Coronary Angiography and Angioplasty Registry. Circ Cardiovasc Interv 2021;14:e010849. [PMID: 34592825 DOI: 10.1161/CIRCINTERVENTIONS.121.010849] [Reference Citation Analysis]
693 Kim HL, Weber T. Pulsatile Hemodynamics and Coronary Artery Disease. Korean Circ J 2021;51:881-98. [PMID: 34595882 DOI: 10.4070/kcj.2021.0227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
694 Alkhalil M, Jabri A, Puri R, Kalra A. Revascularization in the Transcatheter Aortic Valve Replacement Population. Interv Cardiol Clin 2021;10:553-63. [PMID: 34593117 DOI: 10.1016/j.iccl.2021.06.003] [Reference Citation Analysis]
695 Conte E, Mushtaq S, Muscogiuri G, Formenti A, Annoni A, Mancini E, Ricci F, Melotti E, Gigante C, Lorenza Z, Guglielmo M, Baggiano A, Maragna R, Giacari CM, Carbucicchio C, Catto V, Pepi M, Andreini D, Pontone G. The Potential Role of Cardiac CT in the Evaluation of Patients With Known or Suspected Cardiomyopathy: From Traditional Indications to Novel Clinical Applications. Front Cardiovasc Med 2021;8:709124. [PMID: 34595219 DOI: 10.3389/fcvm.2021.709124] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
696 Duarte A, Llewellyn A, Walker R, Schmitt L, Wright K, Walker S, Rothery C, Simmonds M. Non-invasive imaging software to assess the functional significance of coronary stenoses: a systematic review and economic evaluation. Health Technol Assess 2021;25:1-230. [PMID: 34588097 DOI: 10.3310/hta25560] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
697 Bettencourt N, Mendes L, Fontes JP, Matos P, Ferreira C, Botelho A, Carvalho S, Durazzo A, Faustino A, Ladeiras-lopes R, Vasconcelos M, Vieira C, Correia M, Ferreira AM, Ferreira N, Pires‐morais G, Almeida AG, Ferreira MJV, Teixeira M. Consensus document on chronic coronary syndrome assessment and risk stratification in Portugal: A position paper statement from the [Portuguese Society of Cardiology’s] Working Groups on Nuclear Cardiology, Magnetic Resonance and Cardiac Computed Tomography, Echocardiography, and Exercise Physiology and Cardiac Rehabilitation. Revista Portuguesa de Cardiologia (English Edition) 2021. [DOI: 10.1016/j.repce.2021.08.004] [Reference Citation Analysis]
698 Senior R, Khattar R. Stress echocardiography: the quest for risk stratification beyond myocardial ischaemia. Eur Heart J 2021;42:3879-81. [PMID: 34449836 DOI: 10.1093/eurheartj/ehab562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
699 Ciampi Q, Zagatina A, Cortigiani L, Wierzbowska-Drabik K, Kasprzak JD, Haberka M, Djordjevic-Dikic A, Beleslin B, Boshchenko A, Ryabova T, Gaibazzi N, Rigo F, Dodi C, Simova I, Samardjieva M, Barbieri A, Morrone D, Lorenzoni V, Prota C, Villari B, Antonini-Canterin F, Pepi M, Carpeggiani C, Pellikka PA, Picano E. Prognostic value of stress echocardiography assessed by the ABCDE protocol. Eur Heart J 2021;42:3869-78. [PMID: 34449837 DOI: 10.1093/eurheartj/ehab493] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
700 Crea F. The challenge of risk stratification in suspected angina, in myocardial infarction without risk factors, and in frail patients. Eur Heart J 2021;42:3807-11. [PMID: 34598275 DOI: 10.1093/eurheartj/ehab693] [Reference Citation Analysis]
701 Hiraga T, Saito Y, Mori N, Tateishi K, Kitahara H, Kobayashi Y. Impact of Serum Uric Acid Level on Systemic Endothelial Dysfunction in Patients with a Broad Spectrum of Ischemic Heart Disease. J Clin Med 2021;10:4530. [PMID: 34640550 DOI: 10.3390/jcm10194530] [Reference Citation Analysis]
702 Lyu H, Wang C, Jiang H, Wang P, Cui J. Prevalence and determinants of frailty in older adult patients with chronic coronary syndrome: a cross-sectional study. BMC Geriatr 2021;21:519. [PMID: 34592947 DOI: 10.1186/s12877-021-02426-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
703 Hur DJ, Meadows JL, Baldassarre LA, Mojibian HR, Villines TC, Windish DM. Are cardiology fellows receiving enough basic level I cardiovascular computed tomography education during their general fellowship training? Insights from a needs assessment survey at an academic medical center. J Cardiovasc Comput Tomogr 2021:S1934-5925(21)00423-8. [PMID: 34600865 DOI: 10.1016/j.jcct.2021.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
704 Ha ACT, Bhatt DL, Rutka JT, Johnston SC, Mazer CD, Verma S. Intracranial Hemorrhage During Dual Antiplatelet Therapy: JACC Review Topic of the Week. J Am Coll Cardiol 2021;78:1372-84. [PMID: 34556323 DOI: 10.1016/j.jacc.2021.07.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
705 Thompson RC, Bateman TM, Blankstein R, Di Carli MF, Heydari B, Hung J, Kwong RY, Lindner JR, Nieman K, Dorbala S. A Policy Statement on Cardiovascular Test Substitution and Authorization: Principles of Patient-Centered Noninvasive Testing. J Am Coll Cardiol 2021;78:1385-9. [PMID: 34556324 DOI: 10.1016/j.jacc.2021.07.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
706 Picano E. Coronary flow velocity reserve with transthoracic echocardiography: a game changer. Acta Cardiol 2021;:1-4. [PMID: 34565288 DOI: 10.1080/00015385.2021.1980957] [Reference Citation Analysis]
707 Gurzău D, Sitar-Tăut A, Caloian B, Guşetu G, Comşa H, Frîngu F, Zdrenghea D, Pop D. The Role of IL-6 and ET-1 in the Diagnosis of Coronary MicroVascular Disease in Women. J Pers Med 2021;11:965. [PMID: 34683106 DOI: 10.3390/jpm11100965] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
708 Brinza C, Floria M, Covic A, Burlacu A. Measuring Heart Rate Variability in Patients Admitted with ST-Elevation Myocardial Infarction for the Prediction of Subsequent Cardiovascular Events: A Systematic Review. Medicina (Kaunas) 2021;57:1021. [PMID: 34684058 DOI: 10.3390/medicina57101021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
709 Ghafari C, Carlier S. Stent visualization methods to guide percutaneous coronary interventions and assess long-term patency. World J Cardiol 2021; 13(9): 416-437 [PMID: 34621487 DOI: 10.4330/wjc.v13.i9.416] [Reference Citation Analysis]
710 Bassetti B, Rurali E, Gambini E, Pompilio G. Son of a Lesser God: The Case of Cell Therapy for Refractory Angina. Front Cardiovasc Med 2021;8:709795. [PMID: 34552966 DOI: 10.3389/fcvm.2021.709795] [Reference Citation Analysis]
711 Avagimyan A, Mkrtchyan L, Abrahomovich O, Sheibani M, Guevorkyan A, Sarrafzadegan N, Kozhukhov S, Agati L, Astengiano R, Zaritska V, Jndoyan Z. AC-Mode of Chemotherapy as a Trigger of Cardiac Syndrome X: A Case Study. Curr Probl Cardiol 2021;:100994. [PMID: 34571104 DOI: 10.1016/j.cpcardiol.2021.100994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
712 Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC Scientific Document Group . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol 2021:zwab154. [PMID: 34558602 DOI: 10.1093/eurjpc/zwab154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
713 van Diemen PA, de Winter RW, Schumacher SP, Bom MJ, Driessen RS, Everaars H, Jukema RA, Somsen YB, Popelkova L, van de Ven PM, van Rossum AC, van de Hoef TP, de Haan S, Marques KM, Lemkes JS, Appelman Y, Nap A, Verouden NJ, Opolski MP, Danad I, Knaapen P. Residual Quantitative Flow Ratio to Estimate Post-Percutaneous Coronary Intervention Fractional Flow Reserve. J Interv Cardiol 2021;2021:4339451. [PMID: 34548847 DOI: 10.1155/2021/4339451] [Reference Citation Analysis]
714 McElroy S, Kunze KP, Milidonis X, Huang L, Nazir MS, Evans C, Bosio F, Mughal N, Masci PG, Neji R, Razavi R, Chiribiri A, Roujol S. Quantification of balanced SSFP myocardial perfusion imaging at 1.5 T: Impact of the reference image. Magn Reson Med 2021. [PMID: 34554603 DOI: 10.1002/mrm.29019] [Reference Citation Analysis]
715 Toh JZK, Pan XH, Tay PWL, Ng CH, Yong JN, Xiao J, Koh JH, Tan EY, Tan EXX, Dan YY, Loh PH, Foo R, Chew NWS, Sanyal AJ, Muthiah MD, Siddiqui MS. A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01035-1. [PMID: 34560278 DOI: 10.1016/j.cgh.2021.09.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
716 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-726. [PMID: 34447992 DOI: 10.1093/eurheartj/ehab368] [Cited by in Crossref: 209] [Cited by in F6Publishing: 1012] [Article Influence: 209.0] [Reference Citation Analysis]
717 Lee KK, Wereski R, Williams MC, Mills NL. Population Screening With Coronary Computed Tomography Angiography and the Prevention of Coronary Events. Circulation 2021;144:930-3. [PMID: 34543070 DOI: 10.1161/CIRCULATIONAHA.121.055784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
718 Nørgaard BL, Mortensen MB, Parner E, Leipsic J, Steffensen FH, Grove EL, Mathiassen ON, Sand NP, Pedersen K, Riedl KA, Engholm M, Bøtker HE, Jensen JM. Clinical outcomes following real-world computed tomography angiography-derived fractional flow reserve testing in chronic coronary syndrome patients with calcification. Eur Heart J Cardiovasc Imaging 2021;22:1182-9. [PMID: 32793947 DOI: 10.1093/ehjci/jeaa173] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
719 Buechel RR, Kaufmann PA. Diagnostic strategies in suspected chronic coronary syndrome - The case for a hybrid approach. J Cardiovasc Comput Tomogr 2021:S1934-5925(21)00421-4. [PMID: 34607783 DOI: 10.1016/j.jcct.2021.09.003] [Reference Citation Analysis]
720 Leong CL, Teoh TW, Bentley L, O'Rourke E, Allright A, Werkmeister M, Bickell A, Htun NM, Premaratne M. Resource implications following expansion of computed tomography coronary angiography: An Australian experience. J Med Imaging Radiat Oncol 2021. [PMID: 34541762 DOI: 10.1111/1754-9485.13331] [Reference Citation Analysis]
721 Zagatina A, Zhuravskaya N, Caprnda M, Shiwani HA, Gazdikova K, Rodrigo L, Kruzliak P, Shmatov D. Should we routinely assess coronary artery Doppler in daily echocardiography practice? Acta Cardiol 2021;:1-7. [PMID: 34538214 DOI: 10.1080/00015385.2021.1973771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
722 Guduguntla V, Redberg RF. Popular procedures without evidence of benefit: A case study of percutaneous coronary intervention for stable coronary artery disease. Eur J Intern Med 2021;94:15-21. [PMID: 34535375 DOI: 10.1016/j.ejim.2021.08.027] [Reference Citation Analysis]
723 Oyama K, Giugliano RP, Tang M, Bonaca MP, Saver JL, Murphy SA, Ruzza A, Keech AC, Sever PS, Sabatine MS, Bergmark BA. Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial. Eur Heart J 2021:ehab604. [PMID: 34537830 DOI: 10.1093/eurheartj/ehab604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
724 Severino P, D'Amato A, Prosperi S, Magnocavallo M, Mariani MV, Netti L, Birtolo LI, De Orchi P, Chimenti C, Maestrini V, Miraldi F, Lavalle C, Caputo V, Palmirotta R, Mancone M, Fedele F. Potential Role of eNOS Genetic Variants in Ischemic Heart Disease Susceptibility and Clinical Presentation. J Cardiovasc Dev Dis 2021;8:116. [PMID: 34564134 DOI: 10.3390/jcdd8090116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
725 Gabaldón-Pérez A, Bonanad C, García-Blas S, Gavara J, Ríos-Navarro C, Pérez-Solé N, de Dios E, Marcos-Garcés V, Merenciano-González H, Monmeneu JV, López-Lereu MP, Núñez J, Chorro FJ, Bodí V. Stress cardiac magnetic resonance for mortality prediction and decision-making: registry of 2496 elderly patients with chronic coronary syndrome. Rev Esp Cardiol (Engl Ed) 2021:S1885-5857(21)00250-4. [PMID: 34548244 DOI: 10.1016/j.rec.2021.08.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
726 Tereshina OV, Griaznova DA, Vachev AN. [Preoperative stress testing in patients prior to vascular surgery]. Angiol Sosud Khir 2021;27:159-64. [PMID: 34528601 DOI: 10.33529/ANGID2021320] [Reference Citation Analysis]
727 Taylor RS, Dalal HM, McDonagh STJ. The role of cardiac rehabilitation in improving cardiovascular outcomes. Nat Rev Cardiol 2021. [PMID: 34531576 DOI: 10.1038/s41569-021-00611-7] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
728 De Luca L, Formigli D, Meessen J, Uguccioni M, Cosentino N, Paolillo C, Di Lenarda A, Colivicchi F, Gabrielli D, Gulizia MM, Scherillo M; START Investigators . COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry. Eur Heart J Qual Care Clin Outcomes 2021;7:513-20. [PMID: 32559279 DOI: 10.1093/ehjqcco/qcaa054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
729 Sato R, Akita K, Ikoma T, Iguchi K, Murase T, Nakamura T, Akari S, Mogi S, Naruse Y, Ohtani H, Maekawa Y. Association between plasma xanthine oxidoreductase activity and in-hospital outcomes in patients with stable coronary artery disease after percutaneous coronary intervention. PLoS One 2021;16:e0257227. [PMID: 34520495 DOI: 10.1371/journal.pone.0257227] [Reference Citation Analysis]
730 Deng F, Li D, Lei L, Yang Q, Li Q, Wang H, Deng J, Zheng Q, Jiang W. Association between apolipoprotein B/A1 ratio and coronary plaque vulnerability in patients with atherosclerotic cardiovascular disease: an intravascular optical coherence tomography study. Cardiovasc Diabetol 2021;20:188. [PMID: 34526013 DOI: 10.1186/s12933-021-01381-9] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
731 Hudec M, Jiravsky O, Spacek R, Neuwirth R, Knybel L, Sknouril L, Cvek J, Miklik R. Chronic refractory angina pectoris treated by bilateral stereotactic radiosurgical stellate ganglion ablation: first-in-man case report. Eur Heart J Case Rep 2021;5:ytab184. [PMID: 34514297 DOI: 10.1093/ehjcr/ytab184] [Reference Citation Analysis]
732 Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabés JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJS, Deharo JC, Delgado V, Diller GP, Israel CW, Keren A, Knops RE, Kotecha D, Leclercq C, Merkely B, Starck C, Thylén I, Tolosana JM; ESC Scientific Document Group. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2021;42:3427-520. [PMID: 34455430 DOI: 10.1093/eurheartj/ehab364] [Cited by in Crossref: 31] [Cited by in F6Publishing: 157] [Article Influence: 31.0] [Reference Citation Analysis]
733 Wojeck BS, Inzucchi SE. Lessons Learned From Major Clinical Outcomes Trials Involving Sodium-Glucose Cotransporter 2 Inhibitors. Diabetes Spectr 2021;34:235-42. [PMID: 34511849 DOI: 10.2337/ds20-0070] [Reference Citation Analysis]
734 Demir OM, Rahman H, van de Hoef TP, Escaned J, Piek JJ, Plein S, Perera D. Invasive and non-invasive assessment of ischaemia in chronic coronary syndromes: translating pathophysiology to clinical practice. Eur Heart J 2021:ehab548. [PMID: 34516621 DOI: 10.1093/eurheartj/ehab548] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
735 Raptis DG, Sinani O, Rapti GG, Papanikolaou A, Dadouli K, Ntellas P, Kapsalaki EZ, Malli F, Gourgoulianis KI, Xiromerisiou G. Clinically Silent Small Vessel Disease of the Brain in Patients with Obstructive Sleep Apnea Hypopnea Syndrome. Diagnostics (Basel) 2021;11:1673. [PMID: 34574014 DOI: 10.3390/diagnostics11091673] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
736 Zhang W, Jin Y, Li J, Huang J, Chen H. Effects of genetic and nongenetic factors on hyperuricemia in Chinese patients with coronary artery disease. Pharmacogenomics 2021;22:821-31. [PMID: 34505535 DOI: 10.2217/pgs-2021-0053] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
737 Sabatino J, De Rosa S, Leo I, Strangio A, Spaccarotella C, Polimeni A, Sorrentino S, Di Salvo G, Indolfi C. Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work. Front Cardiovasc Med 2021;8:719603. [PMID: 34504879 DOI: 10.3389/fcvm.2021.719603] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
738 Grigorian-Shamagian L, Edel K, Esteve-Pastor MA, Aceña Á, Silva C, Delgado-Silva J, Ntaios G, Demerouti E, Brotons C. Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe. Front Cardiovasc Med 2021;8:663361. [PMID: 34504874 DOI: 10.3389/fcvm.2021.663361] [Reference Citation Analysis]
739 Shanbhag SM, Chen MY. Ultra-High-Resolution Coronary CT Angiography: The "Final Frontier"-Are We There Yet? Radiol Cardiothorac Imaging 2021;3:e210196. [PMID: 34498013 DOI: 10.1148/ryct.2021210196] [Reference Citation Analysis]
740 Asakura M, Hibi K, Shimizu W, Fujii K, Suwa S, Okumura Y, Mano T, Igeta M, Okamoto R, Ishihara M. Design and rationale of the EVOCATION trial: A prospective, randomized, exploratory study comparing the effect of evolocumab on coronary microvascular function after percutaneous coronary intervention in patients with stable coronary artery disease. J Cardiol 2021:S0914-5087(21)00228-8. [PMID: 34518072 DOI: 10.1016/j.jjcc.2021.08.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
741 Topal S, Kızıltunç E, Sezenöz B, Candemir M, Ünlü S, Küçükbardaslı M, Bal AN, Kılıç HK, Erbaş G, Abacı A. Gamma-glutamyl transferase to albumin ratio can predict severity of coronary artery disease detected by coronary computed tomography angiography. Anatol J Cardiol 2021;25:653-60. [PMID: 34498597 DOI: 10.5152/AnatolJCardiol.2021.36330] [Reference Citation Analysis]
742 Padilha JC, Santos VB, Lopes CT, Lopes JL. Prevalence of pharmacological adherence in patients with coronary artery disease and associated factors. Rev Lat Am Enfermagem 2021;29:e3464. [PMID: 34495187 DOI: 10.1590/1518-8345.4554.3464] [Reference Citation Analysis]
743 Sud M, Ko DT, Chong A, Koh M, Azizi PM, Austin PC, Stukel TA, Jackevicius CA. Renin-angiotensin-aldosterone system inhibitors and major cardiovascular events and acute kidney injury in patients with coronary artery disease. Pharmacotherapy 2021;41:988-97. [PMID: 34496067 DOI: 10.1002/phar.2624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
744 Järveläinen N, Halonen P, Nurro J, Hätinen OP, Korpela H, Mäkinen P, Gan LM, Fritsche-Danielson R, Ylä-Herttuala S. Citrate-Saline-Formulated mRNA Delivery into the Heart Muscle with an Electromechanical Mapping and Injection Catheter Does Not Lead to Therapeutic Effects in a Porcine Chronic Myocardial Ischemia Model. Hum Gene Ther 2021;32:1295-307. [PMID: 34494459 DOI: 10.1089/hum.2021.149] [Reference Citation Analysis]
745 Smarz K, Jaxa-Chamiec T, Zaborska B, Tysarowski M, Budaj A. Mechanisms of Exercise Capacity Improvement after Cardiac Rehabilitation Following Myocardial Infarction Assessed with Combined Stress Echocardiography and Cardiopulmonary Exercise Testing. J Clin Med 2021;10:4083. [PMID: 34575194 DOI: 10.3390/jcm10184083] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
746 Sharif D. Coronary computed tomography angiography (CTA): Implications and challenges. Trends Cardiovasc Med 2021:S1050-1738(21)00102-X. [PMID: 34508850 DOI: 10.1016/j.tcm.2021.09.003] [Reference Citation Analysis]
747 Garot J. Improving Risk Stratification of Patients With Known CAD. JACC Cardiovasc Imaging 2021:S1936-878X(21)00572-6. [PMID: 34538629 DOI: 10.1016/j.jcmg.2021.07.017] [Reference Citation Analysis]
748 Yang J, Tang YD, Zheng Y, Li C, Zhou Q, Gao J, Meng X, Zhang K, Wang W, Shao C. The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention. Front Endocrinol (Lausanne) 2021;12:710240. [PMID: 34489866 DOI: 10.3389/fendo.2021.710240] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
749 Zhan S, Liu F, Xia P, Tang M, Shu M, Zhang Z, Wu X; Cochrane Heart Group. Long-term antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease. Cochrane Database of Systematic Reviews 2021;2021. [DOI: 10.1002/14651858.cd014819] [Reference Citation Analysis]
750 Brown JM, Zhou W, Weber B, Divakaran S, Barrett L, Bibbo CF, Hainer J, Taqueti VR, Dorbala S, Blankstein R, Di Carli MF. Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease. Eur Heart J 2021:ehab610. [PMID: 34491335 DOI: 10.1093/eurheartj/ehab610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
751 Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC National Cardiac Societies., ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021;42:3227-337. [PMID: 34458905 DOI: 10.1093/eurheartj/ehab484] [Cited by in Crossref: 76] [Cited by in F6Publishing: 374] [Article Influence: 76.0] [Reference Citation Analysis]
752 Sonaglioni A, Rigamonti E, Nicolosi GL, Lombardo M. Prognostic Value of Modified Haller Index in Patients with Suspected Coronary Artery Disease Referred for Exercise Stress Echocardiography. J Cardiovasc Echogr 2021;31:85-95. [PMID: 34485034 DOI: 10.4103/jcecho.jcecho_141_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
753 Mansour MJ, Mansour L, Bénic C, Mansourati J, Gilard M. Do we need cardiovascular computed tomography angiography in the setting of acute ST-segment elevation myocardial infarction? Int J Cardiovasc Imaging 2021. [PMID: 34482506 DOI: 10.1007/s10554-021-02397-8] [Reference Citation Analysis]
754 Parker WAE, Storey RF. Ticagrelor monotherapy in CKD: better safety at what price? Eur Heart J 2021:ehab607. [PMID: 34480540 DOI: 10.1093/eurheartj/ehab607] [Reference Citation Analysis]
755 Finamore F, Nieddu G, Rocchiccioli S, Spirito R, Guarino A, Formato M, Lepedda AJ. Apolipoprotein Signature of HDL and LDL from Atherosclerotic Patients in Relation with Carotid Plaque Typology: A Preliminary Report. Biomedicines 2021;9:1156. [PMID: 34572342 DOI: 10.3390/biomedicines9091156] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
756 Panov AV. Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Racionalʹnaâ farmakoterapiâ v kardiologii 2021;17:628-37. [DOI: 10.20996/1819-6446-2021-07-02] [Reference Citation Analysis]
757 Karaganov KS, Slepova OA, Lishuta AS, Solomakhina NI, Belenkov YN. Medium-term Effects of Enhanced External Counterpulsation in the Structural and Functional Parameters of Blood Vessels in Patients with Coronary Artery Disease. Racionalʹnaâ farmakoterapiâ v kardiologii 2021;17:557-63. [DOI: 10.20996/1819-6446-2021-08-03] [Reference Citation Analysis]
758 Zykov MV, Barbarash OL. Inflammation and Comorbidity. Are There any Chances to Improve the Prognosis in Patients with Extremely High Cardiovascular Risk? Racionalʹnaâ farmakoterapiâ v kardiologii 2021;17:606-11. [DOI: 10.20996/1819-6446-2021-08-06] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
759 Sörensson P, Dellborg M, Börjesson M. The role of modern cardiovascular imaging in (suspected) coronary artery disease in competitive athletes. Trends Cardiovasc Med 2021:S1050-1738(21)00098-0. [PMID: 34481978 DOI: 10.1016/j.tcm.2021.08.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
760 Collet C, Sonck J, Leipsic J, Monizzi G, Buytaert D, Kitslaar P, Andreini D, De Bruyne B. Implementing Coronary Computed Tomography Angiography in the Catheterization Laboratory. JACC: Cardiovascular Imaging 2021;14:1846-55. [DOI: 10.1016/j.jcmg.2020.07.048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
761 Cuenin L, Honton B, Aminfar F, Meyer P, Mariottini C, Haessler M, Vareille P, Wijns W, Maillard L, Adjedj J. Head to head comparison of quantitative flow ratio using 4-French and 6-French catheters versus fractional flow reserve. Catheter Cardiovasc Interv 2021. [PMID: 34468076 DOI: 10.1002/ccd.29933] [Reference Citation Analysis]
762 Dreyer RP, Pavlo AJ, Hersey D, Horne A, Dunn R, Norris CM, Davidson L. "Is My Heart Healing?" A Meta-synthesis of Patients' Experiences After Acute Myocardial Infarction. J Cardiovasc Nurs 2021;36:517-30. [PMID: 32740224 DOI: 10.1097/JCN.0000000000000732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
763 Beyer C, Birkl K, Feuchtner G, Kofler LM, Friedrich G, Plank F. Clinical management and primary prevention of suspected coronary artery disease guided by computed tomography. J Cardiovasc Med (Hagerstown) 2021;22:680-5. [PMID: 34714258 DOI: 10.2459/JCM.0000000000001191] [Reference Citation Analysis]
764 Nanna MG, Wang TY, Chiswell K, Sun JL, Vemulapalli S, Hoffmann U, Patel MR, Udelson JE, Fordyce CB, Douglas PS. Estimating the real-world performance of the PROMISE minimal-risk tool. Am Heart J 2021;239:100-9. [PMID: 34077743 DOI: 10.1016/j.ahj.2021.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
765 Di Carli MF. Why Will PET Be the Future of Nuclear Cardiology? J Nucl Med 2021;62:1189-91. [PMID: 33608430 DOI: 10.2967/jnumed.120.254979] [Reference Citation Analysis]
766 Marcadenti A, Weber B, Bersch-Ferreira AC, Machado RHV, Torreglosa CR, de Sousa Lara EM, da Silva LR, Santos RHN, Miyada DHK, Sady ERR, Costa RP, Piegas L, de Abreu-Silva EO, de Quadros AS, Weschenfelder C, Dos Santos JL, Souza GC, Parahiba SM, Fayh APT, Bezerra DS, Carvalho APPF, Machado MMA, Vasconcelos SML, Araújo J, de Figueiredo Neto JA, Dias LPP, Nagano FEZ, de Almeida CCP, Moreira ASB, Gapanowicz DP, Purgatto E, Rogero MM, Sampaio GR, da Silva Torres EAF, Duarte GBS, Cavalcanti AB. Effects of a Brazilian cardioprotective diet and nuts on cardiometabolic parameters after myocardial infarction: study protocol for a randomized controlled clinical trial. Trials 2021;22:582. [PMID: 34470656 DOI: 10.1186/s13063-021-05494-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
767 Ono M, Serruys PW, Patel MR, Escaned J, Akasaka T, Lavieren MAV, Haase C, Grass M, Kogame N, Hara H, Kawashima H, Wykrzykowska JJ, Piek JJ, Garg S, O'Leary N, Inderbitzen B, Onuma Y. A prospective multicenter validation study for a novel angiography-derived physiological assessment software: Rationale and design of the radiographic imaging validation and evaluation for Angio-iFR (ReVEAL iFR) study. Am Heart J 2021;239:19-26. [PMID: 33992606 DOI: 10.1016/j.ahj.2021.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
768 Veitch AM, Radaelli F, Alikhan R, Dumonceau JM, Eaton D, Jerrome J, Lester W, Nylander D, Thoufeeq M, Vanbiervliet G, Wilkinson JR, Van Hooft JE. Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update. Gut 2021;70:1611-28. [PMID: 34362780 DOI: 10.1136/gutjnl-2021-325184] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
769 Casolo G, Gabrielli D, Colivicchi F, Murrone A, Grosseto D, Gulizia MM, Di Fusco S, Domenicucci S, Scotto di Uccio F, Di Tano G, Orso F, Grippo G, Abrignani M, Valente S, Corda M. ANMCO POSITION PAPER: Prognostic and therapeutic relevance of non-obstructive coronary atherosclerosis. Eur Heart J Suppl 2021;23:C164-75. [PMID: 34456643 DOI: 10.1093/eurheartj/suab072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
770 Jin S, Zhang C, Zhang Y, Jia G, Zhang M, Xu M. Differential value of intima thickness in ischaemic stroke due to large-artery atherosclerosis and small-vessel occlusion. J Cell Mol Med 2021;25:9427-33. [PMID: 34459107 DOI: 10.1111/jcmm.16884] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
771 Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabés JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJS, Deharo JC, Delgado V, Diller GP, Israel CW, Keren A, Knops RE, Kotecha D, Leclercq C, Merkely B, Starck C, Thylén I, Tolosana JM; ESC Scientific Document Group . 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace 2021:euab232. [PMID: 34455427 DOI: 10.1093/europace/euab232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
772 Dzeshka MS. Coronary microvascular dysfunction-Exploring the hidden part of the iceberg. Trends Cardiovasc Med 2021:S1050-1738(21)00097-9. [PMID: 34464645 DOI: 10.1016/j.tcm.2021.08.013] [Reference Citation Analysis]
773 Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W; ESC/EACTS Scientific Document Group., ESC Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2021:ehab395. [PMID: 34453165 DOI: 10.1093/eurheartj/ehab395] [Cited by in Crossref: 39] [Cited by in F6Publishing: 284] [Article Influence: 39.0] [Reference Citation Analysis]
774 Hanson CA, Patel TR, Villines TC. The New Role of Cardiac Imaging Following the ISCHEMIA Trial. Curr Treat Options Cardiovasc Med 2021;23:23. [PMID: 34447240 DOI: 10.1007/s11936-021-00911-8] [Reference Citation Analysis]
775 Hilvo M, Lääperi M, Jylhä A, Kleber ME, Hurme R, Scharnagl H, März W, Sinisalo J, Laaksonen R. Prior myocardial infarction, coronary artery disease extent, diabetes mellitus, and CERT2 score for risk stratification in stable coronary artery disease. Eur J Prev Cardiol 2021:zwab122. [PMID: 34453528 DOI: 10.1093/eurjpc/zwab122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
776 Ahmed AI, Han Y, Al Rifai M, Alnabelsi T, Nabi F, Chang SM, Chamsi-Pasha MA, Nasir K, Mahmarian JJ, Cainzos-Achirica M, Al-Mallah MH. Added prognostic value of plaque burden to computed tomography angiography and myocardial perfusion imaging. Atherosclerosis 2021;334:9-16. [PMID: 34450557 DOI: 10.1016/j.atherosclerosis.2021.08.032] [Reference Citation Analysis]
777 Winther S, Andersen IT, Gormsen LC, Steffensen FH, Nielsen LH, Grove EL, Diederichsen ACP, Urbonaviciene G, Lambrechtsen J, Zaremba T, Elpert FP, Husain M, Zelechowski MW, Bøtker HE, Bøttcher M; Western Denmark Cardiac CT Study Group. Prognostic value of myocardial perfusion imaging after first-line coronary computed tomography angiography: A multi-center cohort study. J Cardiovasc Comput Tomogr 2021:S1934-5925(21)00416-0. [PMID: 34475016 DOI: 10.1016/j.jcct.2021.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
778 Oikonomou EK, Antonopoulos AS, Schottlander D, Marwan M, Mathers C, Tomlins P, Siddique M, Klüner LV, Shirodaria C, Mavrogiannis MC, Thomas S, Fava A, Deanfield J, Channon KM, Neubauer S, Desai MY, Achenbach S, Antoniades C. Standardised measurement of coronary inflammation using cardiovascular CT: integration in clinical care as a prognostic medical device. Cardiovasc Res 2021:cvab286. [PMID: 34450625 DOI: 10.1093/cvr/cvab286] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
779 Görich HM, Buss SJ, Emami M, Seitz S, Lossnitzer D, Fortner P, Baumann S, Brado M, Gückel F, Sokiranski R, Sommer A, Görich J, Andre F. Short-Time Changes in Coronary Artery Plaques Assessed by Follow-Up Coronary CT Angiography-Characteristics and Impact on Patient Management. Front Cardiovasc Med 2021;8:691665. [PMID: 34434975 DOI: 10.3389/fcvm.2021.691665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
780 Li K, Zemmrich C, Bramlage P, Persson AB, Sacirovic M, Ritter O, Buschmann E, Buschmann I, Hillmeister P. Effect of ACEI and ARB treatment on nitric oxide-dependent endothelial function. Vasa 2021;50:413-22. [PMID: 34428929 DOI: 10.1024/0301-1526/a000971] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
781 Shui X, Wen Z, Chen Z, Xie X, Wu Y, Zheng B, Wu Z, Chen L. Elevated serum lipoprotein(a) is significantly associated with angiographic progression of coronary artery disease. Clin Cardiol 2021;44:1551-9. [PMID: 34432895 DOI: 10.1002/clc.23718] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
782 Vidal-Perez R, Bouzas-Mosquera A, Peteiro J, Vazquez-Rodriguez JM. ISCHEMIA trial: How to apply the results to clinical practice. World J Cardiol 2021;13:237-42. [PMID: 34589162 DOI: 10.4330/wjc.v13.i8.237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
783 Vilela EM, Fontes-Carvalho R. Inflammation and ischemic heart disease: The next therapeutic target? Rev Port Cardiol (Engl Ed) 2021:S0870-2551(21)00321-8. [PMID: 34456098 DOI: 10.1016/j.repc.2021.02.011] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
784 Han J, Attar N. Shortened dual antiplatelet therapy in contemporary percutaneous coronary intervention era. World J Cardiol 2021; 13(8): 243-253 [PMID: 34589163 DOI: 10.4330/wjc.v13.i8.243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
785 Higny J, Dupont M. Cardiac CT findings in patients with family history of premature CAD: an observational study. Acta Cardiol 2021;:1-6. [PMID: 34431450 DOI: 10.1080/00015385.2021.1967612] [Reference Citation Analysis]
786 Wereski R, Kimenai DM, Bularga A, Taggart C, Lowe DJ, Mills NL, Chapman AR. Risk factors for type 1 and type 2 myocardial infarction. Eur Heart J 2021:ehab581. [PMID: 34431993 DOI: 10.1093/eurheartj/ehab581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
787 Feldman DI, Latina J, Lovell J, Blumenthal RS, Arbab-Zadeh A. Coronary computed tomography angiography in patients with stable coronary artery disease. Trends Cardiovasc Med 2021:S1050-1738(21)00093-1. [PMID: 34454051 DOI: 10.1016/j.tcm.2021.08.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
788 Liang B, Gu N. Traditional Chinese Medicine for Coronary Artery Disease Treatment: Clinical Evidence From Randomized Controlled Trials. Front Cardiovasc Med 2021;8:702110. [PMID: 34422929 DOI: 10.3389/fcvm.2021.702110] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
789 Williams H, Mack CD, Li SCH, Fletcher JP, Medbury HJ. Nature versus Number: Monocytes in Cardiovascular Disease. Int J Mol Sci 2021;22:9119. [PMID: 34502027 DOI: 10.3390/ijms22179119] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
790 Blaha MJ, Daubert MA. Assessing the Impact of Coronary Plaque on the Relative and Absolute Risk Reduction With Statin Therapy. JACC Cardiovasc Imaging 2021;14:2411-3. [PMID: 34419396 DOI: 10.1016/j.jcmg.2021.07.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
791 Denormandie P, Simon T, Cayla G, Steg PG, Montalescot G, Durand-Zaleski I, Le Bras A, Le Breton H, Valy Y, Schiele F, Cuisset T, Vanzetto G, Levesque S, Goube P, Nallet O, Angoulvant D, Roubille F, Charles-Nelson A, Chatellier G, Danchin N, Puymirat E. Compared Outcomes of ST-Elevation Myocardial Infarction Patients with Multivessel Disease Treated with Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Non-Culprit Lesions Treated Conservatively and of Those with Low Fractional Flow Reserve Managed Invasively: Insights from the FLOWER MI trial. Circ Cardiovasc Interv 2021. [PMID: 34420366 DOI: 10.1161/CIRCINTERVENTIONS.121.011314] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
792 Oikonomou EK, Siddique M, Antoniades C. Artificial intelligence in medical imaging: A radiomic guide to precision phenotyping of cardiovascular disease. Cardiovasc Res 2020;116:2040-54. [PMID: 32090243 DOI: 10.1093/cvr/cvaa021] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 18.0] [Reference Citation Analysis]
793 Capodanno D, Bhatt DL, Gibson CM, James S, Kimura T, Mehran R, Rao SV, Steg PG, Urban P, Valgimigli M, Windecker S, Angiolillo DJ. Bleeding avoidance strategies in percutaneous coronary intervention. Nat Rev Cardiol 2021. [PMID: 34426673 DOI: 10.1038/s41569-021-00598-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
794 Bjerking LH, Hansen KW, Biering-Sørensen T, Brønnum-Schou J, Engblom H, Erlinge D, Haahr-Pedersen SA, Heitmann M, Hove JD, Jensen MT, Kruse M, Räder S, Strange S, Galatius S, Prescott EIB. Cost-effectiveness of adding a non-invasive acoustic rule-out test in the evaluation of patients with symptoms suggestive of coronary artery disease: rationale and design of the prospective, randomised, controlled, parallel-group multicenter FILTER-SCAD trial. BMJ Open 2021;11:e049380. [PMID: 34426466 DOI: 10.1136/bmjopen-2021-049380] [Reference Citation Analysis]
795 Aj M, We B, P C, R D, Ms K, J LS, L E P, G A, G R. State of the art approach to managing angina and ischemia: tailoring treatment to the evidence. Eur J Intern Med 2021;92:40-7. [PMID: 34419311 DOI: 10.1016/j.ejim.2021.08.003] [Reference Citation Analysis]
796 Gao S, Tian J, Li Y, Liu T, Li R, Yang L, Xing Z. Periodontitis and Number of Teeth in the Risk of Coronary Heart Disease: An Updated Meta-Analysis. Med Sci Monit 2021;27:e930112. [PMID: 34421117 DOI: 10.12659/MSM.930112] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
797 Pezel T, Hovasse T, Sanguineti F, Kinnel M, Garot P, Champagne S, Toupin S, Unterseeh T, Garot J. Long-Term Prognostic Value of Stress CMR in Patients With Heart Failure and Preserved Ejection Fraction. JACC Cardiovasc Imaging 2021;14:2319-33. [PMID: 34419409 DOI: 10.1016/j.jcmg.2021.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
798 Palmisano A, Darvizeh F, Cundari G, Rovere G, Ferrandino G, Nicoletti V, Cilia F, De Vizio S, Palumbo R, Esposito A, Francone M. Advanced cardiac imaging in athlete's heart: unravelling the grey zone between physiologic adaptation and pathology. Radiol Med 2021. [PMID: 34420142 DOI: 10.1007/s11547-021-01411-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
799 Fukase T, Dohi T, Chikata Y, Takahashi N, Endo H, Doi S, Nishiyama H, Kato Y, Okai I, Iwata H, Okazaki S, Isoda K, Miyauchi K, Daida H, Minamino T. Serum apolipoprotein E levels predict residual cardiovascular risk in patients with chronic coronary syndrome undergoing first percutaneous coronary intervention and on-statin treatment. Atherosclerosis 2021;333:9-15. [PMID: 34418683 DOI: 10.1016/j.atherosclerosis.2021.08.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
800 Marwan M. [Non-invasive cardiac imaging in the work-up of coronary artery disease]. Dtsch Med Wochenschr 2021;146:1035-40. [PMID: 34416770 DOI: 10.1055/a-1241-6706] [Reference Citation Analysis]
801 Kasper P, Steffen HM, Michels G. [Cirrhotic cardiomyopathy]. Dtsch Med Wochenschr 2021;146:1070-6. [PMID: 34416775 DOI: 10.1055/a-1321-9523] [Reference Citation Analysis]
802 Liedtke JP, Ahrens I. [Antiplatelet therapy and anticoagulation in patients with coronary heart disease]. Dtsch Med Wochenschr 2021;146:1041-50. [PMID: 34416771 DOI: 10.1055/a-1241-6676] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
803 Zhao Y, Yuan X, Zhong Y, Zhang Y, Zhang S, Li S, Zhao Y, Zheng W, Liu J, Xia Y, Yang Y, Liu Y, Chen F. Single-Nucleotide Polymorphisms in the 3' Untranslated Region of CORIN Associated With Cardiovascular Diseases in a Chinese Han Population: A Case-Control Study. Front Cardiovasc Med 2021;8:625072. [PMID: 34409072 DOI: 10.3389/fcvm.2021.625072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
804 Yıldırım A, Kucukosmanoglu M, Koyunsever NY, Cekici Y, Belibagli MC, Kılıc S. Combined effects of nutritional status on long-term mortality in patients with non-st segment elevation myocardial infarction undergoing percutaneous coronary intervention. Rev Assoc Med Bras (1992) 2021;67:235-42. [PMID: 34406247 DOI: 10.1590/1806-9282.67.02.20200610] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
805 Graby J, Khavandi A, Thompson D, Downie P, Antoniades C, Rodrigues JCL. CT coronary angiography-guided cardiovascular risk screening in asymptomatic patients: is it time? Clin Radiol 2021;76:801-11. [PMID: 34404515 DOI: 10.1016/j.crad.2021.07.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
806 Zimmermann FM, Pijls NHJ, Gould KL, Johnson NP. Stenting "Vulnerable" But Fractional Flow Reserve-Negative Lesions: Potential Statistical Limitations of Ongoing and Future Trials. JACC Cardiovasc Interv 2021;14:461-7. [PMID: 33602443 DOI: 10.1016/j.jcin.2020.05.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
807 Nast A, Altenburg A, Augustin M, Boehncke WH, Härle P, Klaus J, Koza J, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Schlaeger M, Schmid-Ott G, Sebastian M, von Kiedrowski R, Weberschock T, Dressler C. German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 2: Treatment monitoring and specific clinical or comorbid situations. J Dtsch Dermatol Ges 2021;19:1092-115. [PMID: 34288477 DOI: 10.1111/ddg.14507] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
808 Candreva A, Gallinoro E, van 't Veer M, Sonck J, Collet C, Di Gioia G, Kodeboina M, Mizukami T, Nagumo S, Keulards D, Fournier S, Pijls NHJ, De Bruyne B. Basics of Coronary Thermodilution. JACC Cardiovasc Interv 2021;14:595-605. [PMID: 33736767 DOI: 10.1016/j.jcin.2020.12.037] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
809 Di Serafino L, Magliulo F, Esposito G. Functionally Complete Coronary Revascularisation in Patients Presenting with ST-elevation MI and Multivessel Coronary Artery Disease. Interv Cardiol 2021;16:e24. [PMID: 34400971 DOI: 10.15420/icr.2020.28] [Reference Citation Analysis]
810 Shashu BA. The Management of Coronary Artery Disease in Ethiopia: Emphasis on Revascularization. Ethiop J Health Sci 2021;31:439-54. [PMID: 34158796 DOI: 10.4314/ejhs.v31i2.27] [Reference Citation Analysis]
811 Picano E, Ciampi Q, Cortigiani L, Arruda-Olson AM, Borguezan-Daros C, de Castro E Silva Pretto JL, Cocchia R, Bossone E, Merli E, Kane GC, Varga A, Agoston G, Scali MC, Morrone D, Simova I, Samardjieva M, Boshchenko A, Ryabova T, Vrublevsky A, Palinkas A, Palinkas ED, Sepp R, Torres MAR, Villarraga HR, Preradović TK, Citro R, Amor M, Mosto H, Salamè M, Leeson P, Mangia C, Gaibazzi N, Tuttolomondo D, Prota C, Peteiro J, Van De Heyning CM, D'Andrea A, Rigo F, Nikolic A, Ostojic M, Lowenstein J, Arbucci R, Haber DML, Merlo PM, Wierzbowska-Drabik K, Kasprzak JD, Haberka M, Camarozano AC, Ratanasit N, Mori F, D'Alfonso MG, Tassetti L, Milazzo A, Olivotto I, Marchi A, Rodriguez-Zanella H, Zagatina A, Padang R, Dekleva M, Djordievic-Dikic A, Boskovic N, Tesic M, Giga V, Beleslin B, Di Salvo G, Lorenzoni V, Cameli M, Mandoli GE, Bombardini T, Caso P, Celutkiene J, Barbieri A, Benfari G, Bartolacelli Y, Malagoli A, Bursi F, Mantovani F, Villari B, Russo A, De Nes M, Carpeggiani C, Monte I, Re F, Cotrim C, Bilardo G, Saad AK, Karuzas A, Matuliauskas D, Colonna P, Antonini-Canterin F, Pepi M, Pellikka PA, The Stress Echo Study Group Of The Italian Society Of Echocardiography And Cardiovascular Imaging Siecvi. Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging. J Clin Med 2021;10:3641. [PMID: 34441937 DOI: 10.3390/jcm10163641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
812 Nicolau JC, Feitosa Filho GS, Petriz JL, Furtado RHM, Précoma DB, Lemke W, Lopes RD, Timerman A, Marin Neto JA, Bezerra Neto L, Gomes BFO, Santos ECL, Piegas LS, Soeiro AM, Negri AJA, Franci A, Markman Filho B, Baccaro BM, Montenegro CEL, Rochitte CE, Barbosa CJDG, Virgens CMBD, Stefanini E, Manenti ERF, Lima FG, Monteiro Júnior FDC, Correa Filho H, Pena HPM, Pinto IMF, Falcão JLAA, Sena JP, Peixoto JM, Souza JA, Silva LSD, Maia LN, Ohe LN, Baracioli LM, Dallan LAO, Dallan LAP, Mattos LAPE, Bodanese LC, Ritt LEF, Canesin MF, Rivas MBDS, Franken M, Magalhães MJG, Oliveira Júnior MT, Filgueiras Filho NM, Dutra OP, Coelho OR, Leães PE, Rossi PRF, Soares PR, Lemos Neto PA, Farsky PS, Cavalcanti RRC, Alves RJ, Kalil RAK, Esporcatte R, Marino RL, Giraldez RRCV, Meneghelo RS, Lima RSL, Ramos RF, Falcão SNDRS, Dalçóquio TF, Lemke VMG, Chalela WA, Mathias Júnior W. Brazilian Society of Cardiology Guidelines on Unstable Angina and Acute Myocardial Infarction without ST-Segment Elevation - 2021. Arq Bras Cardiol 2021;117:181-264. [PMID: 34320090 DOI: 10.36660/abc.20210180] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
813 Kong Q, Ma X, Zhao X, Chen F, Hou C. Ticagrelor for the primary prevention of stroke in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials. J Thromb Thrombolysis 2020;50:942-56. [PMID: 32221808 DOI: 10.1007/s11239-020-02085-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
814 Antoniades C, West HW. Coronary CT angiography as an 'one-stop shop' to detect the high-risk plaque and the vulnerable patient. Eur Heart J 2021:ehab538. [PMID: 34389864 DOI: 10.1093/eurheartj/ehab538] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
815 Frey SM, Honegger U, Clerc OF, Caobelli F, Haaf P, Zellweger MJ. Left ventricular ejection fraction, myocardial blood flow and hemodynamic variables in adenosine and regadenoson vasodilator 82-Rubidium PET. J Nucl Cardiol 2021. [PMID: 34386864 DOI: 10.1007/s12350-021-02729-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
816 Mpanya D, Ayeni A, More S, Hadebe B, Sathekge M, Tsabedze N. The clinical utility of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in guiding myocardial revascularisation. Clin Transl Imaging. [DOI: 10.1007/s40336-021-00454-9] [Reference Citation Analysis]
817 Sciaccaluga C, Ghionzoli N, Mandoli GE, Sisti N, D'Ascenzi F, Focardi M, Bernazzali S, Vergaro G, Emdin M, Valente S, Cameli M. The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences. Heart Fail Rev 2021. [PMID: 34383194 DOI: 10.1007/s10741-021-10155-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
818 Noyes JD, Mordi IR, Doney AS, Jamal R, Lang CC. Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs. Diseases 2021;9:55. [PMID: 34449608 DOI: 10.3390/diseases9030055] [Reference Citation Analysis]
819 Sieren MM, Maintz D, Gutberlet M, Krombach GA, Bamberg F, Hunold P, Lehmkuhl L, Fischbach K, Reinartz S, Antoch G, Barkhausen J, Sandstede J, Völker M, Naehle C. Current Status of Cardiovascular Imaging in Germany: Structured Data from the National Certification Program, ESCR Registry, and Survey among Radiologists. Rofo 2021. [PMID: 34384112 DOI: 10.1055/a-1554-9236] [Reference Citation Analysis]
820 Ploumen EH, von Birgelen C. Novel DES aims at full thromboresistance: Another promising player on the field? Cardiovasc Revasc Med 2021:S1553-8389(21)00565-0. [PMID: 34391680 DOI: 10.1016/j.carrev.2021.07.029] [Reference Citation Analysis]
821 Lopez DM, Divakaran S, Gupta A, Bajaj NS, Osborne MT, Zhou W, Hainer J, Bibbo CF, Skali H, Dorbala S, Taqueti VR, Blankstein R, Di Carli MF. Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease. JACC Cardiovasc Imaging 2021:S1936-878X(21)00567-2. [PMID: 34419395 DOI: 10.1016/j.jcmg.2021.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
822 Antiochos P, Ge Y, Heydari B, Steel K, Bingham S, Abdullah SM, Mikolich JR, Arai AE, Bandettini WP, Patel AR, Farzaneh-Far A, Heitner JF, Shenoy C, Leung SW, Gonzalez JA, Shah DJ, Raman SV, Ferrari VA, Schulz-Menger J, Stuber M, Simonetti OP, Kwong RY. Prognostic Value of Stress Cardiac Magnetic Resonance in Patients With Known Coronary Artery Disease. JACC Cardiovasc Imaging 2021:S1936-878X(21)00559-3. [PMID: 34419400 DOI: 10.1016/j.jcmg.2021.06.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
823 Sueda S, Sakaue T, De Rosa S. Intracoronary acetylcholine testing among 746 consecutive Japanese patients with angina-like chest pain and unobstructed coronary artery disease. European Heart Journal Open 2022;2:oeab012. [DOI: 10.1093/ehjopen/oeab012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
824 Bulluck H, Paradies V, Barbato E, Baumbach A, Bøtker HE, Capodanno D, De Caterina R, Cavallini C, Davidson SM, Feldman DN, Ferdinandy P, Gili S, Gyöngyösi M, Kunadian V, Ooi SY, Madonna R, Marber M, Mehran R, Ndrepepa G, Perrino C, Schüpke S, Silvain J, Sluijter JPG, Tarantini G, Toth GG, Van Laake LW, von Birgelen C, Zeitouni M, Jaffe AS, Thygesen K, Hausenloy DJ. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2021;42:2630-42. [PMID: 34059914 DOI: 10.1093/eurheartj/ehab271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
825 Fiolet ATL, Opstal TSJ, Mosterd A, Eikelboom JW, Jolly SS, Keech AC, Kelly P, Tong DC, Layland J, Nidorf SM, Thompson PL, Budgeon C, Tijssen JGP, Cornel JH. Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials. Eur Heart J 2021;42:2765-75. [PMID: 33769515 DOI: 10.1093/eurheartj/ehab115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
826 Eikelboom JW, Bhatt DL, Fox KAA, Bosch J, Connolly SJ, Anand SS, Avezum A, Berkowitz SD, Branch KRH, Dagenais GR, Félix C, Guzik TJ, Hart RG, Maggioni AP, Muehlhofer E, Sharma M, Shestakovska O, Yusuf S. Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease. J Am Coll Cardiol 2021;78:14-23. [PMID: 34210409 DOI: 10.1016/j.jacc.2021.04.083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
827 Ding D, Huang J, Westra J, Cohen DJ, Chen Y, Andersen BK, Holm NR, Xu B, Tu S, Wijns W. Immediate post-procedural functional assessment of percutaneous coronary intervention: current evidence and future directions. Eur Heart J 2021;42:2695-707. [PMID: 33822922 DOI: 10.1093/eurheartj/ehab186] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
828 Oikonomou EK, Van Dijk D, Parise H, Suchard MA, de Lemos J, Antoniades C, Velazquez EJ, Miller EJ, Khera R. A phenomapping-derived tool to personalize the selection of anatomical vs. functional testing in evaluating chest pain (ASSIST). Eur Heart J 2021;42:2536-48. [PMID: 33881513 DOI: 10.1093/eurheartj/ehab223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
829 Crea F. The growing complexity of the number one killer: ischaemic heart disease. Eur Heart J 2021;42:2513-7. [PMID: 34244748 DOI: 10.1093/eurheartj/ehab414] [Reference Citation Analysis]
830 Nanna MG, Douglas PS. Precision medicine gets an ASSIST in diagnostic testing. Eur Heart J 2021;42:2549-51. [PMID: 34097021 DOI: 10.1093/eurheartj/ehab313] [Reference Citation Analysis]
831 Lesén E, Hewitt C, Giannitsis E, Hedberg J, Jernberg T, Lambrelli D, Maggioni AP, Simeone JC, Ariza-Solé A, Storey RF, Ten Berg J, Bonaca M; ALETHEIA study team. Extended dual antiplatelet therapy with ticagrelor 60 mg in patients with prior myocardial infarction: The design of ALETHEIA, a multi-country observational study. Clin Cardiol 2021. [PMID: 34365644 DOI: 10.1002/clc.23702] [Reference Citation Analysis]
832 Veitch AM, Radaelli F, Alikhan R, Dumonceau JM, Eaton D, Jerrome J, Lester W, Nylander D, Thoufeeq M, Vanbiervliet G, Wilkinson JR, van Hooft JE. Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update. Endoscopy 2021;53:947-69. [PMID: 34359080 DOI: 10.1055/a-1547-2282] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
833 Saunderson CED, Plein S, Manisty CH. Role of cardiovascular magnetic resonance imaging in cardio-oncology. Eur Heart J Cardiovasc Imaging 2021;22:383-96. [PMID: 33404058 DOI: 10.1093/ehjci/jeaa345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
834 Williams MC, Massera D, Moss AJ, Bing R, Bularga A, Adamson PD, Hunter A, Alam S, Shah ASV, Pawade T, Roditi G, van Beek EJR, Nicol ED, Newby DE, Dweck MR. Prevalence and clinical implications of valvular calcification on coronary computed tomography angiography. Eur Heart J Cardiovasc Imaging 2021;22:262-70. [PMID: 33306104 DOI: 10.1093/ehjci/jeaa263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
835 Smarz K, Jaxa-Chamiec T, Zaborska B, Tysarowski M, Budaj A. Combined use of stress echocardiography and cardiopulmonary exercise testing to assess exercise intolerance in patients treated for acute myocardial infarction. PLoS One 2021;16:e0255682. [PMID: 34351993 DOI: 10.1371/journal.pone.0255682] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
836 van Diemen PA, Wijmenga JT, Driessen RS, Bom MJ, Schumacher SP, Stuijfzand WJ, Everaars H, de Winter RW, Raijmakers PG, van de Ven PM, van Rossum AC, Danad I, Knaapen P. Defining the prognostic value of [15O]H2O positron emission tomography-derived myocardial ischaemic burden. Eur Heart J Cardiovasc Imaging 2021;22:638-46. [PMID: 33200201 DOI: 10.1093/ehjci/jeaa305] [Reference Citation Analysis]
837 Deseive S, Kupke M, Straub R, Stocker TJ, Broersen A, Kitslaar P, Martinoff S, Massberg S, Hadamitzky M, Hausleiter J. Quantified coronary total plaque volume from computed tomography angiography provides superior 10-year risk stratification. Eur Heart J Cardiovasc Imaging 2021;22:314-21. [PMID: 32793952 DOI: 10.1093/ehjci/jeaa228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
838 Witkowski M, Witkowski M, Friebel J, Buffa JA, Li XS, Wang Z, Sangwan N, Li L, DiDonato JA, Tizian C, Haghikia A, Kirchhofer D, Mach F, Räber L, Matter CM, Tang WHW, Landmesser U, Lüscher TF, Rauch U, Hazen SL. Vascular endothelial Tissue Factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis. Cardiovasc Res 2021:cvab263. [PMID: 34352109 DOI: 10.1093/cvr/cvab263] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
839 Khandelwal A, Bakir M, Bezaire M, Costello B, Gomez JMD, Hoover V, Nazir NT, Nichols K, Reisenberg A, Rao A, Sanghani R, Tracy M, Volgman AS. Managing Ischemic Heart Disease in Women: Role of a Women's Heart Center. Curr Atheroscler Rep 2021;23:56. [PMID: 34345945 DOI: 10.1007/s11883-021-00956-x] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
840 Viljoen CA, Millar RS, Manning K, Hoevelmann J, Burch VC. Clinically contextualised ECG interpretation: the impact of prior clinical exposure and case vignettes on ECG diagnostic accuracy. BMC Med Educ 2021;21:417. [PMID: 34344375 DOI: 10.1186/s12909-021-02854-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
841 De Stefano D, Parillo M, Garipoli A, Zobel BB. IMAGING FINDINGS IN A CASE OF MYO-PERICARDITIS ASSOCIATED WITH SARS CoV-2 DISEASE. J Cardiol Cases 2021. [PMID: 34367382 DOI: 10.1016/j.jccase.2021.07.006] [Reference Citation Analysis]
842 Neglia D, Aimo A, Lorenzoni V, Caselli C, Gimelli A. Triglyceride-glucose index predicts outcome in patients with chronic coronary syndrome independently of other risk factors and myocardial ischaemia. Eur Heart J Open 2021;1:oeab004. [PMID: 35919094 DOI: 10.1093/ehjopen/oeab004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
843 Hell MM, Steinmann B, Scherkamp T, Arnold MB, Achenbach S, Marwan M. Analysis of left ventricular function, left ventricular outflow tract and aortic valve area using computed tomography: Influence of reconstruction parameters on measurement accuracy. Br J Radiol 2021;94:20201306. [PMID: 34233477 DOI: 10.1259/bjr.20201306] [Reference Citation Analysis]
844 Serruys PW, Hara H, Garg S, Kawashima H, Nørgaard BL, Dweck MR, Bax JJ, Knuuti J, Nieman K, Leipsic JA, Mushtaq S, Andreini D, Onuma Y. Coronary Computed Tomographic Angiography for Complete Assessment of Coronary Artery Disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;78:713-36. [PMID: 34384554 DOI: 10.1016/j.jacc.2021.06.019] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
845 Capodanno D, Collet JP, Dangas G, Montalescot G, Ten Berg JM, Windecker S, Angiolillo DJ. Antithrombotic Therapy After Transcatheter Aortic Val